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Androgens are well documented as important regulators of male health, primarily in 
the maintenance and development of male sexual characteristics.  However, a decline 
in circulating androgens has also been associated with co-morbidities such as obesity, 
cardiac disease and metabolic syndrome. Previous research has focussed upon the 
body wide impact of adrenal androgens, however whilst androgen receptor (AR) is 
abundantly expressed in the adrenal cortex of both rodents and humans, surprisingly 
little is known about androgen action on the adrenal cortex itself. This gap in our 
understanding is at least in part due to the perceived lack of suitable animal models. 
Rodents have largely been overlooked as a model system as their adrenals are unable 
to produce androgens due to lack of 17α Hydroxylase and 17, 20 lyse activity and they 
therefore do not have a zona reticularis. However, historical studies using castrated 
mice showed that removal of androgens leads to the redevelopment of an additional 
cortex zone known as the transient X-zone. The foetal adrenal is thought to give rise 
the adult adrenal cortex in human and rodents. These foetal cells are maintained for a 
period postnatally and regress differently depending on species and sex. In the human 
this zone is known as the ‘foetal zone’, and the rodent homologue termed the ‘X-zone’. 
The mechanisms underpinning the regression of the X-zone and its purpose and 
maintenance postnatally still aren’t clearly understood.  
To provide a comprehensive overview of androgen signalling in the adrenal cortex, 
multiple mouse models were utilised. First, Cre/loxP technology was used to ablate 
AR specifically from the adrenal cortex. Further androgen manipulation was achieved 
through castration (removal of androgens) and human chorionic gonadotropin (hCG) 
treatment (increased androgens). The initial study investigates the impacts on the male 
mouse adrenal. Histology analysis revealed the presence of an X-zone in all 
experimental cohorts following loss of AR or circulating androgens, confirmed by 20-
α-hydroxysteroid dehydrogenase (20 alpha-HSD) expression. These data demonstrate 
that androgens signalling via AR is required for X-zone regression during puberty. 
However, interrogation of morphology of hCG treated cohorts revealed no phenotypic 
changes compared to controls, this demonstrates that hyper stimulation with androgens 
does not negatively impact the adrenal cortex or influence X-zone morphology. 
xiv 
 
Differences in X-zone morphology and 20 alpha-HSD localization prompted cortex 
measurements which revealed significant differences in X-zone depth and cell density 
depending on ablation of AR, circulating androgens or both. This suggests that 
androgens and androgen receptor are working together and also independently to 
regulate the adrenal cortex. This result was strengthened through analysis of steroid 
enzyme genes and cortex markers, which revealed that normal AKR1B7 expression 
was absent following loss of androgens but not androgen receptor. A final part of this 
study examined the impacts long term androgen receptor ablation and long term 
castration in ageing animals.  
A final part of this study examined the impacts long term androgen receptor ablation 
and long term castration in ageing animals. These results demonstrate that following 
prolonged loss of androgens that there is no major disruption to the adrenal cortex. 
Morphology analysis and X-zone measurements revealed that X-zone regression was 
occurring in mice with long term castration, characterized by a reduction in size and 
pockets of vacuolization throughout the X-zone. This phenotype is also observed in 
ageing females with X-zone regression via vacuolization. These data suggest that 
following prolonged loss of androgens, the male adrenal is feminized and behaves as 
such. In contrast, AR ablation only, results in an enlarged adrenal with large spindle 
cell lesions and X-zone expansion confirmed by X-zone measurements. Initial 
experiments have demonstrated that androgens can work independently of AR to 
regulate the adrenal cortex. Together these data suggests that AR is required to control 
the appropriate action of circulating androgens in the adrenal cortex, with loss of AR 
resulting in off target signalling from circulating androgens in the adrenal leading to 
spindle cell hyperplasia, X-zone expansion and X-zone mislocation.   
A second set of studies were carried out to determine the role of androgen signalling 
in the female adrenal, specifically, if loss of AR leads to the absence of normal X-zone 
regression during pregnancy. To answer this question the same selective AR ablation 
model was used. Analysis of litters comparing observed and expected genetic 
distribution revealed significantly fewer females being born carrying complete 
ablation of adrenal AR. Morphology analysis of these mice revealed severe cortex 
disruption and spindle cell hyperplasia similar to that observed in mutant males. 
Investigation of adrenals following pregnancy revealed that X-zone regression still 
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occurred despite loss of AR. This result shows that X-zone regression in the female is 
under different regulation compared to male adrenal and occurs via an androgen-
independent signalling mechanism. However, loss of AR still leads to anatomical 
dysregulation of the adrenal cortex. 
AR ablation revealed changes in glucocorticoid receptor (GR) expression in the 
adrenal cortex. To dissect this relationship further a final study was conducted, 
attempting to ablate GR from the adrenal cortex also using the Cyp11a1 Cre. Initial 
observations of these mice revealed excessive hair loss through barbering, curved 
spines and stressed behaviour when monitored in the cage under normal conditions. 
Immunohistochemistry was used to confirm GR ablation in the adrenal cortex, 
however, to our surprise, GR expressing cells were not steroidogenic and thus were 
not targeted by the Cre recombinase. Despite no GR ablation in the adrenal, 
morphology analysis revealed severe disruption to the adrenal cortex. The Cyp11a1 
Cre not only targets the adrenal but is expressed in the hindbrain. To determine if GR 
ablation in the hindbrain explains the phenotype, we next used PCR analysis 
interrogating hindbrain genomic DNA to determine if there was recombination of GR. 
Results confirmed GR recombination in the hindbrain. Due to the observation of 
stressed behaviour and adrenal cortex disruption, we wanted to determine if this was a 
result of hyperactivity of the adrenal cortex. Serum corticosterone was analysed and 
was elevated in these animals. These data revealed that GR ablation in the hindbrain 
results in adrenal cortex disruption and an elevated stress response, potentially 
highlighting a new model to investigate stress disorders and their impact on the 
hypothalamic-pituitary-adrenal axis. 
Together this data defines new roles for AR signalling in the adrenal cortex and the 








Lay Summary  
 
The adrenal glands are small glands located on top of each kidney. They produce 
hormones such as adrenaline and stress hormones such as cortisol, they also produce 
sex steroids known as androgens. Androgens are well documented as an important 
regulator of male health, primarily in the maintenance and development of male sexual 
characteristics.  A decline in circulating testosterone has also been associated with a 
number of conditions such as obesity, cardiovascular disease and metabolic syndrome.  
Previous research has focussed upon the body-wide impact of adrenal testosterone 
although surprisingly little is known about testosterone regulation on the adrenal itself. 
This gap in our understanding is at least in part due to the perceived lack of suitable 
animal models. Rodents have largely been overlooked as a model system as their 
adrenals are unable to produce androgens but historical studies using castrated mice 
showed that removal of androgens leads to the redevelopment of an additional cell 
population in the adrenal known as the X-zone, suggesting the adrenal does respond 
to androgens. The fetal adrenal is thought to provide the cells needed to develop the 
adult adrenal in both human and rodents. These fetal cells are maintained for a short 
period after birth and are removed differently depending on species and sex. In the 
human these cells are known as the ‘fetal zone’, and the rodent complement termed 
the ‘X-zone’. The mechanisms controlling the removal of the X-zone and its purpose 
and maintenance after birth still aren’t clearly understood.  
This thesis is comprised of three main studies. The first study uses a mouse model that 
is able to remove testosterone’s receptor known as androgen receptor or ‘AR’ from the 
adrenal. Additional castrated models were used to remove androgens circulating round 
the body. This permitted the examination of the impacts of losing AR, androgens or 
both within the male adrenal. Results revealed the presence of X-zone cells in the 
adrenal that should have regressed during puberty in males. This tells us that androgens 
need AR to be able to remove these cells. X-zone cells were observed in all mouse 
models following removal of AR or testosterone.  Investigation of the structure of these 
X-zone cells revealed differences in size and density depending on whether AR or 
testosterone had been removed, suggesting testosterone can also work independently 
of AR. A final experiment set out to examine the impacts of long term loss of 
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testosterone signalling. This revealed that removal of androgens results in no further 
damage to the adrenal but prolonged loss of AR resulted in severe adrenal disruption 
and large lesions known as spindle cell hyperplasia developed. This highlighted that 
AR is needed to control the effects of androgens on the adrenal.  
A second study to investigate the role of androgen signalling in the female adrenal was 
conducted using the same mouse model. Results describe the same spindle cell lesions 
observed in the aged male adrenal, however the X-zone cells that usually regress 
during pregnancy in females still regressed as normal. This showed that X-zone cells 
in the female are not controlled by AR or testosterone. Despite this, loss of AR still 
leads to damage to the adrenal. 
The final study aimed to investigate the relationship between the adrenal and a receptor 
responsible for stress response known as glucocorticoid receptor or ‘GR’. Using a 
mouse model we attempted to remove GR from the adrenal, however, this model 
resulted in removal of GR from the hindbrain instead. This disruption to GR resulted 
in mice that display stress and anxiety behaviors. These stress behaviors were shown 
through excess hair removal known as barbering and persistent digging in one place 
with no exploration around the cage. Investigation of the adrenal revealed large 
amounts of damage cell death. This study highlights the impacts of hindbrain GR and 
its role in regulating the adrenal. In addition to this, it potentially provides a new model 
to be able to investigate the development of stress disorders.   
In summary, the results of these studies have increased our understanding of the 
complex relationship between AR and androgen signalling in the adrenal. 
Additionally, we have defined new roles for hindbrain GR regulation of the adrenal, 
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Chapter 1: Literature Review 
 
1.1 The Adrenal Gland  
The adrenal glands are a pair of small endocrine organs located on top of each kidney. 
Each gland comprises of essentially two different organs, the outer adrenal cortex and 
the inner adrenal medulla. The adrenal cortex is further divided into concentric zones. 
In humans these zones are known as the zona glomerulosa (ZG), zona fasciculata (ZF), 
and the zona reticularis (ZR) (1). The adrenal cortex is a dynamic tissue which possess 
the capability to renew its zones by replacing senescent cells with newly differentiated 
ones (2). This ability to renew its cortex zones permits organ remodelling to 
appropriately deal with the physiological demands for steroids. Each zone of the 
adrenal is responsible for the production of specific steroids (3). The adrenal medulla 
is located in the centre of the adrenal cortex, which also plays a role in immediate 
stress response (4). 
 
1.1.2 Adrenal Cortex Histology 
The zona glomerulosa is the outermost cortex zone found directly under the adrenal 
capsule. The cells that make up the ZG are ovoid in shape and are arranged in clusters 
or arches, these cells are separated by trabeculae that are continuous with the capsule 
(5). These cells are important for the production and secretion of the hormone 
aldosterone responsible for sodium balance and water reabsorption in the kidney (6).  
The zona fasciculata is the middle and largest zone of the adrenal cortex, comprised of 
cells organised into bundles or fascicles (7). The ZF is described as being columnar in 
appearance and is the primary producer of glucocorticoid hormones responsible for 
stress response (8). The final and innermost zone of the cortex in known as the zona 
reticularis. The cells in this zone are arranged in cord like structures, these cords 
project in different directions giving the appearance of a ‘net’ structure.  These cells 
are responsible for the production of androgens (9). The zones that are present can vary 
between species. To frame the parameters for this thesis, adrenal formation in the




 mouse is also described, which only present with a zona glomerulosa and zona 
fasciculata (10). 
 
Figure 1-1. Location and histology of the adrenal glands.  Schematic 
detailing the location of the adrenal and its cortex zones. (A) Diagram describing the 
shape and location of the different zones in the adrenal cortex. (B) H&E image 
comparing diagram and human adrenal zones. Figure adapted from (11).   
1.1.3 Cortex maintenance and renewal 
The adrenal plays an important role in many physiological processes; to be effective 
in doing so it needs to tightly regulate and renew its zones to deal with the changing 
demand for steroid production. Cortex zones have the ability to reversibly expand, 
contract and alter biochemical processes to accommodate needs and maintain 
homeostasis. The adrenal cortex is described as a dynamic tissue, this is achieved 
through the replacement of senescent cells with newly differentiated cells and 
appropriate clearance of injured or old cells. The mechanisms in which the adrenal 
regulates its zones was first summarized by Jones in 1957 (12), it was proposed that 
cell renewal occurs through inward migration of new cells from the periphery of the 
cortex to the cortex/medulla boundary and that other cells should then undergo 




clearance to permit this dynamic system.  This theory was later confirmed through 
multiple experiments that demonstrated the presence of a progenitor cell population in 
the sub-capsular region of the adrenal, in which these cells are able to give rise to the 
differentiated cells that populate the cortex. This was initially demonstrated through 
following of labelled cells after the pulse administration of titrated thymidine (13, 14). 
This was more recently demonstrated via bromodeoxyuridine and [3H]thymidine 
labelling to provide lineage tracing of cells as they migrate through the cortex (15). 
One of the most noted studies that clearly demonstrated the regenerative capability of 
the adrenal cortex was performed in the rat adrenal and involved the enucleation of the 
adrenal cortex and medulla leaving only capsule. Following this removal, the adrenal 
cortex was repopulated in six weeks (16). This finding was also backed by additional 
studies carried out in bovine adrenocortical cells that were transplanted under kidney 
capsule in immunocompromised mice, and these cells gave rise to adrenocortical tissue 
capable of producing steroids (17, 18). Additionally, it has also now been 
demonstrated that cells do in fact move centripetally until they reach the cortex 
boundary and become apoptotic (15, 19).   
 
Figure 1-2. The cortex is populated from the capsule to the cortex 
medulla boundary. Diagram depicting the mode of action of cell migration and 
population of the adrenal cortex. Stem cells located in the in the sub capsule region 
give rise to progenitor cells located in the glomerulosa. These stem and progenitor 
cells differentiate to populate to the ZF, ZG and ZR.  




1.1.3.1 Adrenocortical stem cells 
Additional studies have investigated the processes of cortex renewal and have revealed 
that the regulation of zonation is much more complex than the initial paradigm 
described. Much research has gone into identifying locations throughout the cortex 
that may contain stem and progenitor cells. They identified the capsule, subjacent 
cortex and the juxtamedullary region as also containing stem and progenitor cells (20). 
These studies also highlighted that they were important through different time points 
and required for responses to extreme physiological stress. Although not the normal 
mechanisms, under certain conditions the adrenal has been shown to be able to 
populate the cortex via centrifugal migration (20). This was demonstrated following 
gonadectomy, which resulted in the development of a cortex zone termed the X-zone 
(21, 22) adjacent to the medulla, (discussed in depth in section 1.5.3), which 
subsequently populated the adrenal cortex from a pool of foetal stem cells. These foetal 
cells also termed X-zone cells, differ from the stem/progenitor populations located in 
the capsule and sub capsule region. They have been shown to have differences in the 
structure of their mitochondrial cristae and stain for their own independent marker, 
20alpha-hydroxysteroid dehydrogenase (23, 24). The mechanisms controlling this cell 
population and their function are still not clearly understood. A list of the known 
progenitor cells can be seen in table 1-1.  
Stem/Progenitor 
Population 
Location  Reference  
WT1+ Capsule (25) 
GLI1+ Capsule (26-28) 
TCF21+ Capsule (26) 
SHH+ Subcapsular Region (26-28) 
Foetal adrenal Juxtamedullary region (21, 29, 30) 
 
Table 1-1. Table describing Stem/progenitor populations in the adrenal cortex.  
 
 




1.1.3.2 Triggers for cortex remodelling 
Various experiments have detailed the changes in size of cortex zones under certain 
biological processes or treatments. The zona glomerulosa has been shown to expand 
upon a decrease in sodium or an increase potassium induced through diet (5, 31), and 
contract the zone and decrease steroid production with the inverse. 
Adrenocorticotropic hormone (ACTH) has been shown to cause expansion of the zona 
fasciculata with a subsequent increase in steroid production, consequently treatment 
with a corticosteroid medication dexamethasone has the opposite effect (32, 33).  
Psychological pressures have also been seen to induce remodelling, an interesting 
study examining social status in the marmoset revealed functional changes in the zona 
reticularis. The rodent X-zone remodelling has been shown to be impacted by a 
number of processes, through development, puberty and pregnancy and showing 
sexually dimorphic regulation of this zone (34-40). The cortex remodelling that occurs 
due to the aforementioned processes are not to be confused with adrenal hyperplasia. 
The expansion and reduction of adrenal zones is essential to cope with demands for 
certain steroids. However, adrenal hyperplasia, which results from overstimulation or 
inherited genetic conditions, disrupts steroid biosynthesis in the adrenal which results 










1.2 Signalling pathways involved in cortex maintenance and remodelling 
An abundance of research has been conducted to identify pathways involved in cortex 
maintenance and function. Key pathways with particular importance to adrenal cortex 
remodelling are described in detail in subsequent sections (1.3.1-1.4.4). However, are 












Table 1-2. Pathways and transcription factors involved in cortex remodelling. 
 
1.2.1 Hedgehog pathway 
The hedgehog pathway is essential in regulating aspects of tissue maintenance, 
renewal and regeneration. The hedgehog family is comprised of a family of 
morphogens named sonic hedgehog (Shh), Indian hedgehog (Ihh) and desert hedgehog 
(Dhh) (66). The only member of this family present in the mouse adrenal gland is SHH 
and can be detected early in foetal development, and becomes restricted to a specific 
cell population in the outer ZG in adulthood. SHH exerts its effects via the Patched-1 
(PTCH1) receptor, a transmembrane receptor found on target cells. PTCH1 inhibits 
Pathways  Reference  
Hedgehog Pathway (28, 43, 44) 
Fibroblast growth factor pathway (45) 
WNT/ β-Catenin pathway (30, 46-48) 
cAMP Signalling (29, 49) 
IGF Signalling (50, 51) 
Transforming growth factor β signalling  (52-54) 
LH Signalling (55, 56) 
Transcription factors  Reference  
SF1 (57, 58) 
DAX1 (59-61) 
WT1 (25, 62) 
GATA-6 (63-65) 




the G-protein coupled receptor Smoothened (SMO) in the absence of SHH. SMO 
signalling promotes the nuclear localisation of Gli1 transcription factors. Binding of 
SHH to PTCH1 relieves the inhibition exerted on SMO and thus prevents proteolytic 
processing of GLI factors and allows them to act on their target genes (67). 
Transcriptional GLI1 is not expressed in the absence of SHH, however, it is 
upregulated by activation of this pathway. Therefore, Gli1 expression can be a useful 
marker for active SHH signalling. Subcapsular adrenal cells that express Sf1 secrete 
SHH, but do not secrete the terminal enzymes that permit the synthesis of corticoids 
(27). Cells that do not express Sf1 can respond to SHH by expressing Gli1. 
Experiments examining cortical growth in embryo, foetus and new-born mouse 
highlighted that GL1+ progenitor cells contribute to cortex formation. GLI+ cells have 
been shown to migrate centripetally into the cortex, where they subsequently lose 
responsiveness to SHH and become steroidogenic, shown through the expression of 
Cyp11b2 as a marker for ZG cells and Cyp11b1 for ZF. Mouse models that 
conditionally ablate Shh from the adrenal demonstrated a shrunken adrenal cortex and 
capsule thinning. These results demonstrate that Shh signalling is required for normal 
cortex formation but not essential in zonation (27, 28).   
 
1.2.2 WNT/β-Catenin pathway 
The mammalian wingless-type MMTV integration site (Wnt) pathway has been shown 
to be integral in organogenesis, homeostasis, and stem cell biology. β-Catenin is able 
to control the interaction between cadherin and adheren complexes and also participate 
in canonical WNT signalling. For the purposes of WNT signalling, β-Catenin acts as 
a co-activator for the TCF/LEF family of transcription factors. Once transcriptionally 
active, detection of β-Catenin can be observed in the adrenal gonadal primordium 
(AGP), the adrenal primordium and adrenal subcapsular cells. WNT/β-Catenin 
signalling is thought to be important in the maintenance of undifferentiated 
adrenocortical/progenitor cells (68). Experiments which have examined SF1+ positive 
cells with targeted mutagenesis of β-Catenin result in eventual adrenal hypoplasia (46). 
This is thought to be due to the eventual depletion of the stem progenitor pool, 




ultimately resulting in adrenal failure. The complexity of the WNT/β-Catenin pathway 
allows for fine tuning in response to morphogen gradients, however, pathways with 
the ability to regulate cell self-renewal often result in the driving mechanism behind 
oncogenesis. The WNT/ β-Catenin pathway has been described as one of the most 
frequently mutated pathways in adrenocortical carcinomas (69).  
 
1.2.3 cAMP pathway 
Hormones involved in regulating proliferation of the adrenal cortex often work via 
binding to G-protein coupled receptors on the cell surface. Activating these receptors 
initiates the stimulation of adenylate cyclase, resulting in cyclic adenosine 
monophosphate (cAMP) production. Once activated, cAMP binds to its regulatory 
subunits of protein kinase A (PKA) subsequently permitting the phosphorylation of 
downstream targets, including those that can enhance expression of steroidogenic 
genes (49). Experiments examining cell specific ablation of the protein kinase-A 
regulatory subunit gene (Prkar1a) under an Akr1b7 promoter results in excessive 
cAMP production in the adrenal cortex. This study noted that these mice when aged 
presented with symptoms consistent with the Carney complex and pituitary 
independent Cushing’s syndrome. The study suggested that the development of these 
diseases was predicated on the resistance to apoptosis and increased proliferation. This 
study also demonstrated the development of an X-zone that was able to produce 
cortisol. These results highlighted the importance of PKA activity in the maintenance 
of the adrenal cortex (29). 
1.2.4 LH signalling  
Luteinising hormone (LH) is secreted from the pituitary upon stimulation of 
gonadotropin releasing hormone (GnRH). LH subsequently binds to the G-protein 
coupled surface receptor, LHCGR and activates the cAMP/PKA, MAPK and PI3K 
pathways (56). As well as being  found on the cell surface of the Leydig cell of the 
testis and theca and granulosa cells of the ovary, cells in the adrenal cortex also express 
LHCGR and are able to respond to surges or losses of LH signalling (70, 71). This was 
demonstrated by the development of adrenocortical neoplasms following 




gonadectomy (GDX) and has been demonstrated in a number a species including goat, 
ferret and certain strains of laboratory mouse (55, 56, 70). Experiments examining 
these neoplasms in the mouse and ferret have demonstrated that LH signalling plays 
an important role in adrenal remodelling. Additionally, the formation of ectopic 
gonadal like tissue in the adrenal cortex following GDX is viewed as an extreme 
example of adrenocortical remodelling (25).   
 
1.2.5 IGF signalling  
Insulin-like growth factor (IGF) has also been implicated in adrenocortical zonation 
and renewal and consists of two ligands, IGF1 and IGF2. These ligands are able to 
bind to a receptor tyrosine kinase known as IGF1R to regulate mechanisms such as 
mitosis and cell survival through the MAPK and PI3K pathways (50). IGF1 and IGF2 
have been shown to be comparably expressed in the adult adrenal.  However, IGFR1 
has been shown to be localised in the subcapsular region of the adrenal cortex, and its 
activity is modulated by IGF binding proteins (50). Mouse models investigating the 
impacts of Igfr1 ablation in the adrenal noted agenesis and male to female sex reversal. 
Interrogation of the adrenogonadal primordium of these knockout mice revealed 
significantly fewer SF1+ cells compared to wildtype mice and was determined as 
essential for adrenocortical cell specification (72). Furthermore, IGF signalling has 
also been demonstrated in enhancing steroidogenesis in the adrenal cortex (73).  
 
 
1.2.6 TGFβ signalling  
Experiments examining the role of Transforming growth factor β (TGF-β) have 
highlighted that this signalling pathway is important in the differentiation of 
stem/progenitor cells in the adrenal cortex (74). Due to the wide array of ligands that 
make up the TGF-β superfamily, this permits regulation and interaction with a 
multitude of pathways. Two important members in relation to adrenocortical renewal 
are activin and inhibin. Numerous experiments dissecting the roles of activing in the 
adrenal cortex have noted that activin can inhibit adrenocortical cell growth (54), 




induce and enhance the clearance of the X-zone from the adrenal cortex and impact 
steroidogenesis (52). Studies investigating adrenal cortex inhibin deficient mice 
revealed that upon gonadectomy, tissue characteristic of ovarian cells accumulates in 
the adrenal cortex. The loss of Inha also demonstrates constitutive TGF-β2 activation 
in adrenal progenitor cells, which result in expansion of cells that express Gata4 and 
other gonadal markers. These studies highlight the importance of activin and inhibin 
in the maintenance of an adrenal cell lineage (52, 53).  
 
1.2.7 FGF signalling  
The fibroblast growth factor (FGF) signalling pathway has been shown to be important 
in adrenal cortex maintenance and homeostasis. Both the adrenal capsule and the 
adrenal cortex express FGF-2 and FGF-9 which signal to FGFR-1 and FGFR-2 (45). 
Studies that ablate Fgfr2 in steroidogenic cells demonstrate adrenal hypoplasia that 
occurs early in embryonic development. The adrenal hypoplasia evident in Fgfr2 
ablated mice results from reduced cortical proliferation during embryogenesis. This 
study highlighted the importance of FGF-2 during adrenal development (75).  
 
1.3 Transcription factors involved in cortex maintenance and remodelling 
1.3.1 SF1  
Steroidogenic factor 1 (Sf1 also known as Nr5a1) is a well described and essential 
regulator of the adrenal cortex. It is integral for regulating genes required for 
development and steroidogenic cell function (76).  SF1 is described as an orphan 
receptor, however recent studies have shown that certain sphingolipids and 
phospholipids are able to bind to and regulate SF1. The importance of Sf1 signalling 
in the adrenal was demonstrated via Sf1 null mice, these animals displayed 
degeneration of the adrenogonadal primordium (AGP) due to apoptosis and the failure 
to develop an adrenal or gonad (77). Additional studies that examined disruption to 
upstream regulators of Sf1 (Wt1, Pbx and Cited) discovered impaired adrenal 
development (25, 62, 78). Further studies that examined Sf1± mice highlighted reduced 
adrenal size, impaired glucocorticoid synthesis under stress and failure to respond to 




unilateral adrenalectomy, which usually sees a compensatory increase in organ size 
(79, 80). Conversely, studies examining the impact of Sf1 overexpression in human 
adrenocortical cells via activated doxycycline treatment revealed that this drives cells 
through proliferation and negate apoptosis (81). An increase in Sf1 expression has also 
been observed in the development of childhood adrenocortical tumours (82).  
1.3.2 Dax1 
Dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X 
(Dax1 also known as Nr0b1), is an X-linked gene which encodes a repressor of 
steroidogenic gene expression. This was demonstrated through examination of Y-1 
mouse adrenocortical cells transfected with DAX-1. Steroidogenesis was supressed in 
these cells following transfection (60). In the adrenal cortex the activity of SF1 is 
modulated by Dax1 (59). Upon stimulation of the adrenal cortex by ACTH SF1+ 
progenitor cells downregulate Dax1 to be able to differentiate. Mutations in Dax1 in 
humans and mice have shown to result in excessive differentiation and eventual 
depletion of the stem progenitor compartment (61).  
1.3.3 WT1 
Experiments analysing the fate of adrenocortical stem cell populations identified 
Wilms tumour 1 positive cells (WT1) as a long-lived progenitor population residing in 
the adrenal capsule. These cells were identified by expression of Wt1 and Gata4, which 
are also markers of the AGP (83). The WT1+ cells become activated following 
gonadectomy, this results in the differentiation of cortical cells into a gonadal cell 
lineage (25, 83). These studies demonstrate the maintenance of a cell population in the 
subcapsular region with AGP properties. Repression of Wt1 in the mouse embryo is 
required for the appropriate expression of Sf1 and differentiation of stem cells into an 
adrenocortical cell lineage (84).  
1.3.4 GATA6 
GATA binding protein-6 (Gata6) is another transcription factor expressed in the 
adrenal cortex of the foetal mouse (85) and becomes localised to the capsule and 
subcapsular regions of the postnatal adrenal cortex. Gata6 ablation in SF1+ cells 
results in cortex shrinkage, cytomegaly, blunted corticoid production and the 




expression of gonadal markers (86). It was therefore hypothesised that GATA6 is 
required to limit the differentiation of adrenal stem cells into gonadal cell types. 
Zonation is also impacted following Gata6 ablation: virgin females lack an X-zone 
and castrated males do not form a secondary X-zone (86). The reason for this is not 
clear as postnatal X-zone cells do not express Gata6. It was hypothesised that it was 
either a result of non-cell autonomous phenomenon or that it occurs in foetal adrenal 
cells that co-express Gata6 and Sf1-Cre.  
 
1.4 The foetal Adrenal: Development and Formation  
The adrenal cortex starts to develop from a condensation of the coelomic epithelium 
in the embryo, called the urogenital ridge which also gives rise to the gonads and 
kidney. The steps of adrenal development are quite different in mice and humans. 
Remarkably, in both species the process of adrenal remodelling continues after birth. 
 
1.4.1 Adrenogonadal primordium (AGP) 
Multiple mechanisms and molecules are integral for the specific and timely 
development of the adrenogonadal primordium and separation from the developmental 
lineage of the kidney. Two in particular, SF1 and DAX1 are essential for the 
maintenance of the adrenal cortex as described in figure 1.3, but also for the 
development of the adrenal cortex and gonads. An identical precursor population for 
the adrenal and gonads was identified through staining for SF1, which revealed a 
population of positive cells located in the developing urogenital ridge from the 
coelomic epithelium to the dorsal aorta at embryonic day 11.5 of rat development (87). 
This cell population then differentiates into the adrenal and the gonadal primordia. The 
process of this differentiation begins upon contact with primordial germ cells.  
Depending on the sex of the organism the gonadal primordium goes onto form either 
the testis or ovary, and the adrenal primordium differentiates into the adrenal cortex. 





Figure 1-3. Development of the adrenogonadal primordium (AGP). 
Diagram depicting the mechanisms driving the development of the adrenal cortex and 
gonad and the important genes required at key differentiation points are highlighted 
in red. Development of the urogenital ridge permits formation of the kidneys, gonads 
and adrenal cortex. Separation of the kidney and AGP is the first step. This is followed 
by contact of the AGP with primordial germ cells. This contact results in the 
separation of the developing adrenal and the bipotential gonad. The bipotential gonad 
will differentiate into a testis or ovary depending on sex. The adrenal cortex continues 
to develop with the integration of neural crest cells that form the adrenal medulla. 
These cells migrate to the centre of the adrenal gland, and the process of cortical 
zonation is initiated.  
 
1.4.2 Formation of the adrenal gland from the AGP  
1.4.2.1 Human 
Condensation of the coelomic epithelium is detectable between 3-4 weeks of gestation. 
During the 4th-6th week of development the migration and proliferation of the coelomic 
epithelial cells begins leading to the morphological differentiation of the two distinct 
foetal adrenal zones, termed the outer definitive zone (DZ) and the inner foetal zone 




(FZ) at around 8 weeks of gestation. The foetal zone is steroidogenically active, 
producing high amounts of DHEA-S from large eosinophilic cells, which is converted 
into oestrogens by the placenta. The definitive zone is made up of a small layer of 
densely packed basophilic cells which are thought to be the reservoir of progenitor 
cells which will ultimately give rise to the defined cortex zones. By weeks 9-10 the 
adrenal primordium is now completely surrounded by the adrenal capsule. 
Approaching the end of gestation, a third layer of the adrenal cortex is now visible, 
termed the transitional zone. This zone is located between the and definitive zones 
(88). After birth the involution of the foetal zone occurs and the definitive zone then 
becomes the adult adrenal cortex.   
1.4.2.2 Mouse  
The adrenogonadal primordium can be observed by day 9 of embryonic development 
in the mouse (E9). As described, SF1 expression can identify these cells which go onto 
progress down either adrenal or gonadal lineages (84). This differentiation can be 
observed by E11.5-E12. By E12 the adrenal primordium becomes infiltrated by cells 
from the neural crest which will ultimately form the adrenal medulla. A distinct adrenal 
cortex and medulla can be observed from E16 in the mouse. From this stage, functional 
zonation of the definitive adrenal cortex can be observed which develops into the adult 
adrenal cortex. This differentiation of the cortex is defined by the expression of 
Cyp11b2 integral for aldosterone synthesis by E19, which localise at the outer adrenal 
cortex and the presence of Cyp11b1 expressing cells which localise in the inner part 
of the adrenal cortex.  After birth, the commonly described rodent foetal zone, known 
as the X-zone becomes evident by day d10 and regresses differently in the male and 
female (Fig. 1-4). Males see X-zone regression by d35 and females see regression at 
first pregnancy (89). Although the timing and presence of the foetal zone/X-zone in 
the human and rodent differ, they are thought to be analogous and programmed by 
similar genes. . 






Figure 1-4. Development of the adrenal cortex from the AGP. Diagram 
depicting the mechanisms driving the development of the adrenal cortex. (A) Human 
adrenocortical development starts from progression of the urogenital ridge to final 
zonation (dark blue zone). Two separate populations of cells migrate from the 
coelomic epithelium to form the foetal (light blue zone) and the definitive zones 
(orange zone) collectively termed the adrenal primordia. Mesenchymal cells then 
migrate to form the capsule (green zone) and finally neural crest cells migrate to the 
centre and form the medulla (red zone). The foetal zone regresses after birth. (B) 
Mouse adrenal development follows a similar process, however zonation is nearly 
complete by birth in rodents and the foetal zone (X-zone) appears postnatally and 
regresses in a sex dependent manner.  
 




1.4.4 Purpose of foetal cells and implications for adult cortex  
In numerous mammalian species, the foetal adrenal cortex consists of the adult and 
foetal cortex zones whose origins and mechanisms of control are still not clearly 
understood. Studies examining the morphology of these zones have resulted in three 
current paradigms. The first of these hypothesises that the adult zone may be derived 
from the coelomic epithelia after cells that form the foetal cells have migrated (90), 
alternatively, the foetal and adult zones may derive simultaneously from discrete 
populations of the coelomic epithelial cells (91). The third model postulates that the 
zones both develop from a single progenitor population, which differs from the other 
two models which suggests the cell fates of these two populations are already decided 
upon migration from the urogenital ridge (92). These models were hypothesised in the 
late 20th century and with the complexity of adrenal development it was difficult to 
determine an exact mechanism. However, recent studies conducted examining lineage 
tracing during adrenal development have suggested that the third model is most 
convincing at this point in time through showing that the adult zone derives from an 
early stage of the adrenal primordium in which the foetal adrenal-specific enhancer 
(FAdE) is transiently activated.  
Additional experiments conducted by Zubair et al demonstrated a foetal adrenal-
specific enhancer of the Ad4bp/SF1 gene which was shown to stain positive in 
precursor cells that contributed to both the adrenal and gonads (84). This study was 
also able to demonstrate the transient foetal X-zone. They observed the increase in cell 
number of the definitive cortex and the eventual regression of the X-zone and 
restriction to the cortex-medulla boundary, thus suggesting the mechanism for 
transition from the foetal to the adult cortex is governed by a similar mechanism across 
most mammalian species. This same group noted through the investigation of Ad4BP-
LacZ-FAdE Tg mice, the presence of distinct population of cells between the foetal 
LacZ-positive cells and LacZ-negative adult adrenal cortex. This band of cells was 
lacZ negative, however, were morphologically similar to foetal cells. They noted that 
some of the cells making up this intermediate zone stained faintly for LacZ. The faint 
LacZ staining and morphology of the intermediate cells led to the hypothesis that this 
band of cells are transitioning from foetal to adult cells. Furthermore, they suggested 




that there is simultaneously a change in enhancer in the Ad4BP/SF-1 locus from the 
FAdE to and adult adrenal enhancer which has still not been identified (93). Although 
further work would need to be carried out to confirm, Dax-1 has been identified as the 
gene potentially responsible for this switch, as models that ablate Dax-1 maintain 
foetal cells in the adult cortex (94).  
 
1.4.3 Rodent X-zone  
In mice, the foetal zone or X-zone can be observed histologically by d10 in postnatal 
development. Regression of this zone occurs in a sex dependent manner, with 
regression occurring during puberty in the male and during first pregnancy in females 
(34, 35, 95). If no pregnancy occurs this zone regresses with age in females. Several 
lines of inquiry have suggested that despite timing and developmental differences 
between the foetal cells in humans and rodents, that the two zones are analogous 
structures and are controlled via similar mechanisms. A number of similarities have 
been drawn between the two structures. They are located in the same position, adjacent 
to the adrenal medulla and both foetal cell populations contain ultrastructural features 
of steroid-producing cells. In addition, loss of DAX1 function in both humans and 
rodents results in a failure of regression of these foetal cells (94, 96, 97). Despite 
numerous studies investigating the X-zone, its origin and true function are still 
unknown, through continuing to identify new models to examine mechanisms 
controlling the formation and regression of the X-zone should help elucidate its 
function.  
1.4.3.1 Androgens and the X-zone 
Experiments conducted as early as 1937 by Deansley and Parkes demonstrated the 
impacts of androgens on the adrenal X-zone. They first demonstrated the regression of 
the mouse X-zone in untreated males during puberty and the redevelopment following 
castration, highlighting that the control of this regions was potentially andromimetic 
(98). Through a series of experiments, they also found that treatment with androgenic 
compounds shortly after birth and in response to castration prevented the development 
of an X-zone. Starkey and Schmidt later examined the effects of testosterone in both 




males and females mice and demonstrated the failure to develop X-zones in both sexes 
following administration of testosterone in prepubertal mice (36). Experiments carried 
out by Jones demonstrated that the X-zone still regresses in hypophysectomised male 
mice given testosterone, highlighting that this regression is not under the control of the 
pituitary, but androgens work directly at the level of the adrenal to remove the X-zone 
(99). Despite this early identification of androgen action on the X-zone, the mechanism 
is still not understood and experiments dissecting this have not expanded on the issue 
much in recent years.  
1.4.3.2 Recent advances in dissecting X-zone control and function 
In addition to Ad4bp/SF1, Dax1 and androgens being highlighted as regulators of the 
adrenal X-zone, additional knockout models have noted an impact on the rodent X-
zone. Sahut-Barnola et al identified the presence of a mislocated X-zone in both males 
and females following the ablation of Prkar1a in the adrenal cortex, they noted that 
with age, the X-zone migrated from its normal location at the medulla boundary up 
through the cortex, highlighting that this pathway could be involved in controlling the 
foetal cell population (29). Another study performed quantitative trait locus mapping 
of the genes associated with the vacuolisation of the X-zone. They highlighted strain 
dependent differences in how the X-zone regresses and a selection of potential genes 
involved (35). Another study investigated the expression of thyroid hormone receptor 
beta (Thrb) in the adrenal cortex through expression of β-galactosidase. Through this 
model they identified a novel TRβ1-positive zone in the adrenal cortex that exhibits 
sexually dimorphic regression at the juxtamedullary region. They also demonstrated 
that treatment with T3 is able to induce a change in morphology of these cells 
suggesting that TRβ1 modulates inner cortical responses at sensitive postnatal time 
points. Furthermore, they showed that treatment with T3 maintained the presence of 
an X-zone after puberty if treated while the X-zone was still present, however if the 
X-zone was allowed to regress normally and treated with T3 the X-zone did not re-
develop (40).  
 




1.5 Adrenal steroidogenesis  
1.5.1 Adrenal steroid production  
The production of adrenal steroids is a dynamic process that relies on de novo synthesis 
from cholesterol, under the control of ACTH and other regulators. The adrenal is 
responsible for the synthesis of mineralocorticoids, glucocorticoids and adrenal 
androgens and it does this in a zone specific manner. Each of the adrenals concentric 
zones expresses specific enzymes that enable production of particular steroids, 
discussed in the subsequent sections. Steroid biosynthesis begins via the mobilization 
of cholesterol from a pool in the outer mitochondrial membrane, which is continuously 
replenished from cytosolic storage droplets of cholesterol esters (3). The steroidogenic 
acute regulatory (StAR) protein facilitates cholesterol transfer from the outer 
mitochondrial membrane to the inner mitochondrial membrane, this enables side-chain 
cleavage enzyme CYP11A1 to catalyse the first and rate limiting step of 
steroidogenesis, the conversion of cholesterol to pregnenolone (100). Zone-specific 
steroid biosynthesis is described in the subsequent sections.  
  






















Figure 1-5. Steroid biosynthesis pathway.  Mineralocorticoid production 
(purple region) - Biosynthesis pathway of aldosterone production under the control 
of angiotensin II and high extracellular potassium in the ZG.  Glucocorticoid 
production (green region) - Biosynthesis pathway of Glucocorticoid production 
upon stimulation of ACTH and negative feedback in the ZF. Primary glucocorticoid 
in humans is cortisol and corticosterone in rodents. Androgen production (blue 
region) - Biosynthesis pathway of androgen production upon stimulation of ACTH 
in the ZR. Conversion of androstenedione and testosterone to Estrogens (pink region) 
occurs in periphery tissues such as the liver and placenta. Adapted from (101)  
Key: 
Mineralocorticoids – Zona Glomerulosa, Glucocorticoids – Zona Fasciculata, Androgens – Zona Reticularis,  
Estrogens – Peripheral tissue.  




1.5.1.1 Mineralocorticoid production and targets  
 
Mineralocorticoid production occurs in the zona glomerulosa which is characterised 
by three distinct features; it expresses angiotensin II receptors, along with the 
expression of P450c11AS, but does not express P450c17. For these reasons the 
glomerulosa is able to exclusively produce aldosterone under the regulation of the 
renin/angiotensin system (102). Presence of angiotensin II and high extracellular 
potassium are the main stimulators of aldosterone synthesis through increased 
intracellular calcium. Synthesis from pregnenolone requires the action of three 
enzymes. 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) in humans and type 1 
in rodents (HSD3B1) performs the irreversible conversion of the hydroxyl group to a 
keto group on carbon 3 and simultaneous isomerization of the double bond from the 
Δ5 to the Δ4 position, converting pregnenolone to progesterone (103). Secondly, 2.21-
hydroxylase (CYP21A2, P450c21) converts progesterone to 11-deoxycosticosterone 
and finally, aldosterone synthase (CYP11B2, P450c11AS) then catalyses the final 
reactions; 11β-hydroxylation, 18-hydroxylation, and 18-methyl oxidation to 
aldosterone. The 18-aldehyde group, from which the name “aldosterone” derives, 
forms an intramolecular cyclic hemiacetal using the 11β-hydroxyl group, with loss of 
water (104). Once released from the adrenal, aldosterone plays a pivotal role in 
electrolyte and fluid homeostasis and therefor is essential in the control of blood 
pressure. Aldosterone has been shown to target the epithelial of the distal colon and 
renal nephron. Upon stimulation, it results in sodium reabsorption and potassium 
secretion (105).    
  
1.5.1.2 Glucocorticoid production and targets  
  
The zona fasciculata does not express angiotensin II receptors or P450c11AS so cannot 
produce aldosterone, instead it expresses the ACTH receptor MC2R and P450c11β. In 
the ZF, CYP17A1 is also able to catalyse the 17α-hydroxylation of pregnenolone and 
progesterone. From this step CYP17A1 is then able to cleave the C17-C20 bond of the 
17-hydroxypregnenolone and 17-hydroxyprogesterone (17OHP). This step does not 




occur in the ZG due to no CYP17A1 expression. This cleavage results in 19-carbon 
steroids and occurs at a single active site but with different regulation. HSD3B2 and 
CYP21A2 perform much the same way as they do during the synthesis of aldosterone, 
17-hydroxysteroids are converted to 11-deoxycortisol. Steroid 21 hydroxylase 
(CYP21) is an enzyme that is unique to the adrenal cortex and permits the biosynthesis 
of mineralocorticoids and glucocorticoids as well as androgens (106).  In the final step 
11β-hydroxylase (CYP11B1, P450c11β), an enzyme which has been shown to be 
closely related to CYP11B2, completes cortisol synthesis. P450c11β is not able to 
convert 18-hydroxycorticosterone to aldosterone, additionally, it has minimal capacity 
to convert corticosterone to 18-hydroxycorticosterone (102). In mice, and many small 
rodents, the zona fasciculata lacks CYP17A1 expression and as a result corticosterone 
is the dominant glucocorticoid. Humans only produce a small amount of corticosterone 
as cortisol is the dominant glucocorticoid (107, 108). Once released into the 
circulation, glucocorticoids regulate a number of biological systems most notably the 
hypothalamic-pituitary-adrenal (HPA) axis and are essential in regulating the body’s 
response to acute and chronic stress (109). Discussed in more detail in section 1.6. 
Glucocorticoids exert their effects through their receptor glucocorticoid receptor, 
discussed in detail in section 1.6.2.    
 
1.5.1.3 Adrenal androgen production and targets  
MC2R is also expressed in the zona reticularis, however with minimal 
P450c21 or P450c11β only a small amount of cortisol is produced. This zone however, 
does express large amounts of P450c17 and cytochrome b5 (107). The expression of 
cytochrome b5 maximises 17,20-lyase activity and production of C19 steroids. 
Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) are the two most abundant 
adrenal steroids that are produced. The production of DHEA from pregnenolone and 
production of androstenedione from progesterone is catalysed by a single enzyme, 
CYP17A1. Despite the presence of CYP17A1 in both the zona fasciculata and zona 
reticularis, through the action of cofactor cytochrome b5 (CYB5A) in the ZR the 17,20-
lyase reaction is enhanced approximately 10 fold (110).  The lack of CYP17A1 in the 




mouse adrenal not only results in the inability to produce cortisol, it also means that 
the mouse adrenal does not produce androgens (111). DHEA is conjugated to DHEAS 
through sulfotransferase SULT2A1 which is essential in regulating the synthesis of 
adrenal androgens. In addition to the production of DHEAS, the adrenal is able to 
synthesise small amounts of testosterone through via the conversion of 
androstenedione by 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5, AKR1C3) 
(112). Stimulation of androgen production from the zona reticularis is primarily by 
ACTH. The zona reticularis, as previously described, bears similarity to the foetal zone 
during foetal development. The foetal adrenal is responsible for the production of the 
C19 substrate for oestrogen synthesis during pregnancy but involutes quickly after 
birth. The zona reticularis forms only a small layer in the adrenal during infancy, 
however expands throughout childhood leading to increased levels of circulating 
DHEAS and the process of adrenarche. Adrenarche is characterised by the 
development of axillary hair and pubic hair in response to the peripheral conversion of 
adrenal androgens to more potent androgens. Production of DHEAS peaks around 25 
years of age and gradually declines with age (113).  In adulthood, circulating 
androgens produced by the adrenal only account for less than 5% of the total 
circulating androgens in men compared to the production of androgens from the testis. 
However adrenal androgens in women account for around 25% of total circulating 
androgens (114). Inappropriate action or production of adrenal androgens has been 
recognised in a number of clinical conditions such as premature adrenarche, castration-
resistant prostate cancer, congenital adrenal hyperplasia and polycystic ovarian 
syndrome (115). Androgens exert their effects through their cognate receptor, 
androgen receptor (AR), discussed in detail in section 1.6.1.    
 
1.5.1.3.1 Gonadal androgen production  
Androgen production not only occurs in the adrenal gland, it is also produced in the 
Leydig cells of the testis and thecal cells in the ovary. Androgen biosynthesis occurs 
as described in the previous section and in figure 1-5. Gonadal androgen secretion 
however is under the control of the hypothalamic-pituitary-gonadal axis.  




Gonadotropin releasing hormone (GnRH) stimulates luteinizing hormone (LH) release 
from the pituitary which targets the gonad to produce androgens and work in a negative 
feedback loop at the hypothalamus and pituitary.  
 
1.6 Steroid Receptors  
Steroid hormone receptors belong to the nuclear receptor family. These receptors are 
ligand-regulated transcription factors activated through the binding of their specific 
hormones. The steroid ligands for these receptors are lipid soluble and so are able to 
cross the plasma membrane to interact with the nuclear receptors directly and do not 
need to be transported through cell surface receptors (116). Unbound steroid receptors 
are sequestered in the cell cytoplasm. When their ligand is bound, nuclear receptors 
undergo a conformational change, lose bound heat shock proteins, dimerise and 
translocate from the cytoplasm to the nucleus to directly control the transcription of 
genes and regulate many cellular processes such as reproduction, cell proliferation, 
metabolism and development. The primary role of nuclear receptors are as 
transcription factors, however, they have also been shown to be able to regulate 
cellular processes in the cytoplasm. For the majority of nuclear receptor specific 
ligands have been identified, however, there are a number of receptors that do not have 
an identified ligand, these are termed ‘orphan receptors’. Whether these receptors have 
specific ligands is unclear, as some nuclear receptors are able to regulate transcription 
in the absence of a ligand (117). AR and GR structure and function are described in 









Figure 1-6. Diagram showing basic nuclear receptor signalling (118). 
Steroid receptors, such as glucocorticoid (GC) and androgen (A) 
receptors, are primarily in the cytoplasm as monomers bound to heat shock 
proteins. Others, such as the oestrogen (E) receptor (ER), are located as 
monomers primarily in the nucleus. Steroid binding to cytoplasmic 
receptors triggers release from the HSPs, receptor dimerization, 
alterations in receptor conformation and nuclear localization. In the case 
of E, the sex steroid binds to nuclear receptors to promote dimerization 
and changes in receptor conformation.  
 
1.6.1. Androgen Receptor 
1.6.1.1 Androgen receptor structure  
The Androgen receptor gene, also known as NR3C4 (nuclear receptor subfamily 3, 
group C, gene 4) is a nuclear transcription factor and is a member of the steroid 
hormone receptor superfamily of genes. AR was first characterised by Migeon et al in 
1981 and is located on the X-chromosome at q11-12 and consist of 8 exons (119). AR, 
like all steroid nuclear receptors, comprises of four different domains that are 
structurally and functionally distinct. These are the DNA-binding domain (DBD), 
which is highly conserved, the ligand-binding domain (LBD), which is moderately 




conserved, and the N-terminal domain (NTD), which is poorly conserved between 
other members of the steroid family. Another region called the hinge region, is a short 
amino acid sequence which separates the LBD and DBD. This region contains a 
bipartite ligand dependent nuclear localisation signal (NLS) which is used for AR 
nuclear transport (120).  
 
Figure 1-7. Diagram detailing AR gene and protein (121). AR is located 
on the X chromosome and consists of eight exons. These code for the NTD, 
DBD, hinge region and LBD. The AR contains two transactivation domains, 
termed AF1 (activation function 1) located in the NTD and AF2 (activation 
function 2) in the LBD. AF2 exhibits weak transcriptional activity, whereas 
AF1 is a strong regulator of transcription.  
 
 
The NTD is the region that acts as a binding site for other proteins in the transcriptional 
regulation complex. It is coded by exon one and is thought to be able to work 
independently of androgen stimulation as it was shown to regulate transcription in 
LBD-mutant mice. (122). Within this domain are two transcription activation regions, 
termed TAU-1 and TAU-5 (123). Experiments examining these two transcriptional 
activation units has noted TAU-5 as being responsible for the majority of the 
constitutive transcriptional activity within the NTD.  




The DBD is coded for by exon 2 and 3 and is composed of two zinc finger motifs. One 
of the zinc fingers contains a P-box motif that co-ordinates recognition of DNA 
sequences and the second contains a conserved D-box motif which helps stabilize 
DNA-receptor interactions through interacting with the phosphate backbone and varies 
between different transcription factors to ensure specific binding to particular steroid 
receptor response elements (124, 125). The hinge region separating the LBD and DBD 
is approximately 50 amino acids and contains the NLS essential for AR nuclear 
transport. This transportation of AR into the nucleus is facilitated by filamin-A, a 
cytoskeleton protein (126). Interrogation of AR transportation into the nucleus of 
filamin-A negative cell lines revealed the failure of AR nuclear transport, even 
following prolonged exposure to androgens (127).  
The LBD is responsible for facilitating the binding of ligands testosterone and DHT to 
AR, this is the primary mechanism for androgen signalling. In the LBD, AF2 interacts 
with LxxLL-containing co-regulators, these co-regulators have been identified as the 
steroid receptor coactivator [SRC] /p160 family(128). LBD contains another binding 
region specifically for heat shock protein 90 (HSP90), which is common to all steroid 
hormone receptors. The primary role of HSP90, as well as other heat chock proteins is 
to prevent interaction of AR with its DNA response elements27, line  in the absence 
of its ligand, in addition to maintaining AR structure (129).  
 
1.6.1.2 Classical mechanisms of AR signalling  
Both testosterone and the more potent DHT are able to bind to AR and initiate the 
regulation of transcription. DHT binds with higher affinity to AR compared to 
testosterone and can activate target genes in lower concentration than testosterone. In 
the absence of a ligand, AR is primarily located in the cell cytoplasm where, as 
previously mentioned, it is bound with heat shock proteins. Upon ligand binding, 
dissociation of heat shock proteins occurs and induction of a conformation change in 
AR takes place where by helices 3, 4 and 12 the LBD go onto form the AF-2 binding 
surface and the unmasking of the nuclear localisation signal. The positioning of helix 
12 across the ligand-binding pocket reduced ligand dissociation (130). Subsequent 




hyper-phosphorylation of AR occurs and induces the recruitment of co-activators and 
the activation of transcription. This complex then translocates to the nucleus (131). 
Dimerization of the ligand-receptor complex is required to permit binding to 
androgens response elements (ARE), these are located in the regions of androgen 
responsive genes. The binding of AR to their specific AREs permits the recruitment 
of histone acetyltransferase (HAT) enzymes, which are a range of co-regulators and 
the necessary machinery for transcription. There are two types of AREs, classical 
which are characterised as being 15bp in length and contain two 6 imperfect bp repeats. 
This is very similar to the response elements for glucocorticoids which permits 
activation of these AREs by GR to enable gene transcription. There are also selective 
AREs which are only androgen responsive (132, 133). For AREs to be able to modify 
transcription, they first need to form AR/ligand homodimers, this results in the 
recruitment additional proteins to help form a transcriptional activation or repression 
complex at discrete sites on the chromatin. Cofactors that are recruited to the 
complexes are thought to be cell response specific, this is due to the wide array of cell 
responses AR can mediate and control and stops off target or inappropriate 
transcription (134).  
 
1.6.1.3 Non-classical mechanisms of AR signalling  
As well as genomic roles of AR signalling, there has been mounting evidence for the 
non-genomic actions of AR signalling (135). AR non-genomic signalling occurs very 
rapidly and has been shown to occur from seconds to minutes. This extremely quick 
response time shows that it does not require transcription and translation from binding 
to response elements. There is a disparity between the wide array of androgen targeting 
effects and the lack of identification of AREs, and it is thought that the non-genomic 
actions of AR signalling can account for this discrepancy. Non-genomic AR action 
occurs in the plasma membrane or the cytoplasm, this activation results in the release 
of intracellular release of calcium and the activation of protein kinases including 
MAPK (ERK), protein kinase A (PKA), Akt and protein kinase C (PKC) (135-137). 
There has been some data to suggest that the activation of these pathways is able to 
feedback upon AR. Furthermore, Phosphorylation of ligand and non-ligand bound AR 




will prevent the degradation of AR and can enhance translocation and transcriptional 
activity (138).  The majority of non-genomic AR signalling will initiate signalling 
cascades that can regulate other nuclear receptors. Although there is not extensive 
literature demonstrating non-genomic AR signalling, it has been noted that the most 
common characteristic in non-genomic effects of exposure to androgens is rapid 
changes to calcium (Ca2+) (135, 139). Modulation of calcium is a rapid process that 
occurs within seconds. For these reasons, it has been postulated that androgens must 
bind to a receptor on the surface of the cell. It has been noted that not all cell types that 
demonstrate a rapid androgen response, express classic nuclear androgen receptor or 
are able to be blocked by AR antagonists. It is currently unknown if the receptor 
located at the cell surface is the classical intracellular AR coupled to other signal 
transduction machinery or if it is a unique protein capable of binding androgens and 
initiating signalling cascades (140, 141). There has also been experiments conducted 
that demonstrate AR ligand independent signalling, this has been quite commonly 
observed in the development of castration resistant prostate cancer and was 
characterised by constitutively-active splice variant of AR that lack the LBD (142-
144).  Additionally, G protein-coupled receptor GPR6A has recently been reported to 
regulate extranuclear androgen-induced kinase signalling in prostate cancer cells 
(145). AR has also been shown to be activated by growth factors and proinflamatory 
cytokines in the absence or low concentrations of androgens (146, 147).  
 
 





Figure 1-8. Genomic and non-genomic actions of androgen signalling 
(148) Through the genomic pathway, androgens can move into the cytoplasm and 
bind to AR. This induces a conformational change and releases AR from heat shock 
proteins. Translocation to the nucleus occurs next, where AR dimerizes and interacts 
with cofactors and subsequently binds to androgen response elements enabling 
regulation of target genes. Non-genomic actions are thought to occur through a 
membrane-bound AR or other receptors, which then transduce the signal into the 
cytoplasm, interacting directly with other membrane bound factors such as PI3K or 
activating other pathways. This leads to changes in second messengers, cytoplasmic 
calcium concentration, actin skeleton changes, and eventually to the activation of 
other nuclear receptors and transcription factors.  
 
1.6.1.3 Androgen manipulation 
Due to the wide array of mechanisms androgens and AR control, there have been 
numerous models in which to investigate their mechanism of action. This comes in the 
form of drugs that are able to target androgen receptor, GDX, naturally occurring 
mutations in AR and genetic manipulation through Cre/loxP technology (149). Drug 
treatments to block AR function has been achieved through the use of flutamide, which 




is a non-steroidal antiandrogen (150). Used for a number of purposes, flutamide 
treatment has been shown to be effective in reducing adrenal androgen excess in 
congenital adrenal hyperplasia (CAH) (151) and in prostate cancer (152). An 
interesting study that investigated the impact of flutamide on the adrenal cortex 
following haemorrhaging in rats described restored cell structure and reduced tissue 
adenoma in the adrenal, this is thought to occur due to overcoming depressed adrenal 
function induced by severe trauma.  However, controls in this study did not include a 
non-haemorrhaged rat treated with flutamide therefore, the impact on the adrenal 
cortex under normal conditions following flutamide treatment has not been described 
in this study (153).  
Castration has also been widely used to investigate the impact of androgen loss on 
various tissues. Following castration, the adrenal has been shown to re-develop the X-
zone, or, if this castration occurs before puberty, maintain the X-zone into adulthood 
(23). In addition to X-Zone re-development, the adrenal has also been shown to 
develop adrenocortical tumours (55, 56), the mechanisms underpinning this still aren’t 
clear however, studies have shown that the loss of androgens results in a chronic 
elevation in LH and is thought to drive neoplastic formation in the adrenal cortex and 
expression of LHR (154). Additionally, treatment with testosterone in GDX mice show 
removal of the X-zone (36). The impacts of GDX on the adrenal cortex in various 
ablation models and the X-zone has also been discussed in section 1.4.3.1.  
Models investigating natural mutations, such as the testicular feminized (Tfm) mouse 
which results in androgen insensitivity and feminised males. Interrogation of the 
adrenals in these mice noted the presence of an X-zone that had also been shown to be 
regulated by androgens in other models, demonstrated the normal involution of the X-
zone in Tfm mice. This study suggested that the X-zone regression may not be entirely 
dependent upon androgen regulation (155). 
A severe genetic mutation in humans known as Complete Androgen Insensitivity 
Syndrome (CAIS), arises due to an androgen receptor defect and prevents cells being 
able to respond to androgens (156). Although the impact of this disorder has been 
extensively researched, its impact on the adrenal cortex has not been described.  Other 




models that have described low circulating androgens is the hypogonadal (hpg) mouse 
(157), which are sexually immature and have arrested germ cell development, but 
again, these studies have not described or investigated the impact on the adrenal cortex. 
In contrast to models that create low circulating androgens, treatment with human 
chorionic gonadotropin (hCG) has been shown to increase serum testosterone (158). 
Although this could be useful to investigate high levels of circulating testosterone in 
rodents and their impact on the adrenal, caution would need to be taken as the adrenal 
cortex has been shown to respond directly to hCG treatment (159). Ascertaining the 
adrenal phenotype as a result of high testosterone or direct hCG stimulation would be 
difficult.  
1.6.1.3.1 Genetic rodent models of AR adrenal manipulation 
 
A number of models have been generated to examine the impact of AR ablation in the 
rodent. These models range from global ablation of AR and cell specific models. 
Global Cre/loxP models were generated through the use of various constitutive 
promoters driving Cre recombinase, these included the use of an ACTB, CMV or PGK 
promoter to achieve global AR ablation. The male mice from these studies mimicked 
the phenotype seen in the testicular feminisation mouse displaying disruption of male 
specific genital structures, cryptorchidism, infertility due to spermatogenic block and 
a feminised external appearance. The females from these studies were not as severely 
affected but did have prolonged oestrus cycles and sub-fertility (160, 161). Very few 
of these studies have investigated the impact of AR ablation in the adrenal cortex of 
these mice, however one study investigating the impact of loss of AR in the pituitary 
of global knockout mice noted a disrupted adrenal with impaired cell death and 
presence of an X-zone. However, this phenotype was thought to be a result of a 
disruption in normal pituitary signalling (162).  Cell-specific androgen receptor 
knockout mouse models have been generated that target many different cell types in 
the body including the testicular Leydig cells (163), Sertoli cells (164), and peritubular 
myoid cells (165), but thus far none have been generated to specifically investigate AR 
signalling in the adrenal. This list is not exhaustive however, highlights a lack of 




knowledge of the role of autocrine AR adrenal signalling and its regulation of the 
adrenal cortex.  
 
1.6.2 Glucocorticoid Receptor  
1.6.2.1 Glucocorticoid receptor structure  
As previously mentioned, glucocorticoids mediate their effects through their receptor 
glucocorticoid receptor (GR NR3C1). Like AR, GR is also a member of the nuclear 
hormone receptor family of ligand-dependent transcription factors (116). Human GR 
was first characterised through expression cloning in 1985 (166), is located on exon 5 
and consists of 9 exons.  GR has been said to repress the transcription of genes that 
account for 10-20% of the human genome (167-169) and is expressed in nearly every 
cell type in the body (170). The impacts of glucocorticoid signalling are extremely 
diverse and exhibit a varying response in tissues and across individuals. Recent studies 
have highlighted expanding roles for the various isoforms of GR which is thought in 
part, to permit the varying response to glucocorticoids, in addition to ligand 
bioavailability, and cofactor expression. Despite being derived from a single gene, GR 
has multiple proteins due to splicing and alternative post-translational regulation to 
further refine signalling properties (171, 172). Furthermore, the intracellular response 
to glucocorticoids is mediated by the complement of GR isoforms present.  
Exon 9 is subject to alternative splicing (Fig. 1-9), which generates multiple GR splice 
variants, two of which, GRα and β, have been the primary focus of most studies due 
to their relative abundance. However GRβ is unable to bind glucocorticoids owing to 
an altered ligand-binding domain and has a more tissue-selective distribution.  
However, translation reinitiation that occurs at seven internal AUG codons in GRα 
mRNA, generates eight known receptor peptides with varying lengths of the N 
terminus. These receptor isoforms are designated GRα-A, -B, -C1, -C2, -C3, -D1, -D2 
and -D3 (173). It is thought that the range of isoforms allows for the tissue specific 
and wide varying roles GR plays within the body.  
 
 






 Figure 1-9. Diagram detailing Glucocorticoid Receptor gene and 
functional isoforms (174). GR is located on chromosome 5q31-32 and is 
comprised of over 140 kb of nucleotides, less than 2% (∼2.5 kb) of which 
make up the 9 exons. Alternative splicing of exon 9 results in the isoforms 
GRα and GRβ.The exons code for the NTD, DBD, hinge region and LBD. 
The GR contains two transactivation domains, termed AF1 (activation 
function 1) located in the NTD and AF2 (activation function 2) in the LBD. 
AF2 exhibits weak transcriptional activity, whereas AF1 is a strong 
regulator of transcription.  GR undergoes multiple posttranslational 
modifications including phosphorylation, SUMOylation, ubiquitination 
and acetylation.  
Like AR, glucocorticoid receptor consists of a NTD, DBD, and an LBD separated by 
the hinge region. The DBD contains the zinc finger motifs essential for the recognition 
and binding to target DNA sequences named glucocorticoid response elements 
(GREs). The NTD contains AF-1 which is responsible for interacting with co-
regulators and basal transcriptional machinery and is a target for post-translational 
modification. The LBD is the region that consists of 12 α-helices and four β-sheets 
(175). These structures form the hydrophobic pocket for binding to glucocorticoids 




and contain AF-2 that interacts with co-regulators in a ligand dependent fashion. 
Nuclear localisation signals NL1 and NL2 can be found in the DBD hinge junction 
and LBD (176).  
 
1.6.2.2 Classical GR signalling 
When there is no ligand present, GR resides as part of a large complex of heat shock 
proteins (HSP90, HSP70, and P23) and immunophilins of the FK506 family (FKBP51 
and FKBP52) in the cytoplasm (177, 178). This complex aids in maintaining receptor 
conformation and ensures inactivation of the receptor, to ensure no signalling occurs 
without the presence of a high affinity ligand. Circulating corticosterone is found 
bound primarily to corticosteroid-binding globulin (CBG), this is essential for the 
distribution and cell entry of glucocorticoids. Cortisol that is CMG-free has the ability 
to passively diffuse across the call membrane (Fig. 1-10), however, its ability to act 
upon cellular processes is mediated by two enzymes, 11β-Hydroxysteroid 
dehydrogenase type 2 (11β-HSD2), this enzyme oxidizes cortisol into the inactive 
metabolite cortisone and the second working in opposition, 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1) converts cortisone to cortisol (179). Upon ligand 
binding to GR, structural changes result in NLS exposure and GR is rapidly 
translocated to the nucleus. Once inside the nucleus, GR is then able to bind to its 
GREs and regulate target genes. GR binds to GREs as a homodimer, studies have 
shown that GREs can not only positively regulate transcription, but can also negatively 
regulate it, these are known as positive and negative GREs respectively (180, 181). 
Binding initiates the control of transcription by facilitating the formation of the 
transcription initiation complex, which includes RNA polymerase II and its ancillary 
components via its AF-1 and AF-2 domains. Transcriptional initiation complexes work 
with numerous co-activators which include the p300/CBP-associated factor (p/CAF), 
which interacts with p300/CBP, but is also a broad transcription coactivator; and also 
the p160 family of coactivators, which interact with the steroid hormone receptors 
(182). The p160 coactivators interact with AF-2 through multiple amphipathic LxxLL 
signature motifs located in their nuclear receptor-binding (NRB) domain (183). These 
coactivator additionally facilitate HAT activity, promoting chromatin decondensation 




and allows transcription (184). GR can also impact signal transduction cascades 
through protein-protein interactions with transcription factors and is thought to be able 
to stimulate or inhibit the rate of transcription of those target genes. The protein-protein 
interactions of GR with other transcription factors may take place on the promoters 
that do not contain GREs (described as the tethering mechanism), in addition to the 
promoters that have both GREs and responsive elements of transcription factors that 
interact with GR, described as composite promoters (185). 
1.6.2.3. Non-classical GR signalling  
GR is also able to mediate cellular responses via a quick non-genomic signalling 
mechanism, which can occur in minutes to seconds and does not involve transcription. 
This signalling mechanism has been shown to act on kinases PI3K, AKT, and MAPKs 
(186). This has been demonstrated in glucocorticoid-dependent release of accessory 
proteins associated with unbound GR in the cytoplasm, such as tyrosine kinase c-Src. 
Release of c-Src initiates multiple kinase cascades that lead to the phosphorylation of 
annexin 1, inhibition of cytosolic phospholipase A2 activity, and impaired release of 
arachidonic acid (187). Additional experiments have identified co-localisation of GR 
at the plasma membrane caveolae via an interaction with caveolin1 (188). Non-
genomic actions of GR in the membrane has been shown to regulate gap junction 
intercellular communication and neural progenitor cell proliferation by non-genomic 
mechanism (189). The mechanisms by which GR controls transcription and cellular 
signalling is extremely diverse and understanding the different mechanisms by which 
GR mediates target genes is essential for understanding glucocorticoid meditated 
diseases and potential therapeutics. 
 
1.6.2.4 Mineralocorticoid & GR Signalling 
Glucocorticoids are not only able to mediate transcriptional regulation through GR but 
also mineralocorticoid receptor (MR). It is thought that the genes for MR and GR 
originate from a common ancestor prior to the evolution of aldosterone (190). 
Corticosteroids are essential in regulating various homeostasis mechanisms, acting 
through GRs and MRs, so it is therefore essential that there is a balanced activation of 




these receptors to maintain health. Both mineralocorticoids and glucocorticoids bind 
to MR with equal affinity (172). Circulating cortisol is 100-1000 fold higher than those 
of aldosterone, so mechanisms are in place to prevent body wide MR being saturated 
by cortisol. This is achieved via the enzyme 11 beta-hydroxysteroid dehydrogenase 
type 2 (11bHSD2) (191). It works by converting cortisol and corticosterone into 
cortisone by a NAD (Nicotinamide Adenine Dinucleotide)-dependent manner. For 
many years it was thought that MR was purely localised to polarized tight epithelia, 
where it was co-localised to with 11bHSD2 to control aldosterone-dependent 
transepithelialsodium transport. However, studies in recent years have highlighted MR 
expression in non-epithelial tissue such as the hippocampus and the hypothalamus as 
well as many others. It has also been highlighted that MR as well as GR function is 
important in psychiatric conditions such as major depression (190).  
 
Figure 1-10. Genomic and non-genomic actions of glucocorticoid 
receptor signalling (192). Glucocorticoids (GC) diffuse across the cell 
membrane where they bind to the glucocorticoid receptor (GR). Binding 
causes conformational changes which permits the release of the receptor 
from an inactive complex bound by heat shock proteins and translocates to 
the nucleus. The receptor dimerizes and can bind to DNA via GREs, or can 
interact with transcription factors to regulate their function. The receptor 
can also act post-transcriptionally to regulate RNA stability  and via non-
genomic mechanisms  




1.6.2.5 Rodent models of GR manipulation 
Due to the presence of GR in nearly every cell type in the body an extensive list of GR 
ablation models has been curated. One of the first models of complete GR knockout 
described ablation of GR through the insertion of a neomycin cassette to exon 2 by 
homologous recombination in ES cells, thereby interrupting GR gene transcription in 
all cells of the body (170). Global GR ablation was achieved through the PGK 
promoter, results from this study highlighted 100% perinatal mortality rate due to 
retarded lung development and respiratory failure. The livers of these mice were not 
appropriately able to deal with key gluconeogenic enzymes and feedback of the HPA 
axis was severely impaired with significant increases in adrenocorticotropic hormone 
and corticosterone, which coincided with a hypertrophic adrenal gland. Another 
method to target GR was developed by Ridder et al, which generated a mutant mouse 
containing loxP sites surrounding Exon 3, a region involved in DNA binding. They 
reported similar findings to Cole et al(193). A final allele developed by Brewer et al 
also utilised a floxed GR transgene with loxP sites that flanked exons 1C and exon 2 
(194). The phenotype observed in these mice were similar to what was observed in 
Cole et al’s global knockout model. Due to the severity of the phenotype observed in 
GR global knockout mice, more refined methods were developed to investigate cell 
specific ablation of GR. Tronche et al generated a conditional GR knockout model in 
which exon 3 was floxed and excision was permitted through the use of a Nestin Cre 
to target cells in the nervous system (195). Additional tissue specific targeting of GR 
has been achieved through GR DNA binding mutants (196), pan-neural GR 
conditional knockouts (195), and forebrain GR (197) conditional knockouts, all 
showing severe defects and highlighting the importance of GR signalling in the 
respective tissues. In addition to loss of function analysis, mouse models were also 
used to examine overexpression of GR. This model was generated by Reichardt et al 
and involved the insertion of an extra copy of the full length GR gene through the use 
of yeast artificial chromosomes and increased protein expression by about 50%. This 
models permitted the investigation of GR overexpression and its impact on stress 
related behaviour (198). Additional tissue-specific over-expression models were 
generated to permit investigation of the forebrain and the overexpression in brain 




structures such as the cortex, hippocampus, CeA, BLA and nucleus accumbens (199). 
This is not an exhaustive list of every GR manipulation model available but does 
highlight some of the keys models to help investigate body wide and cell specific 
impacts of GR manipulation. Despite numerous models for interrogating GR, no 
models thus far have been generated to investigate GR specifically in the adrenal 
cortex.  
1.6.3 Interactions between AR and GR signalling  
Androgens and glucocorticoids have a wide array of physiological targets and 
activities, but both receptors are very close members of the nuclear-receptor family 
and their mechanisms of action are extremely similar, both recognise very similar 
DNA-response elements and utilize overlapping co-regulators to mediate their effects 
on target genes. The primary separation of the effects of these receptors is their cell 
and tissue specific expression and the specificity of their respective ligands. However, 
in cell types that express both receptors, the mechanisms resulting in appropriate 
targeting are unclear (200). Various studies have shown that they are able to interact 
with each other in cellular processes. One of the most notable interactions has been in 
the development of prostate cancer. It has been hypothesised that GR activity in 
prostate cancer is dependent on the activation status of AR. GR has been shown to 
have anti-proliferative effects when AR signalling in not perturbed, however, blockage 
of androgen signalling has shown to increase GR expression and is thought to offer a 
by-pass survival mechanism and aid cancer progression (121, 201-203). This again 
was noted in bladder cancer where they suggested that AR drives pro-inflammatory 
response through interaction with isoform GR alpha (204). Additionally, studies have 
also identified that AR can negatively regulate GR transcription, and this is through a 
negative androgen-response element sequence near the GR gene (203). Studies have 
also suggested that the interaction between these two receptors is not purely limited in 
the context of disease progression, but is required during normal cellular signalling. 
The same group also showed that AR and GR form heterodimers, and the activation 
of hormone response elements is based on a co-operative process (205). Additional 
research would be required to investigate the full range of mechanisms and tissues that 




AR and GR could potentially be working together in and what mechanisms they 
control.  
 
1.7 The HPA Axis 
Animals respond to environmental stressors by employing a number of physiological 
and behavioural responses, which are collectively termed the ‘stress response’. Stress 
is universally described as perturbed homeostasis. To correct for stress, a number of 
process are involved including the endocrine, immune, and nervous systems. 
Behaviour and physiological response to stress serve the primary purpose of survival 
such as improved cognition, euphoria, increased respiratory rate, and cardiovascular 
tone and these are to name a few (206). Due to the wide array of physiological and 
effects of stress, a number of endocrine and neuronal systems work separately and in 
tandem to regulate the body’s response to stress which is regulated by the 
hypothalamus-pituitary-adrenal (HPA) axis.  
To summarise HPA axis feedback which will be described in detail in the sections 
below: stress is initially detected in the neurons localised in the paraventricular nucleus 
(PVN) of the hypothalamus, upon stimulation the PVN synthesizes and secretes 
corticotropin-releasing factor (CRF). Once released, CRF travels via the hypophysial 
portal vessels to target the anterior pituitary. CRF subsequently binds to its receptor 
on pituitary corticotropes and induces the release of ACTH, which is released into 
general circulation. Once in system circulation ACTH is able to target the adrenal 
cortex by binding to its receptor MC2R which is expressed in steroidogenic cells in 
the zona fasciculata. Upon binding of ACTH to MC2R, glucocorticoids are 
synthesised and released from the zona fasciculata. The regulation of the HPA-axis 
works on a negative feedback mechanism in which glucocorticoids bind to various 
regions throughout the brain to inhibit the stress response. However, this system can 
be perturbed and can result in a number of pathologies (207).  
 





Figure 1-11. Diagram depicting basic HPA-regulation and feedback. The 
hypothalamus produces corticotrophin-releasing hormone (CRH), which travels to the 
anterior pituitary. Here it stimulates the release of adrenocorticotropic hormone 
(ACTH). The release of ACTH into the bloodstream allows it to bind to the highly 
specific melanocortin 2 receptors (MC2R) on the surface of the zona glomerulosa, 
stimulating the production of cortisol. Cortisol acts at the level of the hypothalamus to 
produce a negative feedback loop and stop cortisol production. Adapted from (208). 
 
1.7.1 Anatomy of stress response  
Appropriate regulation of glucocorticoid production and response is essential for 
survival, and instances resulting in too much or too little circulating can result in 
serious pathological conditions. Depicted in figure 1-11, a healthy response to stress 
sees a rapid increase in glucocorticoids following a stressful stimulus, this is shortly 
followed by a rapid decline and subsequent termination of the event. However, if the 




stimuli is maintained in the case of chronic stress, this results in the prolonged 
exposure and body wide impacts of glucocorticoids catabolic properties, stress 
peptides and proinflamatory cytokines. This continued stimulus can result in 
neuropsychiatric, metabolic and endocrine disorders (209).   
 
1.7.1.1 Components of the HPA axis 
Corticotropin-releasing factor was originally isolated from ovine hypothalamic tissue 
in 1981, and has since been shown to be the primary regulator of ACTH release from 
the anterior pituitary corticotropes (210). The physiological actions of the CRF family 
of peptides exert their effects through two distinct receptor subtypes which belong to 
the class B family of G-protein coupled receptors, CRF type 1 receptor (CRFR1) and 
CRF type 2 receptor (CRFR2). The regulation of neuroendocrine activities by CRF are 
mediated through its receptor CRFR1 in anterior pituitary corticotrophs. CRF binds to 
CRFR1 and results in the stimulation of adenylate cyclase which is then able to 
stimulate the cAMP pathway and release of ACTH from the anterior pituitary into 
circulation. CRFR1’s essential role in ACTH release was confirmed through 
experiments conducted in mice with an ablation of CRFR1, the results from this study 
demonstrated a highly disrupted HPA axis and increased anxiety related behaviours 
(211, 212).  
The nonapeptide vasopressin is highly expressed in the PVN, supraoptic (SON), and 
suprachiasmatic nuclei of the hypothalamus. The parvocellular neurons of the PVN 
synthesize and release vasopressin into the hypothalamic portal circulation where it 
heightens the effects of CRF on ACTH release from the anterior pituitary. During 
periods of prolonged stress, the role of vasopressin becomes even more important as 
it maintains the responsiveness of ACTH to novel stressors (213, 214).  
ACTH is formed from pro-opiomelanocortin (POMC), a prohormone that is highly 
expressed in the hypothalamus and pituitary. POMC is cleaved into a number of 
bioactive peptides, one of which is ACTH but also include β-lipotropic hormone, β-
endorphin and melanocortins (215). Upon release from the pituitary, ACTH can now 
bind to its receptor MC2R in parenchymal cells of the zona fasciculata of the adrenal 




cortex. The binding of ACTH to MC2R initiates the cAMP pathway that leads to the 
production of steroid products, such as glucocorticoids, mineralocorticoids and 
androgens (216). More specifically, ACTH initiates the conversion of cholesterol into 
5-5 pregnenolone, an essential initial step in the production of glucocorticoids (8, 217).  
 
1.7.2 Regulation of HPA axis   
As described, the HPA axis is regulated via a negative feedback mechanism, under the 
control of glucocorticoids. Inhibition of the HPA axis occurs in the brain, however GR 
has been identified throughout numerous regions in the brain and determining the 
specific region of negative feedback remain elusive. However, two key regions have 
been identified, the hypophysiotropic neurons of the PVN and the hippocampus. The 
PVN was identified through experiments that examined the effects of locally 
administered glucocorticoids on the hypophysiotropic neurons of the PVN. This 
revealed that stimulation of these neurones was able to relieve the effects of 
adrenalectomy-induced ACTH hypersecretion. Again, experiments examining the 
impact of local glucocorticoid administration on the hippocampus revealed not only 
reduced stress response but also decreased basal glucocorticoids (218, 219). 
Glucocorticoids have also been shown to act at the level of the pituitary to modulate 
HPA activity and is thought to be the reason for the appreciable differences in HPA 
axis function across individuals (220). Two distinct mechanisms have been identified 
in which glucocorticoids can regulate this negative feedback through GR. The first and 
most well characterised mechanism occurs through a delayed process in response to 
circulating levels of glucocorticoids and works via genomic alterations (221). The 
second less characterised mechanism of feedback regulation works in response to the 
rate of glucocorticoid production and is thought to work via fast non-genomic actions, 
however this process is still not clearly understood (222).  
 
 




1.7.3 Effects of chronic stimulation or under stimulation of the HPA axis  
The stress response normally only lasts for a short period of time, however, during 
these short periods other bodily functions become supressed with no adverse impacts 
to the individual. These include the suppression of growth, reproductive systems, 
metabolism and immune response. Inappropriate activation of the HPA axis for longer 
than normal can lead to a number of disorders associated with chronic low or high 
levels of glucocorticoids, detailed in table 1-3 (223). Furthermore, disruption of signals 
to the adrenal can result in the alteration of cortex zones. Overstimulation signals or 
loss of signalling can result in enlargement or shrinkage of the affected cortex zone. 
This is not to be confused with the remodelling process that occurs during development 
in which there is a tightly regulated differentiation process (detailed in section 1.4), 
rather it is a loss or increase in the differentiated cell populations of the effected zones 
and the steroids they produce (224).  
Table 1-3. Summary of diseases associated with dysregulated HPA function. Table 
highlighting the impact of sustained high or low circulating glucocorticoids.   
 
Increased HPA Axis Decreased HPA Axis 
Chronic stress Adrenal insufficiency  
Melancholic depression  Atypical seasonal/depression  
Anorexia nervosa  Chronic fatigue  
Obsessive-compulsive disorder  Fibromyalgia  
Panic disorder  Hypothyroidism  
Chronic active alcoholism  Nicotine withdrawal  
Alcohol and narcotic withdrawal Premenstrual tension syndrome  
Panic disorder Postpartum period  
Diabetes mellitus  After chronic stress  
Childhood sexual abuse  Menopause  
Hyperthyroidism  
Cushing’s syndrome   
Pregnancy   




1.7.4 The HPG axis and its cross talk with the HPA axis 
 
The hypothalamic-pituitary-gonadal (HPG) axis is essential for regulation of processes 
involved in development, reproduction and ageing, as well as many others. The 
regulation of the HPG axis is achieved through the release of gonadotropin releasing 
hormone (GnRH) from the hypothalamus which travels to the anterior pituitary to 
stimulate the release of luteinizing hormone (LH) and follicle stimulating hormone 
(FSH) into the blood stream in which it is able to target the gonads. In the testis, LH 
stimulates the leydig cells to produce androgens. In addition to this, FSH stimulates 
the sertoli cells to produce androgen binding protein (ABG) along with inhibin. The 
increased levels of androgens and inhibin then act to create a negative feedback at the 
pituitary and hypothalamus to stop androgen production. In the ovary, LH binds to 
theca cells and FSH binds to the granulosa cells to stimulate the production of 
oestrogens and inhibin. The increased levels of oestrogen and inhibin negatively 
regulates at the level of the hypothalamus (225). The HPG and HPA axis are not 
completely independent entities and research has highlighted cross-talk between the 
two feedback systems. One of the most notable examples of this is how the adrenal 
axis is able to regulate gonadal function. This is illustrated by the inhibitory effects of 
stress on reproductive behaviour and sex steroid release. Furthermore, several 
components of the gonadal axis can have reciprocal effects on the HPA axis. Studies 
investigating humans and rats noted that stress and high doses of glucocorticoids 
generally disrupt many aspects of the HPG axis including reproductive behaviour, 
LHRH expression, plasma LH secretion and sex steroid synthesis and release (226, 
227). Conversely, oestrogens and androgens are able to act on several levels of the 
HPA axis, including adrenocorticoid synthesis, stress-induced ACTH and 
glucocorticoid release and CRH and AVP synthesis in the paraventricular nucleus 








1.7.5 Roles of AR and GR signalling in psychiatric disorders 
 
Intense or chronic bouts of stress have been shown to result in emotional disturbances 
and hormonal disruption that can ultimately culminate in a psychiatric disorder (229). 
In patients that have been diagnosed with conditions such as depression or anxiety 
more than 50% of these have hyperactivity of the HPA axis (230, 231). HPA axis 
activation results in low affinity for food, low sex drive, increased blood flow to 
muscle, increased locomotive activity and raised blood sugars which prime the body 
to respond to a stress event (232). In normal conditions these bursts of activity last for 
only a few minutes at a time, however, prolonged stress is thought to overstimulate the 
HPA axis causing hypersecretion of CRH and can ultimately, if left untreated, lead to 
the dysregulation of the HPA axis potentially promoting the onset of a psychiatric 
disorder (233). Previous studies have highlighted the role of GR in the brain and its 
role in cognitive function (234). For example, it has been shown that glucocorticoids 
acting through GR in the hindbrain can enhance the arterial pressure in response to 
acute restraint stress (235) suggesting that GR is required for an appropriate stress 
response in healthy individuals. Persuasive evidence points to dysfunctional GR in 
HPA axis dysregulation, which has been successfully resolved upon antidepressant 
treatment (232). Additional transgenic studies that use antisense RNA complimentary 
to mRNA to knock down GR in the brain noted that mice display characteristics of 
depression in addition to altered behaviour (236).  Using mouse models to mimic any 
human behaviour is an extremely difficult undertaking, especially in relation to 
psychiatric disorders which are often multifactorial. Patient symptoms are often 
heterogeneous in psychiatric disorders (237). For example, some patients experience 
excessive weight gain while other patients with the same psychiatric condition 
experiences weight loss or chronic fatigue and insomnia (238). In additional to this, a 
mouse’s  response to stress differs due to the lack of conscious self (239). However, 
stress behaviours that can be measured and quantified and therefore permit 
investigation of endocrinological and behavioural alterations have been identified in 
rodents that giving greater opportunity to better understand the aetiology of psychiatric 
disorders.  




Androgens have interestingly also been suggested to play a role in the regulation of 
psychiatric conditions such as anxiety and depression. Men have been shown to have 
a decreased incidence of mood disorder diagnosis compared to women and this is 
thought to be due to the higher levels of circulating testosterone in men (240). This 
was also noted in a study that examined the salivary T levels in young girls and boys, 
and individuals that had lower testosterone experienced higher levels of anxiety and 
depression (241). Age related androgen decline has also been associated with negative 
mood and depression in aging men and women (242). Treatment with exogenous 
androgens in rodents also demonstrated improved cognition and performed better in 
anxiety behaviour tests, demonstrating increased explorative behaviour and time spent 
out in the open (243, 244). The mechanism underpinning the anti-anxiety effects of 
androgens were thought to be due to androgen signalling in the central nervous system 
(CNS), but cell specific ablation of CNS AR using Nestin-Cre demonstrated no impact 
on behaviour or the HPA axis and suggested this stress regulation was occurring at 















The proposed hypothesis is that androgen receptor and glucocorticoid receptor play an 
important role in the development and maintenance of the adrenal cortex and is 
essential in X-zone regulation and appropriate function of the HPA-axis.  
 
1.8.1 Objectives 
1. To utilize a Cre line previously developed in the Smith group to ablate 
androgen receptor or glucocorticoid receptor specifically from the mouse 
adrenal cortex. 
  
2. To define the role of androgen receptor and glucocorticoid receptor in the 
regulation of the male adrenal cortex. 
 
3. To define the role of androgen receptor and glucocorticoid receptor in the 
regulation of the female adrenal cortex. 
 
1.8.2 Rationale 
The regulation of the adrenal cortex by androgens was demonstrated as early as 1927 
(246), and many androgen receptor ablation models have been developed from then in 
the form of global androgen receptor knockouts (160) and cell specific knockouts (163, 
164, 245, 247), that have investigated various cell types in the brain and reproductive 
tissues. Despite this early identification of the potential impact of androgen signalling 
as a regulator of the developing adrenal, and numerous global knockout models 
targeting AR, very little work has touched upon the impact of adrenal AR signalling, 
especially in the rodent. This may be in part due to the fact that the rodent adrenal does 
not produce androgens and has therefore potentially been overlooked as a model to 
investigate its action (111). GR signalling has also been extensively researched and its 
resulting impact on the HPA axis (109), but this research has primarily focused on GR 
targeting in neuronal tissue (199, 248-250), thus far, no models have specifically 
ablated GR from the adrenal cortex. Furthermore, AR and GR have been shown to 




interact in a number of cell types to control target genes (203, 205, 251, 252), but if 
they interact in the adrenal cortex has still not been described.  
1.8.3 Experimental approach  
The first steps in this project is to ablate AR or GR from tissues expressing a Cre 
targeted to the Cyp11a1 locus that will permit the targeting of genes in steroidogenic 
cell types (253). In addition to gene ablation, further androgen manipulation will be 
achieved through castration, and hCG treatment. Following these methods, analysis 
will include, physiological, histological, cellular and molecular techniques to 





Chapter 2. Materials and Methods  
2.1 Mouse breeding and maintenance  
2.1.1 Husbandry and Welfare  
Mouse colonies were housed and maintained in the University of Edinburgh’s BRF 
Little France Animal Facility. Mice were kept in strict housing conditions with 
humidity maintained consistently at 55%, ambient temperatures between 20-25 oC. 
Mice were also kept in a 12 hour light/dark cycle. Food and water supply in the cages 
was unrestricted. Mice were maintained in adherence to conditions laid out by the 
Animals (Scientific Procedures) Act, 1986.  Housing conditions and colony breeding 
adhered to ARRIVE guidelines (254) and UK Home Office regulations under project 
license 80/7704 held by Professor Lee Smith. Day to day animal husbandry and setting 
up of breeding pairs was carried out under my direction by Mike Dodds, whose help 
has been invaluable.  
 
2.1.2 Timed Mating  
To investigate embryos at specific time points, timed matings were performed. One 
male and one female were housed together in the afternoon, with copulation to be 
expected in the next dark cycle. Females were checked for vaginal plugs at 8am the 
following morning, this allowed appropriate calculation of gestational age of the 
embryos. Morning of plug discovery is designated e0.5. Mice are not sexually mature 
until postnatal day d50, so to ensure successful mating, mice from d50 onward were 
used. 
 
2.1.3 Transgenic mouse lines; Cre/loxP recombinase  
Cre recombination technology is a well described and extremely useful tool in 
investigating gene function within a specific tissue. This system works by method of 
site-specific recombination occurring in P1 bacteriophage (255) Cre recombinase is an 
enzyme that can recombine DNA between two 34 bp loxP sites. These sites consist of 
directional components that dictate the result of the recombination. If loxP sites are 
inverted this will result in an inversion of the DNA between these sites, if the 
directionality of loxP sites are repeated this will result in deletion of the DNA between
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these two sites and if the loxP sites are located on different chromosomes, this can 
result in chromosomal translocation (256).  
 
2.1.3.1 Cell-Specific Cre recombinase  
Transgenes constructed with Cre recombinase driven by cell specific promoters permit 
the expression of Cre in specific cell types of interest. An additional level of control is 
achieved by introducing a fused Cre to a ligand-inducible nuclear translocation signal, 
such as that found in the nuclear hormone receptor family. A Cre generated using this 
method does not transport to the nucleus and execute recombination until introduced 
to a ligand specific to the hormone receptor of choice. A corresponding ‘floxed’ line 
is then generated to surround the selected sequence by loxP sites.  The sequence 
selected can either be the whole gene, or part of a gene, such as an exon that codes for 
a region essential for that protein’s function (257). The same mechanisms can also be 
used to investigate a ‘reporter gene’ which can be chromogenic or fluorescent. 
Transgenic constructs can be created with a reporter gene of interest inserted into a 
ubiquitously expressed locus with an upstream stop codon which is flanked by loxP 
sites. The resulting recombination permits excision of the stop codon and subsequent 
expression of the reporter gene. Setting up matings with a ‘Cre’ line to a ‘floxed’ line 
results in some offspring inheriting both transgenes and undergoing a cell specific 
ablation of the required gene, or the activation of a gene of interest. The general 
principle of this is illustrated in figure 2-1.  
 
Figure 2-1. Cre/lox Mouse Breeding (258). 
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2.1.3.2 Generation of Cyp11a1-GC Cre; YFP Reporter line  
This line was generated through use of Rosa26 mice (259) carrying an insertion of a 
yellow fluorescence protein (YFP) transgene downstream from a stop codon flanked 
by loxP sites (260). When females homozygous for Rosa26YFP (R26YFP) are bred to 
a male carrying a Cre transgene under control of a desired promotor, 100% of the 
resulting offspring will inherit one copy of the R26YFP transgene from the mother but 
50% of the offspring will inherit the Cre transgene from the father, thus allowing cell 
specific expression of YFP (Figure 2-1).  To generate adrenal specific knockout mice, 
Cre expression in the adrenal cortex needed to be confirmed, so R26YFP female mice 
were bred to males of a Cre line driven by a Cyp11a1 promoter. This line was created 
by insertion of a GC-GFP transgene to the endogenous Cyp11a1 locus (Cyp11a1+/GC) 
(253). The Cyp11a1+/GC Cre line permitted cell specific recombinase action in tissues 
expressing Cyp11a1 and thus an appropriate Cre line for conditional ablation of steroid 
genes from the adrenal cortex. 
 
2.1.3.3 Generation of androgen receptor knockout mice 
Ablation of androgen receptor specifically from the adrenal cortex was achieved 
through the use of the Cyp11a1+/GC Cre line as described in 2.1.3.1 and a floxed AR 
line. The AR floxed (ARflox) line was generated through homologous recombination 
of a transgene construct to insert a loxP site in exon 1 and exon 3 of the AR gene (164, 
247), thus resulting in a floxed exon 2 after recombination by Cre (261). Matings set 
up with females that were homozygous ARflox to a male carrying a Cre of interest, will 
result in male offspring all carrying the ARflox transgene. Due to the location of AR on 
the X-chromosome it is always inherited from the mother. Additionally, 50% of the 
litter will also carry the Cre transgene which will result in tissue specific recombination 
of AR.  ARflox females were bred to Cyp11a1+/GC males to produce offspring with total 
adrenal androgen receptor ablation (Ad-ARKO). As previously described, AR is on 
the X-chromosome and due to X-chromosome inactivation females from the 
aforementioned mating inherit a floxed AR from their mother but a wild-type AR from 
their father, resulting in mosaic adrenal AR ablation. To fully ablate AR from the 
adrenal cortex in females a second round of breeding is required, this involved the 
breeding on Cre+ Ad-ARKO male to an ARflox female. The subsequent litters now 
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have females carrying complete ablation of AR from the adrenal cortex. Both 
generations were used in this thesis as part of the female study and were termed 1st 
Generation Ad-ARKOs and 2nd Generation Ad-ARKOs respectively.  The ARflox line 
used in this thesis was originally obtained from Karel de Gendt and Guido Verhoeven, 
University of Leuven, Belgium.  
 
2.1.3.4 Generation of glucocorticoid receptor knockout mice 
Ablation of glucocorticoid receptor from the hindbrain was achieved through the use 
of the Cyp11a1+/GC Cre line as described in 2.1.3.1 (253) and a floxed GR line. The 
GR floxed (GRflox) line was generated through homologous recombination of a 
transgene construct to insert a loxP site into an EcoRI restriction site in intron 1-2 and 
upstream of a BamHI site in intron 3-4, thus resulting in floxed exon 3 (248). A 
Cyp11a1+/GC female was mated to a male homozygous for floxed GR The first 
generation from this mating resulted in litters heterozygous for GRflox that were either 
Cre- or Cre+. For total GR ablation from the hindbrain, a Cre+ GR heterozygous male 
was mated to a GRflox female. The resulting offspring were Cre- Hom termed 
‘littermate control’ (LMC), Cre- Het, termed ‘Het littermate control’ (Het LMC),  Cre+ 
Hom, termed ‘Hindbrain GR knockout’ (HB-GRKO), Cre+ Het, termed ‘Het 
hindbrain GR knockout’ (Het HB-GRKO). In addition to these mice, an external 
control group of c57bl/6J wildtype (WT) male and female mice that have had no 
interaction with GR knockout mice but have been housed on the same shelf and under 
the same conditions. These animals are termed ‘WT Bl6’. GRflox mice used in this 
thesis were obtained from an established colony being maintained in BRR little France 
animal facility, University of Edinburgh. 
 
2.2 Treatments  
2.2.1 Human chorionic gonadotropin (hCG) 
It has been documented that hCG is able to stimulate Leydig cells to produce increased 
levels of circulating androgens. This treatment was used to generate mouse models 
with high circulating androgens. For single treatments, 200 IU/ml of hCG solution was 
IP injected at a volume of 0.1 ml to administer a final dose of 20 IU. Single injection 
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animals were culled 16 hours later. Injections were carried out at 5pm and collected 
the following morning at 9am. hCG treated animals. Injections were carried out by 
BRR technician Mike Dodds or by myself.   
 
2.2.2 Castration  
Generating mouse models with no circulating androgens was achieved through 
castration. This was achieved through making a single 1cm incision into the scrotum 
exposing the testes and removing them. Following removal of the testes, the site of 
incision was closed with sterile sutures. Mice were injected subcutaneously with 
Buprenorphine 0.05mg/kg whilst anaesthetised, then were allowed to recover whilst 
being monitored. Mice were then closely monitored over the next 24 hours for any 
welfare problems, and twice daily from then onwards. Castrations were carried out by 
BRR technician William Mungal. Mice were then collected two weeks later to ensure 




2.3.1 Culling of Mice 
Culling of postnatal animals was carried out by inhalation of rising CO2 
concentrations. Confirmation of death via cervical dislocation. In instances when 
bloods or pituitaries were collected, animals were culled via inhalation of CO2 and 
once bloods were collected confirmation of death was carried out by exsanguination 
through cutting the main artery in the leg or underarm. Culling of neonates was 
performed by decapitation.  
2.3.2 Whole mouse observations and measurements  
After culling, mice were examined for overall condition which included coat condition 
and any signs of barbering; as the adrenal was targeted this can be a clear indication 
of stress. As androgens were disrupted each mouse was also weighed and anogenital 
distance (AGD) measured through the use of electronic callipers (Faithful Tools, Kent, 
UK). AGD is a standard measurement for androgen action throughout development 
(262).  




2.3.3 Collection of bloods and serum  
To analyse circulating hormones, bloods were collected immediately after CO2 
inhalation via cardiac puncture. Due to the quick nature in which serum levels of 
ACTH and corticosterone can rise due to handling stress, animal cage movement and 
handling was kept to a minimum prior to culling. All blood samples were taken at 
10am. A 21 gauge needle (Becton Dickson, UK) was used with a wide bevel to prevent 
blood lysis, collected into a 1ml syringe (Becton Dickson, UK). The needle was not 
coated with an anticoagulant but following collection blood samples were immediately 
decanted into 0.5% EDTA coated tubes (Greiner bio-one, Austria). Due to the unstable 
nature of adrenocorticotropic hormone (ACTH) blood needed to be centrifuged within 
20 minutes of collection. The blood samples were centrifuged at 26,054g for 10 
minutes in a 4oC chilled microcentrifuge. Centrifugation resulted in two the formation 
of two layers: serum and pellet.  Serum should be clear, if samples are pink or red this 
denotes red blood cell lysis and could impact serum quality. Serum was then carefully 
collected and stored at -80 oC for long-term storage.  
 
2.3.3.1 Serum analysis by ELISA  
Analysis for the presence of corticosterone (Abora Assays, KO14-H5) or ACTH 
(Antibodies Online, ABIN415571) in serum samples was achieved through enzyme-
linked immunosorbent assay (ELISA) according to the manufacturer’s instructions. 
This assay is able to measure the concentration of an antigen in a sample of interest by 
binding to a target antibody. There are a few variations of ELISA kits, the two methods 
that were used in this thesis were a sandwich ELISA for corticosterone and a 
competitive ELISA for ACTH. A sandwich ELISA works by quantifying antigens 
between two layers of antibodies termed ‘capture’ and ‘detection’ antibodies. The 
general principle for this method is as follows: Plate is coated with capture antibody; 
the sample is then added to the plate and any antigen binds to the capture antibody; the 
detection antibody is added and binds to the antigen; enzyme-linked secondary 
antibody is added and this then binds to the detecting antibody; finally, the substrate 
is added and this converts the enzyme into a detectable form which can then be 
analysed. A competitive ELISA works based on a competitive-binding process, 
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achieved through a sample antigen and an add-in antigen. The general principle for 
this method is as follows; an unlabelled primary antibody is incubated with a sample 
antigen; these complexes are then added to a 96-well plate which are pre-coated with 
the same antigen; washes are then performed to remove any unbound antibody 
remaining (the more antigen in a sample of interest will result in less antibody able to 
bind to antigens in the plate); the secondary antibody that is specific to the primary 
antibody and conjugated with an enzyme is then added; a substrate is then added that 
reacts with enzymes to elicit a colour change inversely proportional to the amount of 
antigen in a sample. Once this is done, plates can be analysed on a plate reader at the 
manufacturers recommended wavelength. Both Assay were analysed on a plate reader 
at a wavelength of 450nm. Plates were analysed using ELISAanalysis.com to plot a 
standard curve.  The standard curve was created with the log of ACTH/Corticosterone 
concentration on the y-axis and absorbance on the x-axis. The best fit straight line 
through the standard points was determined by regression analysis.  
 
2.3.4 Collection of Tissues  
Organs of interest were collected as described in the subsequent sections. Tissue was 
either frozen immediately in dry ice for RNA analysis or fixed in Bouins (Clin-Tech, 
Guildford, UK) for histological analysis.  
 
2.3.4.1 Adrenal tissue  
To prevent RNA degradation, tissues were collected immediately after culling. To 
recover adrenals, access to the main cavity was required. This was achieved through 
an incision made in the stomach following a wash with 70% ethanol above the genitals 
to avoid disruption and an incision made on both sides of the body. As the adrenals are 
located on top of the kidney, the intestines had to be carefully moved to one side. To 
provide experimental consistency, the left adrenal was collected and fixed in Bouin’s 
solution for four hours. The right adrenal was more difficult to collect as it is located 
behind the intestine and liver and is closer to a main artery compared to the left adrenal, 
this on occasion lead to disruption or damage during collection and for these reasons 
the right adrenal was used for RNA analysis as the tissue would ultimately be 
homogenised. Adrenal tissue for RNA analysis was snap frozen in dry ice and stored 
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at -80oC long-term.  Adrenals are surrounded by a lot of fat, for removal, a fat pad was 
lifted with fine dissection forceps and a cut made between the adrenal and the kidney, 
with careful attention made to not grab the adrenal itself. Once removed from the body, 
the adrenal still had a lot of fat surrounding it. For accurate weight measurement and 
to prevent contamination of future RNA samples fat was removed with fine dissection 
scissors ether by eye or under a dissection microscope. As it has been previously noted 
that the adrenals on the left and right have slightly different shapes, a small cohort 
(n=5) were collected were the right adrenal was fixed and the left adrenal frozen. 
Human adult adrenal tissue was generously gifted by Dr Anne Jorgenson of 
Copenhagen University, Denmark. Two individual male samples were provided 
following patient biopsies. Foetal adrenal tissue was generously gifted by Dr Rod 
Mitchell, Edinburgh University, UK. Again, two individual male samples at 19 weeks, 
were provided from human foetal tissue obtained via elective abortion. Ethical 
approval for human tissue was obtained for the use of archived human testicular tissue 
from the pathology departments at the Western General Hospital in Edinburgh (REC 
Reference number-10/S1402/33) and Erasmus MC-University Medical Centre, 
Rotterdam (Institutional review board-MEC 02.981 and CCR2041). 
 
2.3.4.2 Testis tissue 
Once the abdomen was opened as described in 2.3.3.1, the testis were pulled up from 
the scrotum by using forceps to pull on the fat pads. This results in the movement of 
the testis from the scrotum to the abdomen for easy removal. Again, handling of the 
testis was by holding the surrounding fat to avoid organ damage. Only testis tissue was 
collected, therefor careful removal of the epididymis and vas deferens was performed. 
Once removed, the testes were weighed and left testis was fixed in Bouin’s for 5 hours, 
cut in half and left to fix for another hour to ensure complete penetration of fixative. 
The right testis was cut in half and snap frozen in dry ice then kept at -80oC for long-
term storage.    
2.3.4.3 Ovary tissue  
The main body cavity was opened as described in 2.3.3.1. Intestines were carefully 
moved to the side to expose the ovary and the uterine horn. The uterine horn was 
followed to the top to locate the ovary. The ovary was lifted by surrounding fat and a 
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cut made between the ovary and the uterine horn and any remaining fat removed. For 
consistency the left ovary was fixed in Bouin’s for four hours and the right ovary was 
snap frozen in dry ice and kept in -80 for long-term storage.  
 
2.3.4.4 Brain and pituitary tissue  
To collect brain and pituitary tissues, the head was first washed with 70% ethanol, 
mice where then decapitated carefully to ensure no disruption to the base of the skull 
to protect the pituitary. Hair was then removed and in incision was wade from the back 
of the skull to between the eyes, scissors were then delicately placed between the 
incisions and opened. This resulted access to the brain, which was then delicately lifted 
out and dissected into the fore, mid and hindbrain sections. These sections were 
individually snap frozen in dry ice and stored at -80 for future genomic DNA 
extraction. Once the brain was removed the pituitary could then be seen at the base of 
the cranium.  The pituitary was carefully removed by placing fine forceps underneath 
the pituitary and scooping it out. Pituitaries used in this study were all snap frozen in 
dry ice and kept at -80 for long-term storage.  
 
2.3.4.5 Foetal adrenal   
To obtain embryos, plug checked pregnant dams were culled via inhalation of CO2 and 
confirmation of death via cervical dislocation. The pregnant dam was then opened as 
described in 2.3.3.1 to reveal the pregnant uterus. The whole uterus was removed and 
then each embryo was removed from its amniotic sac and placed immediately into 
chilled PBS if fine dissection was required or into Bouin’s fixative for 8 hours. Fine 
dissection of adrenals were then placed into Bouin’s for 2 hours.  
 
2.3.4.6 Analysis of tissue weights 
To be able to appropriately analyse organ weight, for each experimental group an n=5-
8 were averaged and plotted using Prism GraphPad 7. Error bars displayed on graphs 
are standard error of the mean (SEM) and were analysed using the most appropriate 
statistical test depending on ages being analysed or number of groups being compared.  
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2.3.4.7 Barbering Scale  
To determine if barbering observed falls out with normal cage behaviour, hair loss was 
graded as follows; No hair loss = 0, removal of whiskers = 1, removal of whiskers and 
facial hair = 2, removal of whiskers, facial hair that extends to head = 3, removal of 
whiskers and hair on the face, head and back = 4 and removal of whiskers and hair on 
the face, head, back and stomach = 5. Hair loss that was noted from 0-2 was deemed 
to fall within the normal range of barbering that would be expected in WT animals, 
any barbering scored 3 or higher was deemed abnormal and was more severe than 
would be expected under normal conditions (263, 264).  
 
2.4 Histology  
2.4.1 Fixation, embedding and sectioning of tissues  
After being fixed in Bouin’s for the appropriate amount of time, tissues were removed 
and then placed into 70% ethanol for storage (no more than 6 months) until they were 
processed for embedding. Samples undergo automated processing which involves 
Bouin’s fixed tissue placed through a series of graded alcohols for 17.5 hours in an 
automated Leica TP1050 tissue processor (Leica Microsystems, Milton Keynes, UK) 
and embedded by hand in paraffin wax. Tissue processing was carried out by Garry 
Menzies in the SURF department of University of Edinburgh.  
To be able to perform analysis on embedded tissue, a microtome (Leica, model RM 
2135) was used to cut tissue section with a width of 5µm. These sections were then 
floated in a water bath (Lamb RA, model E/65) to help dissipate any wrinkles in the 
wax before mounting on slides that were statically charged to provide appropriate 
adherence of the tissue to the slide. For health and safety purposes, white slides were 
used for mouse tissue and pink slides for human tissue (Leica Biosystems, Germany). 
Slides with mounted sections were then dried overnight in an oven set to 50 oC. Slides 
were allowed to cool before performing any analysis.  
2.4.2 Haematoxylin and Eosin (H&E) staining 
To be able to perform histological analysis tissue sections need to be stained to make 
tissue structures visible which is made possible through the use H&E staining. Slides 
are first dewaxed, this is achieved by immersion in xylene for 5 minutes, and this step 
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is performed twice. Following xylene, slides are then rehydrated which involves 
immersing the sections in decreasing concentrations of alcohol (figure. 2-2). After 
briefly being washed with tap water tissue is then stained for 5 minutes in 
haematoxylin, this stains the nuclei blue. Slides are again washed in tap water and 
placed in 1% alcohol acid, again briefly washed in tap water and placed into Scott’s 
tap water, eosin for 30 seconds, tap water, and then dehydrated by increasing 
concentrations of ethanol. Slides were finally placed in xylene for 5 minutes and then 
mounted with a coverslip (VWR, UK) and Pertex mountant (Cell path, UK).  
 
 
Figure 2-2. Schematic of H&E protocol  
 
2.5 Immunohistochemistry  
Immunohistochemistry is an extremely useful tool that permits the visualization of a 
specific protein in thin sections of fixed tissues. This can be achieved either via 
chromogenic or fluorescent detection systems that use an antibody against the protein 
of interest. Visualization of proteins in experimental animals was performed on no 
fewer than five different samples per group. All immunohistochemistry experiments 
performed included appropriate littermate and age matched controls, in addition to a 
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positive control slide, which the antibody in known to work in, along with a negative 
control to ensure staining observed is not unspecific or inappropriate binding.  
 
 
Figure 2-3 Schematic of different immunohistochemistry techniques  
 
 
2.5.1 General protocol  
Detailed steps are denoted in subsequent sections (2.5.1-2.5.9) 
 Section fixed in Bouin’s and embedded in paraffin wax were sectioned at 5µm 
and placed on a slide and dried.  
 Sections went through dewaxing and rehydration.  
 Slides were placed in a decloaking chamber for antigen retrieval  
 Non-specific antigens were blocked through use of serum 
 Tissue was then incubated at 40C overnight in specific primary antibody  
 A secondary antibody was then added and detected using various amplification 
systems 
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 Protein of interest was detected using various colour detections. This could be 
achieved through colour reaction (DAB) or fluorophore excitation (direct or 
indirect fluorescence) 
 Once stained slides were then covered with a coverslip with pertex or Permafluor 
depending on method used.   
 
2.5.2 Sectioning, dewaxing and rehydrating  
These steps are detailed in sections 2.4.1 and 2.4.2  
 
2.5.3 Antigen retrieval  
Tissue fixatives can impact the ability for a primary antibody detect antigens of 
interest. This occurs in Bouin’s fixative and this is because it creates protein cross-
linking which is very beneficial in maintaining the integrity of tissue samples but this 
results in masking of protein and antigenic sites. For best results and best antigen 
detection, cross link removal was needed. This was achieved in a pressure cooker 
(Instapot, Amazon, UK) which enabled heat induced antigen retrieval.  Slides were 
rehydrated, placed in a plastic rack and immersed in a citrate buffer solution. Citrate 
buffer pH depended on the antibody being used, concentrations commonly used were 
pH6 and pH9 (25mls citrate buffer; and 225mls of dH2O). Following immersion of 
slides in citrate solution they were placed in the pressure cooker for a 50 minute cycle. 
Temperature increased over a 20 minute period to 125 oC and was maintained for five 
minutes. At the end of the five minute period the pressure cooker was vented and 
allowed to cool for 20 minutes before removal. Slides were cooled and rinsed in tris 
buffered saline (TBS; Section 2.12.2.1) for five minutes.  
2.5.4 Blocking non-specific sites   
Antibodies will show preferential avidity for specific antigens, however there is the 
potential for partial non-specific binding to sites on non-specific targets particularly 
when polyclonal primary antibodies are used. Preventing non-specific binding is 
essential as it results in background and has the potential to mask the antigen of 
interest. Prevention of non-specific staining can be achieved through peroxidase 
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blocking and serum blocking. Peroxidase blocking is essential for blocking 
endogenous peroxidases found in the tissue, if not blocked, can result in high 
background and unspecific staining. This blocking step is particularly important in 
human tissue, however is also important for some rodent tissue. To do this, slides are 
first washed in hydrogen peroxide (25mls) and TBS (225mls) to produce an 3% 
H2O2;1x TBS solution. Slides were submerged in this solution for 15 minutes 
minimum to block endogenous peroxidases. Concentrations of hydrogen peroxide 
solutions can vary depending on type and species of the tissue and must be checked 
before completing this step. Higher concentrations of endogenous peroxidases need a 
stronger hydrogen peroxide concentration when washing. After this step slides were 
then washed in 1x TBS for 2x 5 minutes. Following these washes, slides were dried 
and tissue drawn round with a hydrophobic pen (Vector, UK). Preventing non-specific 
binding is essential as it results in background and has the potential to mask the antigen 
of interest. Prevention of non-specific staining can be achieved through serum 
blocking. Diluted blocking serum, described in section 2.12.1.6 was chosen based on 
the species the secondary antibody was raised in. Slides were then incubated for 1 hour 
in a humidity chamber at room temperature.  
 
2.5.5 Primary antibody  
Before use on experimental tissue each primary antibody was optimised for all samples 
and ages examined in this thesis. The primary was diluted in the specific serum and 
evenly distributed over the tissue. A negative control was included which had no 
primary antibody and serum only and incubated at 4oC overnight in a humidity 
chamber. Primary antibodies used and dilutions are detailed in the table below (Table 
2.1).  
 





Table 2.1 Primary antibodies, method and dilutions for immunohistochemistry  
 
Protein stained for Method Dilution Primary antibodies 
HSD3B Single fluorescence 1:1000 HSD3B: Santa Cruz #sc30820 
AR Single fluorescence 1:800 AR: Spring Bioscience #M4070 
AR-N20 DAB 1:100 Santa Cruz Biotechnology #sc-816 
PCNA DAB 1:1000 Sigma #P-8825 
AKR1B7 Single fluorescence 1:25 Santa Cruz Biotechnology #sc-27763 
HSD20alpha Single fluorescence  1:1200 Aviva Systems Biology #40002 
GR DAB 1:200 Cell Signaling  #12041 
CYP21 DAB 1:100 Bioss antibodies #bs-2443R 
CASP3 Bond 1:100 CASP3: Abcam #ab4051 
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2.5.6 Secondary antibodies  
To remove primary antibody slides were washed in 1x Tris-Buffered Saline-triton 
(TBST) for 1x 5 minutes and 1x TBS for 2x 5 minutes. Following these washes the 
secondary was added to the tissue. All secondary antibodies used are described below 
in table 2.2.  
2.5.6.1 DAB chromogenic secondary antibody protocol 
Following the wash steps in section 2.5.6, slides were wiped to remove any excess 
buffer before applying a biotinylated secondary antibody diluted in appropriate serum. 
Slides were then left to incubate for 30 minutes in a humidity chamber at room 
temperature. Slides were then washed as previously described. Once wiped clean, 
slides were then treated with streptavidin HRP reagent (Dako, UK) diluted 1:1000 in 
1x TBS at room temperature for 30 minutes in a humidity chamber.  
 
2.5.6.2 Fluorescent secondary antibody protocol 
Washes to remove primary antibody were performed as described 2.5.6. Slides were 
wiped clean to remove any excess buffer before applying the secondary. Depending 
on the primary antibody, the appropriate peroxidase-conjugated secondary antibody 
was applied diluted at 1:200 in appropriate serum and incubated for 30 minutes in a 
humidity chamber at room temperature. 
 
2.5.7 Antigen detection  
2.5.7.1 DAB Chromogenic detection and counterstain 
Amplification of the biotinylated secondary antibody signal was achieved through 
incubation with streptavidin/horseradish peroxidase (HRP) (Vector, UK). Streptavidin 
was diluted 1:500 in 1xTBS in a humidity chamber for 30 minutes at room 
temperature. To visualise the antibody, slides were then incubated in 3, 3’– 
diaminobenzidine (DAB; DAKO) diluted 1 drop/ml of supplied buffer and used 
immediately. A successful reaction resulted in the development of a brown pigment 
located at antigenic site of interest as monitored under a microscope. This is a result 
of streptavidin catalysing the deposition of the brown pigment (Fig 2-3). Once a brown 
pigment could be observed the reaction was stopped by emersion in water. Slides were 
then counterstained for 5 minutes with haematoxylin. 



















Secondary antibody Conjugate Dilution Product number  
Chicken anti Rabbit Biotinylated  1:500 Santa Cruz Biotechnology (sc-2986) 
Goat anti Rabbit Biotinylated 1:500 Vector, UK (BA-1000) 
Goat anti Rabbit  Peroxidase 1:200 Vector, UK (PI-1000) 
Rabbit anti Goat Peroxidase 1:200 Sigma (A5420) 
Donkey anti Goat Peroxidase 1:200 Santa Cruz Biotechnology (sc-2020) 
Mouse on Mouse HRP Polymer Peroxidase Neat Abcam (ab-127055) 
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2.5.7.2 Fluorescence detection and counterstain  
For visualization of peroxidase labelled secondary antibodies, slides were incubated 
for 10 minutes in a fluorescent dye using the ‘Tyramide Signal Amplification’ system 
(Perkin Elmer, USA) at room temperature in a humidity chamber. Detection of 
tyrimide works through HRP catalysing the deposition of fluorescent precipitate on 
the tissue. Tyramide was diluted 1:50 in supplied buffer and used immediately. After 
a ten minute period the reaction was stopped by immersing slides in 1x TBS for 3x 5 
minute washes. Once tyramide was applied and washed off slides were kept covered 
as much as possible to prevent bleaching of the tissue. Following TBS washes, sections 
were then stained in Sytox green (Invitrogen, USA) diluted 1:12000 for ten minutes in 
a humidity chamber and ensuring minimal exposure to light. Following this, the slides 
were washed in 1xTBS for the last time.   
 
2.5.8 Dehydration and mounting  
For DAB staining, once slides had been counterstained with haematoxylin they were 
rehydrated as per the protocol described in 2.4.2. Once finished in xylene slides were 
moved into mounting xylene and covered with glass coverslips, adherence of 
coverslips was achieved by the use of pertex (Cell path, UK) and allowed to dry for 2 
hours and can be imaged or stored at room temperature. Mounting slides for IF does 
not require dehydrating, coverslips are adhered to the slide through the use of 
Permafluor (Thermo scientific). Slides were allowed to dry for a minimum of 4-5 hours 
and could be imaged or stored at 4oC for up to six months.  
 
2.5.9 Automated immunohistochemistry for Cleaved Caspase 3  
Another method used for antigen detection can be achieved through the use of an 
automated immunostaining machine (Leica Microsystems, UK) termed ‘Bond’. This 
automated machine can do up to 30 slides per run, with the use of a polymer 
amplification instead of streptavidin. For experimental cohorts requiring cleaved 
caspase staining automated immunohistochemistry was performed using cleaved 
caspase primary antibody (Cell Signalling Technology) diluted 1:100. This dilution 
was chosen based on an optimisation run with appropriate tissue and controls. A 
Polymer Refine Detection kit according to standard manufacturer protocol. Slide 
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mounting was also automated. Slides could then be stored at room temperature. This 
protocol was optimised and run by Lyndsey Boswell SURF, University of Edinburgh. 
 
2.5.10 Microscopy  
2.5.10.1 Light Microscopy  
Slides stained using DAB or Bond immunodetection were examined using a Provis 
microscope (Olympus Optical, London, UK) and images were captured on a digital 
camera (Canon DS126161) attached to the microscope. Images were also captured on 
an Axiovert Scan.Z1 slide scanner (CarlZiess, Germany). These enabled automated 
scans of whole tissue sections. Images captured by both methods were captured edited 
on Zen lite 2 software.   
2.5.10.2 Fluorescent Microscopy  
To visualise immunostained sections, slides were imaged on a Ziess LSM 710 or LSM 
510 Axio-Imager microscope (CarlZeiss Ltd, UK). This microscope was fitted with an 
HVC20 camera (Hitachi Denshi Europe, UK). Images were also captured on an 
Axiovert Scan.Z1 slide scanner (CarlZiess, Germany). These enabled automated scans 
of whole tissue sections. Images captured by both methods were captured edited on 
Zen lite 2 software.   
 
2.6 Stereology  
Stereology is an important tool in providing interpretation of a two-dimensional cross 
section of tissue. It provides the ability to extract quantitative data about a three 
dimensional tissue from a measurement taken on a two-dimensional section. Providing 
measurements like these helps confirm visual morphology observations. H&E stained 
slides were examined using a Provis microscope (Olympus Optical, London, UK) and 
images were captured on a digital camera (Canon DS126161) attached to the 
microscope. Images were also captured on an Axiovert Scan.Z1 slide scanner 
(CarlZiess, Germany). These enabled automated scans of whole tissue sections. 
Images captured by both methods were captured edited and measured on Zen lite 2 
software. 
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2.6.1 Serial Sectioning for cortex measurements  
Due to the unusual shape of the adrenal, measurements taken at random sections 
throughout the adrenal would give inconclusive and highly variable results between 
sections and experimental cohorts. To account for this variation in shape, adrenals 
were serial sectioned the whole way through with one section per slide. One adrenal 
provided on average 40-50 single section slides. For H&E staining and analysis, slides 
15, 25 and 35 were selected from each adrenal. This provided a good range throughout 
the adrenal that had the presence of all cortex zones. Each group analysed had an n=5.  
 
Figure 2-4 Schematic detailing regions slides were taken from to perform 
cortex measurements.  
 
2.6.2 X-zone cell density measurements  
Cell density of X-zone cells were counted at x40 magnification. The image once 
opened had a 5x4 square grid placed over the top of the image. Each square was 
assigned a number 1-20 and 5 of these sections were randomly selected with a 
calculator. Once the grids were selected, an event marker was used to count the number 
of cells present in each 2000 µm square. Cells were counted in a similar fashion to cell 
counts on a haemocytometer, cell touching the bottom and right light line were 
included in the box, cell touching the top and left sides of the box were not. These 
measurements were then recorded under the measurement tab in the Zen profile and 
could then be exported into excel. The image could be saved with all these 
measurements so they can be accessed after the image file has been closed (Fig. 2-5).







Figure 2-5. Screen grab of X-zone cell density measurements in Zen lite 2 . An image of an X-zone at x40 magnification. 
Numbers for individual square counts can be seen on the right under name and number. 
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2.6.2 X-zone depth measurements  
To measure the proportion of the cortex the X-zone was occupying, the distance of the 
X-zone from the cortex medulla boundary to the outer edge of the X-zone was 
measured on x10 magnification images. Five individual measurements were taken at 
even intervals along the X-zone, these measurements can be seen figure 2-6.  
 
2.6.3 Whole cortex depth measurements   
The thickness of the whole adrenal cortex was measured at x10 magnification from 
the cortex-medulla boundary to the outer cortex. These distance measurements were 
taken at even intervals along the cortex. These measurements can be seen in figure 2-
7. 
2.6.4 Combined zona glomerulosa and zona fasciculata measurements 
To determine if presence of an X-zone impacted the remaining adrenal cortex size, 
combined measurements of the zona glomerulosa and zona fasciculata thickness were 
calculated from subtracting the X-zone depth from the overall cortex depth.  
 
2.6.5 Spindle cell occurrence  
Analysis of spindle cell occurrence was achieved via serial sectioning 5 samples per 
experimental group. Multiple sections were selected evenly throughout each block and 
H&E stained to carry out morphology analysis. When the presence of spindle cells 
were observed it was noted and converted into a percentage out of 100. For example, 
5 samples analyzed if only one sample presented with spindle cells it would equate to 
20% occurrence for that group. These measurements accounted for presence/absence 
not severity.  
 
2.6.6 PCNA positive cell counts  
To investigate proliferation in control and experimental groups, sections were stained 
for PCNA under the protocol described in 2.5. Five sections from each sample were 
stained with an n=5 per group. Each section was scanned on the Axioscan to provide 
a whole section view. These sections were then counted for every PCNA positive cell 
observed in that section in Zen lite 2, these counts can be seen in figure 2-8.  




Figure 2-6. Screen grab of X-zone depth measurements in Zen lite 2.  An image of an X-zone at x10 magnification. Numbers for 
individual line measurements can be seen on the right under name and number







Figure 2-7. Screen grab of whole cortex depth measurements in Zen lite 2.  An image of an adrenal at x10 magnification. 
Numbers for individual line measurements can be seen on the right under name and number.







Figure 2-8. Screen grab of PCNA cell counts in Zen lite 2.  Whole section scan, numbers for PCNA positive cells can be seen on 
the right under name and number
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2.7 qRT-PCR  
2.7.1 RNA extractions 
RNA extraction was achieved through the use of an RNAeasy® mini kit (Qiagen, 
Crawley, UK) as per manufacturer’s standard protocol for animal tissue. Whole 
adrenals were defrosted on ice to maintain RNA integrity. Whole adrenals were then 
lysed using an RLT buffer, essential for tissue lysis, and homogenised using Qiagen 
TissueLyser homogeniser (Qiagen, Crawley, UK) for three minutes to successfully 
dissociate the tissue. To allow appropriate RNA binding conditions, 70% EtOH was 
added to the lysate following homogenisation. Samples were then added to an 
RNeasy® mini spin column. The membrane present in these columns binds the RNA 
and allows for decontamination via a series of washes with RW1 buffer that efficiently 
removes biomolecules such as carbohydrates, proteins, and fatty acids. Although 
recommended in the protocol as an optional step, a DNAse digest was performed. This 
was to remove any DNA contamination that may remain in the sample. This is 
particularly important when running qRT-PCR. RNA was finally eluted in 30µl of 
sterile water, this step was performed twice to achieve maximum yield.  
 
2.7.2 RNA quantification  
A Nanodrop ND-1000 spectrophotometer (LabTech International, UK) was used to 
quantify the amount of RNA in the sample. Additionally to confirm the integrity of the 
RNA, the sample was also assessed using the 260/280 absorbance ratio. A non-
contaminated sample should fall within a ratio of 2.0-2.2. Any reading out with 
indicates a sample contaminated with genomic-DNA.  
 
2.7.3 cDNA Synthesis  
SuperScript VILO cDNA synthesis kit (Invitrogen, Paisley, UK) was used to reverse 
transcribe RNA samples to create a single strand complementary DNA (cDNA) via 
the manufacturer’s standard protocol. Each sample consisted of 10x superscript 
enzyme mix (2µl) responsible for the reverse transcription of single RNA strands into 
cDNA, 5xVilo reaction mix (4µl) which includes random primers, MgCl2, and dNTPs 
in a buffer formulation that has been optimized for qRT-PCR, 2µg of RNA (varied 
amount) topped up by sterile water to 14µl. This gave a final sample volume of 20µl. 
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Samples were then placed in thermocycler under the following conditions:  25 °C for 
10 minutes for primer extension, 42 °C for 60 minutes for cDNA synthesis, and 85 °C 
for 5 minutes to terminate the reaction. Only cDNA in immediate use was stored at -
20 °C, whereas stock cDNA was frozen at -80 °C for further analysis.   
2.8 Quantitative gene expression  
To be able to quantify gene expression in experimental samples, quantitative real-time 
polymerase chain reaction (qRT-PCR) was achieved via the probe-based qRT-PCR 
method. This method provided greater sensitivity over conventional qPCR.  
 
2.8.1 UPL probe and primer design  
The qRT-PCR method used in this study requires specific probes purchased from the 
Universal Probe Library (UPL) (Roche, West Sussex, UK). The Universal 
ProbeLibrary uses the hydrolysis probe format for real-time PCR detection. The probe-
based real-time PCR assay specificity is achieved through a combination of the PCR 
primers that specify the exact target amplicon among billions of nucleotides, and the 
probe. The real-time PCR probe is able to enhance specificity, and ensures that 
fluorescence is only generated when the target of interest is amplified. UPL probes 
have been designed to be no longer that 26-35 nucleotides in length, this ensures 
thermal stability that is essential during PCR. UPL probes are fluorogenic and permit 
relative quantification of a cDNA template through fluorescence detection. For genes 
of interest, the specific mouse probe was appropriately chosen. This probe was labelled 
with fluorescein (FAM) at the 5’ end and a dark quencher dye at the 3’ end which has 
a wavelength of 488nm. Prior to binding, the quencher dye is used to suppress the 
signal from the fluorophore. The qRT-PCR reaction involves annealing of the probe 
to the appropriate region of target DNA providing it is present in the sample being 
analysed, this binding occurs between the forward and reverse primers. The 
polymerase enzyme begins by binding to the 5’ region of the primer until it reaches 
the probe, which then becomes cleaved. Upon cleavage the fluorescent FAM dye is 
released producing a signal. This reaction occurs at the end of an amplification cycle 
and is what provides quantitative measurements for gene expression in a sample.  




Figure 2-9. RT PCR using fluorescent reporters.  The polymerization-
associated 5´–3´ nuclease activity of the DNA polymerase detaches the reporter from 
the quencher during the PCR reaction 
 
Roche provides an online service in which you can design primers which can be found 
at www.universalprobelibrary.com that designs and provides primer sequences and the 
most appropriate UPL probe for that gene of interest. These probes are also ranked in 
order to highlight the best probe for your set criteria. Primer pairs were then ordered 
from Eurofins, UK and validated prior to any use on experimental samples (2.8.4), this 
was to ensure appropriate cycling efficiency of the primers. The reactions carried out 
in this thesis was achieved through singleplex and beta-actin used as a housekeeping 
gene. 
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Table 2-3: qPCR assays used, with sequences of primers and UPL probe numbers 
for each assay 
 
Transcript 5’ Primer 3’ primer Roche UPL 
probe 
Nr3c4 ttatgaagcagggatgactctg gctgccagcattggagtt 12 
Nr3c1 ccactgcaggagtctcacaa gcaaagcatagcaggtttcc 91 
Cyp21a1 ccaacctggatgagatggtt ggattcttcccaggttccag 107 
Srd5a1 gggaaactggatacaaaataccc ccacgagctccccaaaata 41 
Hsd3b1 gaactgcaggaggtcagagc gcactgggcatccagaat 12 
Akr171c8 tggccctagccaagagttt gccaattggaaatcaaagacc 91 
Akr1b7 ccaccttcgtggaactcag cttggcctggggaagact 104 
Ctnnb1 gcagcagcagtttgtgga  tgtggagagctccagtacacc 25 
Gli1 ctgactgtgcccgagagtg cgctgctgcaagaggact 84 
Dax1 cgtgctctttaacccagacc ccggatgtgctcagtaagg 3 
Sf1 tccagtacggcaaggaaga ccactgtgctcagctccac 18 
Star ttgggcatactcaacaacca acttcgtccccgttctcc 11 
Prkar1a gctgaagtttacactgaggagga cagccattgtcttataatcttttgg 16 
Gata6 aaagcttgctccggtaacag atcactgatgcccctaccc 21 
Cyp11a1 aagtatggccccatttacagg tggggtccacgatgtaaact 67 
Hsd11b1 ggagcccatgtggtattgac ttcaaggcagcgagacacta 69 
Cyp11b1 ctggaaagtgtccatggtagc ccccaaaaagaacaaagtgg 47 
Cyp11b2 cctggagatgcatcaggtct tccggcaacatcacagatac 98 
C-kit agcgctgcctttccttatg cgcagatctccttggttttg 68 
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2.8.2 Preparing the qRT-PCR assay 
To ensure reproducibility and accuracy of results all samples were plate in triplicate, 
all samples were additionally run with appropriate experimental controls and gene 
controls. To ensure there was no contamination of samples or fluorogenic compounds, 
plates were also run with a ‘no template control’ and a ‘no reverse transcriptase 
control’. All plates when possible where run on the same 384-well plate ABI 7900, to 
try and account for any machine differences.  
 
Table 2-4 Reagents used for qRT-PCR 
 
2.8.3 qRT-PCR analysis: ΔΔCt method  
Once running of the plate was complete, the results were displayed as amplification 
curves which reflected the release of fluorescent product released during the 
amplification of a target gene, which is directly proportionate to the amount of that 
gene in a tissue of interest.  This gene expression is shown as an amplification curve, 
this curve is split into three regions. The baseline region is where any background 
fluorescence is detected. Depending on the amount of a gene in a sample, after a certain 
PCR cycle, gene expression enters the exponential phase. During this phase there is an 
exponential increase in fluorescence detected, followed by the final phase in which the 
reaction plateaus. In order for a reaction to increase into the exponential phase, the 
fluorescence needs to be greater than the background and this increase is shown when 










2X Universal AB1 master mix 1x 17.5 µl 255 µl 
Target gene Forward Primer 200nM 0.875 µl 1.25 µl 
Target gene Reverse Primer 200nM 0.875 µl 1.25 µl 
Target gene Probe 100nM 087.5 µl 1.25 µl 
PCR-clean water  11.375 µl 16.25 µl 
cDNA  3.5 µl 5 µl 
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which this occurs. Lower the Ct value denotes higher level of the target gene 
expression in the sample. These areas are described in figure 2-10.  
 
Figure 2-10. SDS file expression curve 
 
Following this, the results need to be analysed and this is done through the comparative 
ΔΔCt method (265). Fold change is normalised to a reference sample such as an 
untreated control and relative to an internal positive control. The Ct values of 
experimental cohorts were first standardised to the external control to account for 
variation between the samples. For each sample, the ΔCt was first calculated by 
subtracting the the Ct for the internal positive control gene, in this case beta-actin 
(which is labelled with a VIC dye with a wavelength of 538) from the ΔCt of the target 
gene. The triplicates of each sample were then averaged and compared to a reference 
sample. To calculate this, the ΔCt was subtracted from the ΔCt value if the reference 
sample and is then referred to ΔΔCt. By using the formula 2-∆∆Ct then provided the 
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sample. Once the fold change was calculated the subsequent values could then be 
statistically analysed.  
2.8.4 Primer and probe validation 
Before use on experimental samples, primers had to be optimised to ensure they were 
cycling within an appropriate range. Appropriate amplification should be a doubling 
of an amplicon every cycle during the exponential phase, if this did not happen the 
ΔΔCt method is not valid. To test this, a five-fold dilution series was performed with 
wildtype adrenal cDNA (figure 2-11). Diluted cDNA was added to mastermix and 
plated in triplicate. The plate was run on an ABI 7900 (2.8.2) machine and the ΔCt for 
each concentration was calculated (1.8.3) and values were then plotted on a scatter 
graph with the log of the template concentrations on the X-axis. A trend line was then 
added and the slope of the line examined. Cycling efficiency should fall between 3 and 
3.6 and anything without this range is deemed not working.   
Figure 2-11. Amplification plot of series diluted primers  
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2.9 PCR Genotyping 
To determine if an animal is carrying Cre recombinase, ARflox, GRflox or R26R-YFP 
in offspring from transgenic matings, DNA was prepared from ear clips or tail tips at 
weaning. From this tissue genomic DNA was extracted through a DNA-digest with 
25μL TE-Tween (section 2.12.3.3) and 2μL proteinase K (10mg/ml) per ear clip. Once 
DNA was extracted samples were run on a thermocycler programme set to 55°C for 1 
hour, then 95°C for 7 minutes followed by 25°C for 10secs on a GenePro Thermal 
Cycler (Hang Bioer Technology Ltd.).  Tissue was then vortexed and centrifuged at 
7,717g for 5 minutes. The resulting extracted DNA was carefully removed and diluted 
1:10 with distilled water and stored at -20 for long-term storage.  
2.9.2 PCR assay 
Along with detection of Cre recombinase in samples, an internal control Interleukin-2 
(IL-2) was used. This was to ensure that DNA amplification has occurred and is 
especially important in controlling for samples that are Cre-. The assay is set up as 
follows: 1μL of DNA was added to 0.1μL of each primer (Table 1), 5μL BioMix Red 
(Bioline, UK), and water to make up a 10ul reaction per sample. The programme used 
to amplify specific primer products was set up as follows: 94 °C for 3 minutes, 94 °C 
for 30 seconds, followed by 35 cycles at 57 °C for 30 seconds and 72 °C for 30 seconds, 
followed by a final incubation at 72 °C for 5 minutes. In addition to samples of interest, 
Cre recombinase negative DNA and dH2O were also run on the same programme, this 
was to ensure there was no contamination introduced during sample preparation. This 
programme was used to detect the presence of Cre in the Cyp11a1-Cre line. Expected 
product sizes for this Cre was 100bp and 324bp for IL-2. Primer sequences listed in 
table 2-5.  
2.9.2.1 Inheritance of floxed AR  
First, a PCR mix was made as previously described and PCR was performed on Ar 
exon 2 on a programme for 94 °C for 3 minutes, 94 °C for 30 seconds, followed by 40 
cycles of 61°C for 1 minute and 72 °C for 1 minute, followed by a final incubation at 
72 °C for 5 minutes. Product size for floxed Ar was expected at approximately 852bp. 
Primer sequences in table 2-5.   
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2.9.2.2 Inheritance of floxed GR  
First, a PCR mix was made as previously described and PCR was performed on Gr 
exon 3 on a programme for 95 °C for 5 minutes, 95 °C for 30 seconds, followed by 35 
cycles at 62 °C for 1 minute, 72 °C for 1 minute, 72 °C for 5 minutes, 72 °C for 5 
minutes).  Expected product sizes were 240bp for wild type GR and 300bp for 
recombined GR. Primer sequences listed in table 2-5.  
 
2.9.2.3 YFP insertion in R26R-EYFP mice 
To identify if Rosa26 mice were carrying an insertion of YFP, a PCR mastermix was 
set up as described in 2.9.2. Both Rosa26 wildtype and YFP insertion regions were 
amplified on a PCR programme as follows: 94 °C for 3 minutes, 94 °C for 30 seconds, 
followed by 36 cycles at 58 °C for 1 minute, 72 °C for 1 minute, 72 °C for 2 minutes, 
72 °C for 5 minutes and finally 25 °C for 10 seconds).  Expected product sizes were 
600bp for wild type Rosa26 and 320bp for YFP insertion. Primer sequences are listed 
in table 2-5. 
Transgene Primer sequence 
Cre forward GCGGTCTGGCAGTAAAAACTATC 
Cre reverse GTGAAACAGCATTGCTGTCACTT 
Interleukin-2 forward CTAGGCCACAGAATTGAAAGATCT 
Interleukin-2 reverse GTAGGTGGAAATTCTAGCATCATCC 
AR floxed forward GCTGATCATAGGCCTCTCTC 
AR floxed reverse TGCCCTGAAAGCAGTCCTCT 
GR floxed forward GGCATGCACATTACTGGCCTTCT 
GR floxed reverse 1 GTGTAGCAG CCAGCTTACAGGA 
GR floxed reverse 2 CCTTCTCATTCCATGTCAGCATGT 
Rosa26 wild type GGAGCGGGAGAAATGGATATG 
Rosa26 wild type AAGTCGCTCTGAGTTGTTAT 
YFP insertion AAGACCGCGAAGAGTTTGTC 
Table 2-5. Primer sequences.  
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2.10 Statistical analysis 
All statistical analysis was carried out on GraphPad Prism version 7 (GraphPad 
Software Inc, San Diego, CA, USA). All values are presented with error bars as 
standard error of the mean ±SEM. Data was first analysed via D’Agostino-Pearson 
normality test to determine if the data had a normal distribution, if this was the case an 
appropriate parametric test was performed based in the samples size, number of groups 
being compared and if post-hoc analysis was required . Parametric analysis used in the 
thesis involved a two-tailed, unpaired t-test was used to compare two groups, one-way 
ANOVA to compare multiple groups and two-way ANOVA to compare multiple 
groups and treatments. If a post-hoc analysis was required, a Tukey’s analysis was 
performed that allowed comparison of the mean of each group to the means of every 
other group or a Dunnett’s test if comparing multiple groups to a single control group. 
If groups failed the normality test, a Mann-Whitney U test was performed. For multiple 
group analysis The Kruskal–Wallis test was carried out for 3 or more groups in case 
of non-parametric data.  
 
2.11 PET/CT Scanning 
Computed tomography (CT scans are a useful tool in examining bone structure and 
density. From the images constructed from CT scans measurements can be taken that 
can reveal changes in shape, structure and density.  
 
2.11.1 Ex-vivo analysis of spinal curvature 
Interrogation spinal curvature was achieved via CT scanning. Whole body micro CT 
images of mice was acquired. 8 groups of animals were be included in this study with 
5 animals per group between male and female controls and knockout mice. Collected 
CT images were reconstructed and analysed using PMOD software. Mice were 
carefully positioned head first prone in the scanner bed for collection of coronal and 
sagittal plane radiographs using a nanoPET/CT scanner (Mediso, Hungary) and the 
following settings: side or top view, X-ray energy of 50 kVp, exposure time of 300 ms 
and maximum field of view. Coronal and sagittal plane radiographs were used for 
animal positioning for high-resolution microCT imaging, which was acquired using 
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the following parameters: semi-circular full trajectory, 720 projections, maximum 
zoom, tube voltage of 50 kVp, exposure time of 300 ms, binning of 1:4. Nucline 
software (Mediso, Hungary) was used to reconstruct microCT images using the 
following parameters: voxel size medium, slice thickness medium and cosine filter 
with 100% cutoff (combined voxel resolution: isotropic 251 μm). The Nucline 
software was also used to assess gross anatomical measurements and to measure the 
magnitude of the largest scoliotic and thoraco-lumbar kyphotic curves, according to 
the Cobb method (266)/Fergunson method (267). 
 
2.12 Commonly used solutions  
 
2.12.1 Immunohistochemistry 
2.12.1.1 Harris’s haematoxylin 
25 ml of 10% haematoxylin in absolute alcohol was added to 500 ml of 10% warm 
aluminum potassium sulphate solution. The solution was heated to boiling point and 
1.25 g of mercuric oxide (1.25g) was added slowly. The haematoxylin solution was 
plunged into ice to cool before filtering it into a staining dish. Finally, glacial acetic 
acid was added (4 ml per 100 ml haematoxylin). 
2.12.1.2 Eosin 
An aqueous eosin solution was made by dissolving 1% w/v eosin in water, and an 
alcohol solution was made by dissolving 1% w/v eosin in methylated spirit. The 
solutions were mixed at 1 part alcohol to 3 parts aqueous and filtered. 0.5 ml/L of 
formaldehyde was added to prevent bacterial growth. 
2.12.1.3 Acid alcohol 
1% concentrated hydrochloric acid was added to 70% ethanol. 
2.12.1.4 Scotts tap water 
0.2% w/v potassium hydrogen carbonate and 2% w/v magnesium sulphate were added 
to tap water 
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2.12.1.5 Bouin’s fixative 
Bouin’s fixative is a well-established formaldehyde based fixative, which appears 
bright yellow in colour (purchased from Triangle Biomedical Sciences Ltd, 
Lancashire, UK). 
2.12.1.6 Normal sera 
Normal chicken and goat sera were obtained from Biosera, UK. Normal serum: 
phosphate-buffered saline: bovine serum albumin (NS: PBS: BSA) NS from the 
animal of choice was diluted 1 in 4 with PBS (section 2.9.2.1) containing 5% BSA. 
Normal serum: tris-buffered saline: bovine serum albumin (NS: TBS: BSA) NS from 
the animal of choice was diluted 1 in 4 with TBS (section 2.9.2.2) containing 5% BSA. 
2.12.2 Buffers 
2.12.2.1 Tris-Buffered Saline 
For  1L  of  10X  TBS  stock  (0.2M  Tris,  1.5M  NaCl,  pH  7.6),  24g  Tris  HCl  
(Sigma Aldrich,  Dorset,  UK),  5.6g  Tris  base  (Sigma Aldrich,  Dorset,  UK)  and  
88g  NaCl  (Sigma Aldrich, Dorset, UK) were dissolved in 900mL deionised water 
and adjusted to pH 7.6 using concentrated HCl or NaOH to decrease or increase pH 
respectively. The volume was then made up to 1L and the solution stored at 4oC TBS 
solution was very carefully adjusted to pH 7.4 using concentrated HCl and stored as a 
stock solution at 4°C.  
 
2.12.2.2 Citrate Buffer 
For 2L of Citrate buffer, Citric acid monohydrate (Sigma, Dorset, UK) 42.02g and 
1900mL dH2O was combined. The pH of citrate buffer was adjusted to pH6.0 or pH9.0 
using saturated NaOH solution and used at 0.01M by dilution (1:10) in dH2O. 
2.12.3 DNA extraction 
2.12.3.1 Tris-acetate-EDTA (TAE) 
To make a 50x solution, 242 g of Tris base, 57.1 mL glacial acetic acid (BDH, UK) 
and 100 mL 0.5M EDTA were made up to 1 L with ultra-filtered water. The solution 
was adjusted to pH 8.5 by a saturated solution of NaOH and the stock solution was 
diluted to 1x with ultra-filtered water before use. 
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2.12.3.2 0.5M EDTA 
186.1 g EDTA was added to 800 ml of ultra-filtered water. The solution was adjusted 
to pH 8.0 with a saturated solution of NaOH to allow the EDTA to dissolve then diluted 
to 1 L with ultra-filtered water. 
2.12.3.3 Tris-EDTA-Tween (TE-Tween) 
Fresh Tris-EDTA-Tween was prepared before use. This was achieved by adding 
2.5mL  1M  Tris  (2.9.1.1),  100μL  0.5M  EDTA  and  250uL  tween 20 (Sigma, UK)  
to  48mL  deionised  water.  After  thorough  mixing, the solution  was  sterile  filtered  



















Chapter 3: Androgens and androgen receptor can work together and 
independently to regulate aspects of adrenal function and 
morphology         
 
3.1 Introduction   
 
Androgens have been well documented as important regulators of male health, 
primarily in the maintenance and development of male sexual characteristics (268).  
However, a decline in circulating androgens has also been associated with co-
morbidities such as obesity (269) cardiac disease (270) and metabolic syndrome (271). 
Androgens primarily exert their effects through their cognate androgen receptor (AR), 
a nuclear receptor that binds to testosterone and dihydrotestosterone and translocates 
into the nucleus to regulate gene transcription (272). Androgens and the androgen 
receptor can also act independently of each other to affect cellular processes (273). 
90% of androgen production in men occurs in the testis with the remainder produced 
in the zona reticularis (ZR) of the adrenal cortex (274).   
Previous research has focussed upon the body-wide impact of adrenal androgens, 
however whilst AR is abundantly expressed in the adrenal cortex of both rodents (275), 
(276) and humans (120), surprisingly  little is known about androgen action on the 
adrenal cortex itself. This gap in our understanding is at least in part due to the 
perceived lack of suitable animal models. Mice have largely been overlooked as a 
model system as their adrenals are unable to produce androgens due to lack of 17α 
hydroxylase and 17, 20 lyse activity and therefore do not have a zona reticularis (10), 
(111). However, historical studies using castrated mice showed that removal of 
androgens leads to the redevelopment of an additional cortex zone (23). The foetal 
adrenal is thought to provide the necessary stem/progenitor cells  to populate  the adult 
adrenal cortex in  human and mice (277) (20). These foetal cells are maintained for a 
period postnatally and regress differently depending on species and sex. In the human 
this zone is known as the ‘foetal zone’, and the mouse  homologue termed the ‘X-zone’ 
(57), (278). The mechanisms underpinning the regression of the X-zone and its 
purpose and maintenance postnatally still aren’t clearly understood
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The redevelopment of the X-zone following castration and the abundant expression of 
AR in the mouse adrenal suggests that androgens are important regulators of the 
adrenal cortex and that the mouse, despite not producing adrenal androgens, has utility 
for dissecting the role of androgen signalling within the adrenal. Previous global 
knockouts have ablated AR from the whole body and then examined the adrenal (162), 
however the caveats of this, like many global knockout models that focus on the 
endocrine system, is that the adrenals both produce and respond to multiple endocrine 
stimuli that may also be disrupted in a global knockout model. Being able to attribute 
any phenotype to perturbed endocrine signalling locally, versus from disruption of the 
wider hypothalamic-pituitary-axis is extremely difficult.  
For these reasons an adrenal specific androgen receptor knockout model (Ad-ARKO) 
was generated that completely ablates AR from the adrenal cortex in foetal and adult 
life (253), allowing investigation of adrenal AR signalling. Due to the ability of 
androgen receptor and androgens to act independently of each other, additional models 
of castrated wild-type, castrated AR ablated, and hCG treated animals were 
investigated to fully elucidate androgen and AR action in the adrenal. Results 
demonstrate that not only are androgens signalling via androgen receptor required for 
X-zone regression, but androgens and androgen receptor also work independently to 
regulate multiple aspects of cortex function and morphology. 
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 To establish androgen receptor localisation in the human and mouse adrenal 
cortex 
 To create adrenal specific androgen receptor knockout mice through the use of 
a Cyp11a1-Cre mouse line bred to AR floxed mice. 
 To define the impacts on adrenal development following AR ablation 
 To determine the impacts on cortex morphology, function and stress response 
following AR ablation in adulthood 
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3.2 Results  
3.2.1 Androgen receptor is widely expressed throughout the human and mouse 
adrenal cortex  
Previous studies have examined the expression of AR in the adrenal, however this was 
restricted to transcript, protein localisation was not established (279). To establish 
where AR is localised in the adrenal cortex, human and mouse adrenals were examined 
following immunohistochemistry. AR protein localisation is observed in human foetal 
adrenals (Fig. 3-1A) and human adult adrenals (Fig. 3-1B). Similar analysis of the 
mouse foetal adrenal shows AR localisation at (e)13.5 (Fig. 3-2A). AR protein is 
expressed in the postnatal mouse adrenal when examined at d12, d21, d35 and d80 
(Fig. 3-2B). AR is localised at the cortex medulla boundary at d12, by d21 AR is 
localised throughout the zona fasciculata (ZF) and from d35 onward AR can be seen 
in the ZF and zona glomerulosa (ZG). These data confirm the expression of AR in 
similar locations and timings in both human and mouse adrenals during development 
and in adulthood, suggesting that despite not producing androgens, the mouse adrenal 















Chapter 3: Androgens and androgen receptor can work together and 






Figure 3-1. Androgen receptor expression in the human adrenal cortex.  
(A) Androgen receptor immunostaining details AR expression in human foetal 
adrenals. Staining can be seen in the region of the definitive zone. N=2 (B) Androgen 
receptor immunostaining details AR expression in adult human adrenals. Staining can 
be seen in the zona reticularis region. N=2. Scale Bars 50µm.









Figure 3-2. Androgen receptor expression in the mouse adrenal cortex. (A)  Androgen receptor localisation can be detected at 
e13.5 in embryonic adrenals, with staining in the central region of the foetal adrenal. ‘Ad’ denotes foetal adrenal, boundaries denoted by 
white dotted lines. (B) Expression observed during development shows a migration from the inner most cortex/medulla boundary (WT d12) 
and migrates outwards with age (WT d21, d35, d80). By d80 androgen receptor expression can be observed across the whole cortex. N=5. 
Red: androgen receptor protein, Green: sytox counterstain. Scale bar 50µm. Annotations; M=medulla, ZF= zona fasciculata, ZG = zona 
glomerulosa. 
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3.2.2 Confirmation of ablation of androgen receptor from the mouse adrenal 
The Smith lab has previously described a novel method to ablate target genes from 
steroidogenic cell types through the development of a GFP-Cre-GC targeted to the 
mouse Cyp11a1 locus to drive Cre Recombinase expression (253). The lab previously 
established that this Cre line targets less than 20% of testicular Leydig cells (253), and 
that loss of AR from Leydig cells has no discernible impact on circulating testosterone 
levels. The paper also highlights no discernible impact from off target effects in 
unspecified tissues. Immunostaining shows that Ad-ARKO mice have complete 
ablation of AR protein throughout the adrenal cortex (Fig. 3-3A), demonstrating that 
this model permits the cell-specific dissection of androgen signalling in the adrenal 
cortex. Interestingly, the adrenal capsule does not express Cyp11a1 therefore 
Cyp11a1-Cre does not target these cells, resulting in AR expression still being 
maintained in the capsule (253, 44), an important positive control for downstream 
studies.  
 
3.2.3 Ad-ARKO mice have enlarged adrenals and failed X-zone regression   
Ad-ARKO adrenal weights are similar to controls in d12 or d21 mice, however, at d35 
and d80 there is a significant increase in adrenal weight in the Ad-ARKO compared to 
controls (Fig 3-3B). Examination of gross adrenal morphology reveals the presence of 
a thicker and larger X-zone in d12 and d21 male Ad-ARKO adrenals compared to 
controls. From d21 to d35 involution and regression of the X-zone occurs in male mice, 
leaving only two cortical zones in adulthood (280). However, in Ad-ARKO mice the 
X-zone fails to regress during this period and remains present in adulthood, occupying 
a large proportion of the adrenal cortex (Fig. 3-4A). Female mice also have an X-zone 
that remains present until first pregnancy in adulthood (34). As Ad-ARKO male 
adrenals have an X-zone, they were compared to age-matched WT female mice, to 
determine whether loss of AR had ‘feminised’ the male adrenal. However, the X-zone 
in Ad-ARKO males appear much larger and occupies a greater portion of the cortex 
compared to WT females, suggesting loss of AR in males does not simply feminise 
the male adrenal.  
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Figure 3-3. Ad-ARKO mice show an increased adrenal weight and size.  
(A) Immunofluorescence staining confirms ablation of AR from adrenal cortex in d80 
mice (Scale Bars 50µm). N=5 Red: androgen receptor protein, Green: sytox 
counterstain. (B) Observations of whole tissue show Ad-ARKO males have larger 
adrenals at d35 and d80 (Scale bar 1mm). N=5 (C) Ad-ARKO males have significantly 
larger adrenals from d35 (Two-Way ANOVA; ** p<0.001, n=5, Tukeys post-hoc 
analysis, error bars SEM), this difference in size is maintained into adulthood (Two-
Way ANOVA; **** p<0.0001, n=5, Tukeys post-hoc analysis, error bars SEM). 
Annotations; M=medulla, ZF= zona fasciculata, ZG = zona glomerulosa. N=8.    
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Figure 3-4. The X-zone of Ad-ARKO mice persists into adulthood.  (A) 
Adrenal histology in d12 and d21 mice do not appear to show any major differences 
compared to controls. Full regression of the X-zone is usually complete by d35 which 
is demonstrated in controls, however there is an additional inner cortical zone still 
present in Ad-ARKO males at this time point. This inner cortical zone can again be 
observed in d80 males, with this extra cortical zone occupying a large proportion of 
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3.2.4 Androgens are essential for normal morphology of the male adrenal  
 
To frame the parameters of the study, examination of the gross morphology of the 
adrenal in models of high (hCG stimulation) and low (castration) circulating 
testosterone were performed. Treatments with hCG have been shown to result in 
elevated circulating testosterone following a single dose (acute), with daily treatments 
able to maintain high levels of testosterone for two weeks (chronic), beyond this time 
point hCG specific antibodies are generated rendering the treatment ineffective and 
circulating testosterone returns to normal (158). Disruption of androgen signalling 
leads to regeneration of the foetal X-zone region, consistent with previous studies (23), 
however, acute or chronic increased circulating androgens did not impact the adult 
adrenal cortex or X-zone morphology, implying that an upper limit to androgen 
stimulation exists (Fig. 3-5 A, B). For these reasons, the remainder of the chapter 
focuses on the impact of loss of androgens and its impact on the adrenal cortex.   
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Figure 3-5. Increased circulating androgens does not impact adrenal 
morphology. (A) Morphology analysis of d80 control and Ad-ARKO treated with a 
single dose of hCG and control castrated and Ad-ARKO castrated treated with hCG 
show no further changes to morphology in the cortex or X-zones compared to non-
treated controls. N=5 (B) Chronic treatment with hCG in d80 WT males showing no 
impact on the morphology of the adrenal cortex. Scale bars 50µm. Annotations; 
M=medulla, ZF= zona fasciculata, ZG = zona glomerulosa, X= X-zone. N=5.  
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3.2.5 20 alpha-HSD expression confirms maintenance of foetal cells in 
adulthood in Ad-ARKO   
Androgens can act independently of their receptor to modulate transcriptional activity 
(144, 273), therefore additional cohorts were included that consisted of  Bl6 castrated 
and Ad-ARKO castrated cohorts in the study (both cohorts) castrated at d80. To 
determine receptor and ligand-independent effects on adrenal regulation. These 
additional cohorts also have a significant increase in adrenal weight compared to 
controls (Fig. 3-6A). Investigation of the histology of Bl6 castrated, and Ad-ARKO 
castrated mice revealed the presence of X-zones in their cortex (Fig. 3-6B). 
Immunohistochemistry for 20-α-hydroxysteroid dehydrogenase (20 alpha-HSD), a 
specific marker for the foetal cells that make up the rodent X-zone (40, 281), confirms 
that the additional cortical zone present in the experimental cohorts is composed of 
foetal cells (Fig. 3-6 C, D). Although all experimental cohorts have developed X-zones 
there are clear differences in 20 alpha-HSD localisation (Fig. 3-7A). This suggests that 
X-zone cells and the cortex are impacted differently depending on whether circulating 
androgens or AR have been targeted. In addition to this, as females maintain an X-
zone into adulthood, a control female adrenal was included in the comparison (Fig. 3-
7B). Morphology of the female adrenal again is different from what is observed in the 
male cohorts, with differences in size and X-zone cell morphology. For these reasons 
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Figure 3-6. X-Zone markers confirm the maintenance of foetal cells in 
Ad-ARKO Mice. (A) In all experimental cohorts an increase in weight was detected 
when compared to controls (one-way ANOVA; n=8, *** p<0.0001, **** p<0.0001, 
**** p<0.0001, Tukeys post-hoc analysis, error bars SEM (B) All experimental 
cohorts have developed and additional cortical zone. N=5 (C) qRT-PCR data confirms 
20 alpha HSD expression in castrated, Ad-ARKO and Ad-ARKO castrated mice (one-
way ANOVA; n=7-8, *p<0.05, *p<0.05, *p<0.05, Tukeys post-hoc analysis, error 
bars SEM). (D) Immunostaining for 20alpha-HSD (green) confirms that the extra 
cortical zone developed in all experimental cohorts. N=5. Red: 20 alpha HSD protein, 
Green: sytox counterstain. Scale Bars 50µm. Annotations; M=medulla, ZF= zona 
fasciculata, ZG = zona glomerulosa, X= X-zone. 
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Figure 3-7. Closer inspection of X-zone reveals differences in 
morphology. (A) Further investigation of X-zones present in these cohorts show 
morphological differences in X-zone size and cell density. Cohorts with removal of 
circulating androgens have shrunken cytoplasm’s compared to AR ablation alone. 
They also appear to occupy different proportions of the cortex. N=5 (B) Control 
female adrenal highlighting X-zone cells for comparison. Scale Bars 50µm. 
Annotations; ZF= zona fasciculata, ZG = zona glomerulosa, X= X-zone. N=5.   
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3.2.6 Morphologies of X-zones in Bl6 castrated, Ad-ARKO and Ad-ARKO 
castrated show distinct characteristics  
To distinguish differences in morphology, the X-zone depth, cell density and cortex 
depth were measured. X-zones in Ad-ARKO and Ad-ARKO castrated mice are 
significantly larger than Bl6 castrated mice (Fig. 3-8A). X-zones in Bl6 castrated and 
Ad-ARKO castrated have significantly denser X-zones than Ad-ARKO mice (Fig. 3-
8B). Combined measurements of the zona glomerulosa (ZG) and zona fasciculata 
depth (ZF) show that Ad-ARKO mice have a significantly smaller ZF/ZG ratio 
compared to both castrated cohorts (Fig. 3-8C). Measurements of complete cortex 
depth show no differences, demonstrating that the X-zones are occupying different 
proportions of the cortex (Fig. 3-8D). These data coupled with morphological analysis 
suggest that AR and circulating androgens are able to act on the adrenal gland 
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Figure 3-8. X-zones in BL6 Castrated, Ad-ARKO, and Ad-ARKO Castrated mice 
have distinct morphological differences. (A) X-Zone measurements of depth showed 
that Ad-ARKO and Ad-ARKO Castrated mice have a significantly larger X-Zone than 
BL6 Castrated mice (one-way ANOVA; ** p<0.001, *p<0.05, Tukeys post-hoc 
analysis, error bars SEM). (B) The X-zone in BL6 Castrated mice is significantly 
denser than in Ad-ARKO mice, however upon castration of Ad-ARKO males, this cell 
density changed to be similar to Bl6 castrated mice, (one-way ANOVA; **** 
p<0.0001, ****p<0.0001, Tukeys post-hoc analysis, error bars SEM). (C) A 
significantly smaller zg/zf depth is observed in Ad-ARKO mice compared to the 
castrated cohorts (one-way ANOVA; * p<0.05, *p<0.05, Tukeys post-hoc analysis, 
error bars SEM). (D) There was no significant difference in the overall cortex depth 
between the three cohorts. X-zone measurements are presented as averages, for 
individual counts refer to Appendix figure 1. 
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3.2.7 Disruption to AR signaling results in an increased stress response in the 
adrenal cortex 
To establish the impact of loss of AR signalling on adrenal function key biomarkers 
of the adrenal stress response pathway were analysed; circulating corticosterone 
concentration (282), adrenal Mc2r expression (283) and circulating pituitary ACTH 
concentration (249) in Bl6 castrated, Ad-ARKO and Ad-ARKO castrated mice. Ad-
ARKO mice show an increase in circulating corticosterone compared to controls, 
which is normalised by castration (Fig. 3-9A). Interrogation of Mc2r transcript shows 
a significant increase in all cohorts when compared to controls (Fig. 3-9B). Circulating 
ACTH shows no changes in any cohort examined, suggesting that the increase in 
corticosterone is from disruption within the adrenal and not a result of signalling from 
the pituitary (Fig. 3-9C). These results reveal an increased stress response in Ad-
ARKO mice that is resolved upon castration, suggesting circulating androgens are 
acting independent of AR to stimulate the adrenal cortex.   
 
Chapter 3: Androgens and androgen receptor can work together and 






Figure 3-9. Disruption to androgen signalling results in an increased 
stress response in the adrenal cortex.  (A) Circulating corticosterone levels are 
elevated in Ad-ARKO males compared to controls (One-way ANOVA; n=8, 
**p<0.001, Tukeys post-hoc analysis, error bars SEM), however this is not observed 
in the other experimental cohorts investigated. (B) Mc2r gene expression shows an 
increase in all cohorts compared to controls (one-way ANOVA; n=8, *** p<0.0001, 
*p<0.05, **p<0.001, Tukeys post-hoc analysis, error bars SEM). (C) Circulating 
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3.2.8 Loss of AR or androgens results in changes in key developmental and 
cortex renewal genes 
Failed X-zone regression in Ad-ARKO and/or castrated mice shows that AR signalling 
is required in the prepubertal adrenal for normal development and cortex maintenance 
in adulthood. Therefore, 20 alpha-HSD staining at key time points in the postnatal 
developing adrenal, and expression of Sf1, Dax1 and Prkar1a, all key genes well 
characterised as important drivers of the development and maintenance of the adrenal 
cortex (57, 65, 59) were analysed. Previous studies have suggested that any influence 
androgens have on the adrenal cortex does not occur until puberty (280), however, 
investigation of 20 alpha-HSD localisation in developing adrenals shows that the X-
zone in Ad-ARKO mice is much larger than controls before, during and after puberty 
(Fig. 3-10A). Transcript analysis of Sf1 shows a significant increase in all experimental 
cohorts when compared with controls at d80 (Fig. 3-10B). Dax1, a downstream target 
of Sf1 (57), shows no increase in Bl6 castrated or Ad-ARKO mice, however, there is 
a significant increase in transcript in Ad-ARKO castrated mice (Fig. 3-10C). Prkar1a 
gene encodes for a subunit of an enzyme called protein kinase A, essential in cAMP 
signalling. A knockout of this gene in the adrenal cortex has been associated with the 
development of foetal cells (29). Due to a similar phenotype being observed in Ad-
ARKO and/or castrated mice, investigation of transcript levels of Prkar1a in 
experimental cohorts was carried out and results showed a significant downregulation 
of this gene in all experimental cohorts when compared with controls (Fig. 3-10D). 
Together these data suggest an important role for androgens during postnatal adrenal 
development, and support the hypothesis that genes thought to be regulating the X-
zone may be direct or indirect downstream targets of AR signalling.  
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Figure 3-10. Loss of androgen signalling results in changes in key 
developmental and cortex renewal genes.  (A) Protein localisation of 20 alpha-
HSD in the developing postnatal adrenal. It can be seen that from d12 that the X-zone 
in Ad-ARKO mice is more developed and larger in size compared to controls. N=5. 
Red: 20 alpha HSD protein, Green: sytox counterstain. (B) Sf1 gene expression shows 
an increase in all experimental cohorts. (One-way ANOVA; n=8, ** p<0.001, 
**p<0.001, ***p<0.0001, Tukeys post-hoc analysis, error bars SEM), however this 
increase was not observed in Ad-ARKO castrated males. (C) Dax1 gene expression 
has increased in Ad-ARKO castrated males, however this is not observed in the 
experimental cohorts (One-way ANOVA; n=8, *** p<0.0001, Tukeys post-hoc 
analysis, error bars SEM). (D) Prkar1 gene expression has decreased in all 
experimental cohorts compared to controls (one-way ANOVA; n=8, *** p<0.0001, 
*p<0.05, ***p<0.0001, Tukeys post-hoc analysis, error bars SEM).  Annotations; 
M=medulla, X= X-zone. 
Chapter 3: Androgens and androgen receptor can work together and 




3.2.9 Disruption to androgen signalling results in changes to steroid enzyme 
gene expression and protein localisation. 
To ascertain the impact of loss of androgens or AR signalling on adrenal 
steroidogenesis, analysis of the expression of a panel of key steroidogenic enzyme 
genes relevant to adrenal function and their protein localisation was performed. 
Cyp21a1 is involved with the biosynthesis of the steroid hormones aldosterone and 
corticosterone and is usually produced by ZF cells (15). Cyp21 disruption has been 
associated with diseases such as congenital adrenal hyperplasia (41). An increase in 
Cyp21a1 expression is observed in the adrenals of Ad-ARKO and Ad-ARKO castrated 
mice when compared to controls (Fig. 3-11A). Interestingly, in all experimental 
cohorts CYP21A1 protein localisation is observed in all cortex zones compared to 
controls where protein is solely localised to the ZF (15) (Fig. 3-11B). This could lead 
to overactive steroidogenesis in the adrenal glands. Hsd3b1 encodes for the enzyme 
3β-HSD and is responsible for the biosynthesis of progesterone from pregnenolone, 
17α-hydroxyprogesterone from 17α-hydroxypregnenolone, and androstenedione from 
dehydroepiandrosterone (DHEA) in the adrenal gland (284), and is expressed 
throughout the adrenal cortex. Investigation of Hsd3b1 shows no changes in transcript 
levels in any experimental cohort compared to controls (Fig. 3-11C) but shows 
differences in protein localisation in all experimental cohorts compared to controls. 
Bl6 castrated mice have X-zones that express 3βHSD. Ad-ARKO mice show sporadic 
localisation of 3βHSD in the X-zone, however, when Ad-ARKO mice are castrated no 
3βHSD localisation can be observed in the X-zone (Fig. 3-11D). ZF marker Akr1b7, 
shown to play an important role in the detoxification of lipid peroxidation by-products 
(40, 285) shows no change in gene expression in any of the cohorts (Fig. 3-11E). 
However, AKR1B7 protein is no longer observed in the adrenal cortex in Bl6 castrated 
and Ad-ARKO castrated mice. Interestingly, AKR1B7 is still expressed in Ad-ARKO 
mice (Fig.3-11F), suggesting androgens promote this expression via an AR-
independent mechanism. Additional genes that were analysed as part of this study but 
revealed no changes are detailed in table 3-1.  
 
 









Figure 3-11. Androgens can work independent of their receptor to regulate steroid enzyme localization . (A) Transcript 
analysis of Cyp21a1 shows an increase  in expression in Ad-ARKO and Ad-ARKO castrated males mice (one-way ANOVA; 
* p<0.05, **p<0.001, Tukeys post-hoc analysis, error bars SEM). (B) Interrogation of CYP21A1 protein localisation 
shows in control adrenals that staining is localised to the ZF, how ever upon androgen disruption the staining can be 
observed in all zones in the cortex. N=5 (C) Hsd3b1 gene expression shows no changes in transcription following androgen 
loss of androgen signalling in any of the experimental cohorts.  (one-way ANOVA, Tukeys post-hoc analysis, error bars 
SEM). (D) 3bHSD immunostaining (Protein; red, sytox counterstain; green) shows the X-zone in castrated mice still 
positive for 3bHSD, however expression in Ad-ARKO X-zones is more sporadic with less positive cells and Ad-ARKO 
castrated mice show no expression in their X-zones. N=5. (E) Akr1b7 gene expression shows no difference in expression 
any of the cohorts.  (one-way ANOVA, Tukeys post-hoc analysis, error bars SEM). (F) AKR1b7 immunostaining (Protein; 
Green, sytox counterstain; blue) is lost in both cohorts that have been castrated, however AKR1B7 expression can still be 
observed in Ad-ARKO mice.  N=5. Scale Bars 50µm. Annotations; M=medulla, X=X-zone. 
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Gene Detected? P value  
Cyp11b1 Yes 0.402 
Cyp11b2 Yes 0.8311 
Star  Yes 0.8060 
Prlr  Yes 0.4013 
Pa2g4  Yes 0.7940 
Tgfb3 Yes 0.7381 
Ctnnb1 Yes 0.4445 
Gata6 Yes 0.3521 
Wnt4 Yes 0.6777 
Gli1 Yes 0.2615 
Cyp19a1 No -- 
ERα No -- 
ERβ No -- 
Lhr No -- 
Fshr No -- 
Gata4 No -- 
Wnt1 No -- 
 
Table 3- 1. Table of genes analysed in this study. Genes investigated in this study that 
revealed no changes in Ad-ARKO mice compared to littermate controls. Genes that 
showed no detection in adrenal samples had testis, ovary or pituitary controls to 
ensure that the qPCR had worked.   
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3.2.10 Disruption to apoptosis and undifferentiated cell clusters can be 
observed in Ad-ARKO castrated mice.  
 
GR has been shown to interact directly with AR in various tissues to regulate cellular 
processes (203, 205, 252, 286), to determine if loss of adrenal AR signalling impacts 
GR, transcriptional and protein analysis was performed. Investigation of GR in the 
adrenal cortex shows an increase in Gr transcript in Bl6 castrated and Ad-ARKO 
castrated mice (Fig. 3-12A). GR immunostaining identified clusters of GR positive 
cells in the outer cortex of Ad-AKRO castrated mice that extend from the capsule to 
the ZF (Fig.3-12B) which are not observed in Bl6 castrated or Ad-ARKO mice. 
Immunostaining of AR shows protein localisation in the same capsule cell clusters 
observed in Fig. 3-12B in Ad-ARKO castrated mice (Fig. 3-12D), this suggests that 
these cells have not expressed the Cre and are not steroidogenic, additionally, it is 
known from AR/GR double immunohistochemistry analysis of control mice that AR 
and GR are not expressed in the same cells, AR is located in the large steroid producing 
cells, whereas GR can be seen in endothelial like cells (Fig. 3-13). This suggests that 
these cell clusters in the outer cortex are cells that are undifferentiated (287). Due to 
failed regression of X-zone cells from the cortex during puberty and cell cluster 
development in the outer cortex of Ad-ARKO castrated mice, immunostaining of 
cleaved caspase 3 was used to determine if there is any disruption to apoptosis. 
Immunostaining of cleaved caspase 3 shows that in controls adrenal cells undergo 
apoptosis at the cortex-medulla boundary, but in BL6 castrated and Ad-ARKO mice 
no cleaved caspase positive cells can be seen. However, Ad-ARKO castrated mice 
show aberrant apoptosis throughout the cortex (Fig.3-12E). These results suggest that, 
in the absence of androgens and/or AR, the adrenal is failing to appropriately 
differentiate its cortex zones in addition to disruption to cell clearance from the cortex.   









Figure 3-12. Ad-ARKO Castrated mice display cell clusters in the adrenal capsule. (A) Glucocorticoid receptor gene expression is 
significantly upregulated in cohorts following castration (one-way ANOVA; n=7-8 * p<0.05, Tukeys post-hoc analysis, error bars SEM) (B) 
GR immunostaining shows increase localisation in cohorts following castration, clusters of cells expressing GR can also be observed at the 
zona glomerulosa of Ad-ARKO castrated mice. N=5. (C) Androgen receptor gene expression has a significant upregulation in castrated 
males (one-way ANOVA;** p<0.001, Tukeys post-hoc analysis, error bars SEM). (D) AR immunostaining (Red) shows an increase in 
expression in the X-zone region of the cell with a loss of expression in the ZG. Clusters of AR positive cells in the ZG can be observed in Ad-
ARKO Castrated mice. Green: sytox counterstain. N=5. (E) Cleaved caspase 3 immunostaining shows cell death at the cortex medulla 
boundary. No cleaved caspase staining can be observed in Bl6 castrated mice or Ad-ARKO animals. In Ad-ARKO castrated mice cell death 
can be seen throughout the cortex. N=5. Scale Bars 50µm. Annotations; M=medulla, X= X-zone. 
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Figure 3-13. Immunostaining reveals AR and GR are not localised in the 
same cell populations.  AR localisation in the WT male adrenal does not occupy 
the same cell types that localise. Scale Bars 50µm. Arrows highlight the different cell 
types expressing AR (large circular nuclei of steroidogenic cells) and GR (small 
spindle shaped nuclei located between the steroidogenic cells). Annotations; ZF= zona 
fasciculata, 
 
3.2.11 Aged Ad-ARKO mice show increased disruption to adrenal cortex. 
A study investigating Prkar1a gene ablation in the adrenal cortex noted the presence 
of an X-zone and that a Cushing’s Syndrome phenotype develops when the mice were 
aged to 12 months (12m) (285). Due to the presence of an X-zone in all experimental 
cohorts, in addition to the downregulation of Prkar1, (Fig. 3-7D) a cohort of Bl6 
castrated, Ad-ARKO and Ad-ARKO castrated mice were aged to 12 months to see if 
a similar phenotype or additional disruption to the adrenal cortex can be seen following 
prolonged loss of AR or circulating androgens.  
Comparison of adrenal weights from d80 to 12m showed no changes in Bl6 castrated 
and Ad-ARKO castrated cohorts following prolonged loss of circulating androgens 
but a significant increase in adrenal weight was observed in 12m Ad-ARKO mice 
compared to d80 Ad-ARKO mice (Fig. 3-14A). Consistent with this, interrogation of 
adrenal morphology revealed no obvious visual difference in structure in 12m controls 
compared to d80 controls (Fig. 3-14B). Prolonged loss of circulating androgens in 12m 
Bl6 castrated mice also results in no major disruption to the adrenal cortex compared 
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to d80 Bl6 castrated mice (Fig. 3-14B). Likewise, analysis of 12m Ad-ARKO castrated 
mice show no disruption the adrenal cortex compared to d80 Ad-ARKO castrated mice 
(Fig. 3-14B), however the X-zone is significantly smaller at 12m than at d80 and is 
breaking down (Fig. 3-14A). Despite this, in accordance with the increase in adrenal 
weight, a worsening of cortex disruption is observed in 12m Ad-ARKO animals 
compared to d80 Ad-ARKO mice (Fig. 3-14B). Large spindle cell lesions can be 
observed in the adrenal capsule, that extend down into the ZF. Additionally, 12m Ad-
ARKO mice have an X-zone that is significantly larger than the X-zone that is 
observed in d80 Ad-ARKO mice (Fig. 3-15A). Analysis of 12m Ad-ARKO X-zones 
also reveals enlarged hypertrophic eosinophilic cells (Fig. 3-15C). Circulating 
corticosterone remains significantly increased in 12m Ad-ARKO males compared to 
12m controls, similar to that observed at d80 (Fig.3-15B). Similarities can be drawn 
between the phenotype observed in 12m Ad-ARKO mice and Prkar1a KO mice, such 
as enlarged, mislocated X-zone, presence of cell clusters in the outer cortex and 
elevated corticosterone. This highlights a potential relationship between AR and 
Prkar1a1 in adrenal cortex regulation. Together these data show that, whilst chronic 
loss of androgens does not exacerbate the phenotype established earlier in life, 
continued AR signalling is essential to prevent age-related degeneration of the adrenal 
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Figure 3-14. Aged Ad-ARKO mice display large cell clusters in capsule and large 
eosinophilic cells (A) Adrenal weight analysis showed a significant increase in 12m 
Ad-ARKO mice compared to (d)80 Ad-ARKO mice (two-way ANOVA; n=5-8 *** 
p<0.0001, Tukeys post-hoc analysis, error bars SEM), and no weight changes are 
observed in any other cohort. (B) Morphology analysis of 12m old Bl6 castrated, Ad-
ARKO and Ad-ARKO castrated mice reveals in 12m cohorts with no circulating 
androgens show no major cortex disruption and X-zone regression. 12m Ad-ARKO 
mice have severe cortex disruption, with presence of large spindle cell lesions in the 
outer cortex (highlighted by dotted lines) and an enlarged X-zone. d80 cohorts have 
n=5, 12m cohorts have n=3. Annotations; M=medulla, ZF= zona fasciculata, ZG = 
zona glomerulosa, X= X-zone. 
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Figure 3-15. Aged Ad-ARKO mice X-zones are larger than those in early 
adulthood.  (A) Measurement of X-zone depth show a significant increase in 12m Ad-
ARKO mice compared to (d)80 Ad-ARKO mice (two-way ANOVA; n=5-8 **** 
p<0.0001, Tukeys post-hoc analysis, error bars SEM). In contrast 12m Ad-ARKO 
castrated mice show a significant decrease in X-Zone depth when compared to (d)80 
Ad-ARKO mice (two-way ANOVA; n=5-8 **** p<0.0001, Tukeys post-hoc analysis, 
error bars SEM). (B) Circulating corticosterone analysis display no significant 
difference between (d)80 and 12m cohorts, however, 12m Ad-ARKO mice have a 
significant increase in corticosterone compared to 12m controls (two-way ANOVA; 
n=5-8 * p<0.05, Tukeys post-hoc analysis, error bars SEM). (C) Interrogation of X-
zone morphology revealed X-zone regression via shrinkage and vacuolisation when 
compared to d80 Bl6 castrated and Ad-ARKO castrated mice. 12m Ad-ARKO mice 
show large multinucleated cells (denoted by arrows) in the X-zone and enlargement 
compared to d80 Ad-ARKO mice. N=5. Scale bars 50µm.  
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3.3 Discussion  
 
To investigate the role of androgen receptor signalling in the adrenal a novel mouse 
model with a specific ablation of androgen receptor in the adrenal cortex was used, 
compounded with additional manipulation of circulating androgen levels. Results 
show AR expression in the human and mouse adrenal and highlight that the mouse is 
a viable model to investigate androgen signalling in the adrenal cortex. Results 
demonstrate that androgen signalling exclusively via AR is required for X-zone 
regression during puberty. Cortex measurements define differences in X-zone 
morphology depending on whether circulating androgens or AR have been targeted, 
suggesting androgens and androgen receptor are working both together and 
independently of each other in different adrenal processes. This result is further 
strengthened by loss of AKR1B7 localisation in models following removal of 
circulating androgens but not AR which still maintained AKR1B7 positive cells. 
Prolonged loss of circulating androgens in aged mice reveal apparent adrenal 
feminisation with eventual X-zone regression. However, aged animals with AR 
ablation reveal severe cortex disruption, spindle cell hyperplasia and X-zone 
expansion. These data together show AR signalling is required to facilitate X-zone 
regression and mediate circulating androgen action on the adrenal cortex, with loss of 
AR leading to excessive stimulation of the adrenal and development of X-zone 
expansion and spindle cell lesions.  
Investigation of androgen receptor signalling in the developing mouse adrenal 
highlighted that AR expression can be observed as early as e13.5, this expression is 
maintained into adulthood and is present in all cortical zones. AR is not only observed 
in developing mouse adrenal, it is also expressed in the human second trimester foetal 
tissue. Results also show expression of AR in the adult human adrenal. Localisation 
of AR in the human adrenal has previously never been shown. This may be because 
previous research has focussed on androgen production and its impacts thereafter, 
however little research has focused on the autocrine regulation of AR in the adrenal 
itself, despite the fact that the adrenal has been shown to react to the loss of androgens 
through castration by the development of an X-zone (23, 56). However, the mechanism 
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underpinning this and its importance remains unexplored. By describing the 
localisation in human and mouse, this highlights that not only can the rodent be used 
as a suitable model to explore androgen action within the adrenal but AR is important 
in the control of adrenal development and function. An addition issue with examining 
human adrenal AR may be due to the difficulty of detection of AR at a protein level. 
During the course of trying to localise AR in human samples involved the use of 
numerous antibodies until one was found that worked. Due to there being no literature 
detailing AR localisation, where AR would be localised would be unclear. To ensure 
the antibody has worked, additional human foetal and adult testis controls were used. 
Interestingly, in human adrenal the localisation appears to be cytoplasmic.  
To provide a comprehensive overview of the impact of androgens on the adrenal 
cortex, it was important to ascertain the impacts not only of the loss of androgens but 
also to establish if androgens had the potential to over stimulate the adrenal cortex or 
impact the X-zone and its morphology. Following a single or chronic dose of hCG, 
examination of adrenals revealed no changes in cortex morphology in controls or in 
any experimental cohorts. Additionally, there appears to be no impact on X-zone 
morphology in any of these cohorts. For these reasons, animals treated with hCG were 
not taken any further as part of this study. This data highlights that there may be an 
upper limit to circulating androgen action on the adrenal cortex.  
Confirmation of AR ablation from steroidogenic cells in the adrenal cortex was 
achieved via AR immunostaining. Initial investigation of the adrenal reveals an 
increase in adrenal weight from d35 and maintained into adulthood in Ad-ARKO mice, 
this coincides with the presence of an additional cortical zone with characteristics of 
the rodent X-zone. This data demonstrates that expression of AR in the adrenal cortex 
is essential during puberty for regression of the X-zone (34).  
Androgens and AR can work together and independently of each other to regulate gene 
expression (273, 288, 201), so to fully investigate the impact of androgen signalling 
on the adrenal, additional models were added to the study, these include Bl6 castrated 
(in which adrenal AR was present but not circulating testosterone) and Ad-ARKO 
castrated mice (in which neither adrenal AR or circulating testosterone were present). 
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All cohorts have increased adrenal weight in adulthood compared to controls, and 
morphology analysis and staining with 20 alpha-HSD (281) show that they have all 
developed X-zones. This suggests that androgens binding to AR is required for 
appropriate removal of X-zone cells from the cortex during development, and that AR 
or testosterone cannot act independently to promote X-zone regression. Analysis of 
the X-zone morphology highlights that the X-zones appears to be denser and occupy 
different proportions of the cortex depending on whether androgens or androgen 
receptor have been disrupted, suggesting that not only is AR signalling through AR to 
regulate the cortex zonation but they are acting independently of each other as well. 
Cortex measurements confirmed significant morphological differences between 
cohorts. Measurements highlighted differences in X-zone cell density and X-zone 
depth. This result further strengthened the argument for androgen AR independent 
signalling in the adrenal. To explore these differences in more detail and determine 
potential mechanisms that androgen or AR controlled, markers for stress, development 
and steroidogenesis were investigated. 
Investigation of circulating corticosterone, a key indicator of adrenal stress response 
(282, 289), shows that Ad-ARKO animals have an increase in circulating 
corticosterone, that resolves upon castration. This potentially suggests that castration 
is rescuing the increased stress response from the adrenal induced by AR ablation. 
Circulating androgens target numerous tissues and the impact of castration has been 
demonstrated in the hypothalamus and its release of gonadotropin releasing hormone 
(GnRH) (290) and also can exert feedback directly at the level of the pituitary and 
impact LH secretion (291). This disruption to organs that can regulate the adrenal 
cortex may also play a role. When analysing corticosterone, the handling of the 
animals must be considered. Prior to the collection of the animals, minimal stress must 
be achieved to obtain true basal levels. Upon handling, there is only a brief window 
(2-5 minutes) before circulating corticosterone becomes elevated (292). Attempts were 
made to cull the animal as quickly and efficiently as possible from the initial cage 
handling to being placed in the CO2 box. However, this handling process may not have 
been the most efficient practice. Animals were not separated and in instances where 
there was a struggle to catch the animal, all gives opportunity for corticosterone levels 
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to be elevated. The handling procedure aforementioned has resulted in minor stress to 
the mice and elevated corticosterone levels. For true basal levels a more refined 
method would need to be used. This could be achieved by leaving animals in a quiet 
room prior to collection and separating into individual cages to lessen the contact time 
for the animals. Other culling methods such as decapitation over CO2 has been 
suggested to be preferential due to the quick nature of the process. However, it can be 
argued that all conditions the mice were collected under are relative to the controls. 
Despite having corticosterone levels at the level deemed ‘minor stress’, all mice were 
collected under the same conditions so are relative to the controls.  
Due to the early expression of AR, it was important to investigate the potential impact 
of androgen ablation throughout development. Any literature regarding androgens and 
their regulation of the X-zone have determined androgen action does not occur until 
puberty, it was thought that once circulating testosterone reached high enough 
concentration this would ultimately lead to X-zone regression (95). However, 
investigation of 20 alpha-HSD staining throughout postnatal development shows that 
X-zone cells are already more developed in size and abundance compared to controls 
at d12, d21 and d35. This tells us, contrary to the literature, that this regulation of the 
adrenals by androgens is occurring before puberty and that androgens are potentially 
positively regulating these foetal cells during development. Essential regulators of the 
adrenal cortex, Sf1 and Dax1 (57, 59), were investigated in d80 adrenals to determine 
if disruption to androgen signalling impacted these genes. Results show a significant 
up regulation in Sf1 transcript in all experimental cohorts compared to controls. It has 
previously been shown that androgens are a repressor of Sf1 activity (293), this is an 
important mechanism to regulate Sf1 and its target genes. The expression of Sf1 is a 
tightly regulated process during development (293), sustained elevated levels of Sf1 
could have serious implications for the developing cortex and a number of diseases are 
associated with elevated Sf1 expression, such as childhood adrenocortical tumours 
(82). Removal of AR and circulating androgens resulted in an increase in Dax1 
expression. Dax1 is important for the differentiation of stem and progenitor cells 
located in the adrenal capsule (294, 295), this increase in expression could suggest that 
following the complete loss of both androgens and AR signalling, adrenal cortex cell 
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differentiation is affected. Due to the ectopic maintenance of an X-zone in androgen 
signalling depletion models, investigation of transcript levels of Prkar1 was carried 
out. This gene has previously been shown to regulate X-zone cells and when ablated 
resulted in a condition known as Primary Pigmented Adrenocortical Disease (PPNAD) 
(29). Results highlight that there is a significant downregulation in its transcript levels 
in all experimental cohorts. There is little literature to suggest that AR could be 
upstream of Prkar1a, so to say that AR is directly regulating this gene would be an 
over simplification. However, there is some literature that describes AR signalling 
working in congress with Prkar1 in driving castration resistant prostate cancer (142). 
These results combined, show an important regulatory role for androgen signalling in 
the adrenal cortex during development and adult cortex maintenance and highlights 
relationships between key adrenal regulators and AR signalling.  
To assess if the loss of androgen signalling impacted steroidogenesis, a panel of 
steroidogenic enzyme genes were investigated. Cyp21a1 is involved with the 
biosynthesis of the steroid hormones aldosterone and corticosterone and is usually 
found in ZF cells (15). Results revealed an increase in Cyp21a1 expression and CYP21 
localisation throughout the entire adrenal cortex following loss of androgen signalling. 
An abundance of literature can be found detailing the impacts of loss of function or 
mutated Cyp21 but there is little literature detailing the impacts of overexpression in 
the adrenal cortex, further analysis into would be needed to ascertain the direct impact, 
however, it could lead to overactive steroidogenesis in the adrenal glands.  
3β-HSD is essential in the biosynthesis of steroid hormones in the adrenal gland (284), 
and is expressed throughout the adrenal cortex. Protein localisation of 3β-HSD shows 
varied staining in the experimental cohorts. X-zones in Bl6 castrated animals stained 
positive for 3βHSD, this suggests potentially that these cells have come from a 
steroidogenic lineage. However, 3βHSD localisation in Ad-ARKO mice showed 
sporadic positive cells with Ad-ARKO castrated animals showing no staining for 
3βHSD in the X-zone. The presence of 3β-HSD positive cells in the X-zone of Ad-
ARKO mice could potentially be X-zone cells that have differentiated from foetal cells 
to steroid producing cells, this differentiation could potentially be driven by continued 
signalling from androgens and following castration this could explain why no positive 
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cells are observed in Ad-ARKO castrated mice. AKR1B7 is a well-established ZF 
marker (40) that is integral for detoxifying the adrenal cortex from toxic by-products 
arising from cholesterol cleavage (296). Due to change in cortex composition, it was 
important to assess how this impacted Akr1b7 expression. Results highlights no 
changes in transcript levels however in both castrated experimental cohorts in which 
androgens are removed, no AKR1B7 positive cells can be observed in the cortex. 
However, Ad-ARKO mice still express AKR1B7 in the adrenal cortex. This data along 
with the changes in morphology observed in the X-zone, shows that androgens can act 
independently of their receptor to mediate gene expression in the adrenal cortex. 
AKR1B7 has previously been shown to be regulated by androgens in the vas deferens 
(297), however it was thought its regulation in the adrenal cortex was under the 
regulation of Sf1 (298). The data suggests that this is potentially not the case, that either 
androgens are regulating AKR1B7 or are working with Sf1 to regulate its expression. 
Due to the known relationship between AR and GR (162, 205), analysis of the impact 
of AR ablation on GR expression in experimental cohorts was investigated. 
Investigation of GR signalling in the adrenal cortex revealed a significant increase in 
GR transcript in cohorts following castration. Protein localisation reveals clusters of 
GR-positive cells in the outer cortex in Ad-ARKO castrated mice which also stained 
positive for AR, however, AR and GR are not normally expressed in the same cell 
types in the adrenal cortex, suggesting the presence of an abnormal cell population that 
potentially may be undifferentiated cells. Adrenocortical cells under normal conditions 
migrate towards the cortex-medulla boundary and undergo apoptosis (53). Due to 
failed clearance of X-zone cells and the development of cell clusters in the cortex, 
investigation of apoptosis marker cleaved caspase 3 was used to determine if the cortex 
was still able to appropriately clear cells from the cortex. Protein localisation of 
Cleaved caspase 3 shows no positive cells in BL/6 castrated and Ad-ARKO mice, 
suggesting that following loss of androgen signalling the adrenal does not show normal 
patterns of cell death. This phenotype has been documented before in a global AR 
knockout model, however, this was thought to be a result of loss of signalling from the 
pituitary (162), results demonstrate that this is potentially not the case and that adrenal-
specific androgen receptor signalling is responsible is the driving this phenotype.     
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The majority of this study focused on animals in early adulthood or short-term loss of 
circulating androgens, so the final part of the study investigated the implications of 
chronic loss of androgen signalling on the adrenal cortex. The study investigating 
Prkar1 ablation in the adrenal cortex and the noted the presence of foetal cell did not 
detect a phenotype until aged (29). To determine if chronic loss of androgens resulted 
in a similar or more severe phenotype, mice were aged to 12 months. Investigation of 
morphology revealed significant disruption to the adrenal cortex of 12m Ad-ARKO 
mice with significant enlargement of the X-zone, which also presented with large 
eosinophilic cells throughout. A similar large multinuclear cell population was also 
observed in 6m Leydig cell ARKOs, which were shown to be large infiltrating 
macrophages. Staining with cleaved caspase could help determine if these enlarged 
cells are adrenocortical cells or are infiltrating macrophages. Furthermore, large cell 
clusters in the outer cortex were present that protruded into the centre of the cortex. 
These cell types are characteristic of spindle cell hyperplasia ‘type A’ cells (299).  
Morphology and X-zone measurements show that X-zone regression is occurring in 
long term castrated cohorts, with no disruption to the remainder to the cortex outside 
of that which could be expected with age. X-zone morphology and regression observed 
in 12m Ad-ARKO castrated animals is typical of what would be observed under 
normal conditions in an aged WT female (34). The X-Zone in WT females is 
maintained into adulthood, and regresses at first pregnancy, however if there is no 
pregnancy, the X-zone eventually regresses with age via vacuolization (89). However, 
in 12m Ad-ARKO mice there is severe disruption to the cortex and a progressive 
phenotype observed. Elevated circulating corticosterone is also maintained in 12m Ad-
ARKO mice, highlighting a sustained stress response. Prolonged periods of 
corticosterone excess is known to be involved in a number of clinical conditions such 
Cushing’s syndrome (300), cardiovascular disease (301) and decreased bone density 
(302). Together this data demonstrates that prolonged loss of circulating androgens 
does not progress the phenotype observed in d80 castrated mice, and that potentially 
the adrenal has become feminized. The adrenal following loss of AR only, results in a 
large spindle cell lesions and X-zone expansion and maintained elevated 
corticosterone. Throughout this chapter, the results demonstrate that androgens can act 
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both with and independently of their receptor, prolonged exposure of the adrenal 
cortex to androgens without AR could potentially lead to off target activation of 
signalling pathways by androgens leading to X-zone expansion and spindle cell 
hyperplasia.  
In conclusion, this analysis highlights numerous targets of androgen signalling within 
the adrenal cortex. Not only are androgens signalling through their receptor essential 
for the regression of the X-zone during puberty, but that they can work together and 
independently to modulate adrenal function. Prolonged loss of androgens results in a 
phenotype similar to a virgin female adrenal, however loss of AR alone results severe 
cortex disruption with an increase in X-zone size, development of hyperplasia and 
maintained elevated stress response. Additionally, these results highlight that despite 
the mouse adrenal not producing androgens, androgen action plays a key functional 
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Androgens signalling through androgen receptor (AR) have been well characterised in 
the development of male specific phenotypes, including embryogenesis, 
spermatogenesis (164, 303), sexual behaviours (304) as well as maintaining fertility 
throughout life (305), however the role of androgen signalling has also been shown to 
be integral in the female, during ovarian folliculogenesis (306), embryonic 
implantation (307) and uterine and breast development (308). Androgens in the female 
are secreted by the adrenal and the ovary and can also be formed peripherally, 
particularly from adrenal DHEAS (114). In women the adrenals account for 
approximately 25% of circulating androgens (309), with cross sectional analyses 
revealing that decreased circulating androgens impact health and wellbeing in young 
and aging women (114, 310). The primary focus of adrenal androgen research has been 
on the disruption to production of androgens from the adrenal cortex with scarcely any 
research covering the role of adrenal AR signalling itself. This could be in part due to 
the perceived lack of suitable rodent model, as the mouse adrenal does not produce 
androgens (111).  
Despite this, treatment with testosterone in both males and females have shown to 
impact the mouse adrenal X-zone (34, 36, 311). The X-zone in the mouse adrenal is 
sexually dimorphic and regresses differently in males and females. Both the male and 
female mouse adrenal develops an X-zone during postnatal development and as 
previously described, involution occurs during puberty in males and at first pregnancy 
in females. If no pregnancy occurs, regression occurs eventually over time with age 
(34, 38). Historical studies in female mice show that the X-zone regresses following 
treatment with testosterone-propionate, suggesting that androgens are able to regulate 
the female adrenal cortex (36). Studies that investigated the effects on the adrenal 
following the loss of circulating androgens through gonadectomy noted the re-
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development of the X-zone and in certain strains, the development of adrenocortical 
tumours were more frequent in females (56).  
Adrenal masses can be detected in approximately in 4% of the population, with the 
majority of these originating from the adrenal cortex region (312). It is thought that 
adrenocortical tumours (ACT) may result in aberrant steroid production and in cases 
where tumours become cancerous, lead to high mortality rates due to tumour growth 
(312, 313).  Studies investigating the mechanisms of adrenal tumour development have 
advanced greatly through the use of appropriate technology to dissect the relationship 
between tumour development and the potential genes involved in its progression (22, 
285, 312). However, despite adrenocortical cancer being rare, its mortality rates are 
high and little is known about the underlying mechanisms driving its progression from 
benign to cancerous. A main precursor for the development of ACTs in humans and 
in rodents is the development of spindle cell hyperplasia (299). Some of these studies 
also noted that the phenotype observed in females was often more severe than in males 
(285, 287, 299). Certain mouse strains, IQI/Jic mice in particular, have been used to 
investigate the development of spindle cell hyperplasia as they are thought to help 
elucidate the underlying mechanism driving tumour progression (299, 314).  
For these reasons, adrenal androgen receptor knockout females were investigated to 
determine if the loss of AR impacts female adrenal cortex development, if it has the 
potential to regulate the X-zone in the female during pregnancy and if loss of AR leads 
to the development of ACTs. Results show that, despite previous literature, AR is 
dispensable for the postnatal developing female adrenal and during X-zone regression 
following pregnancy. Furthermore, results highlighted that following disruption to 
adrenal AR, the development of spindle cell hyperplasia could be seen in young adult 
females that progressed with age. These result point to dysfunction androgen signalling 
as a possible mechanism in the development of spindle cell hyperplasia.   
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 To determine if ablation of androgen receptor impacts the postnatal developing 
female adrenal 
 To determine if loss of androgen receptor impacts adult cortex morphology, 
function and stress response 
 To determine if Ad-ARKO females develop spindle cell lesions   
 To establish if loss of androgen receptor results in failed X-zone regression 
during pregnancy 
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4.2 Results  
4.2.1 Confirmation of ablation of androgen receptor from the female adrenal 
Because AR is X-linked, first generation Ad-ARKO females are in fact mosaic for 
presence/absence of AR expression (due to random X-chromosome inactivation), 
whilst the F2 animals completely lack adrenal AR from steroidogenic adrenocortical 
cells. Both mosaic and total Ad-ARKO females are used in this study as partial 
ablation enables investigation of autocrine AR action in the adrenal cortex in addition 
to the effects of complete loss of adrenal AR (Fig. 4-1A). AR is expressed in all zones 
of the adrenal cortex in littermate controls, in contrast, partial ablation of AR from 
steroidogenic adrenocortical cells can be seen in 1st Generation Ad-ARKO females 
and complete ablation from steroidogenic adrenocortical cells in 2nd Generation Ad-
ARKO females (Fig. 4-1B). These data confirm the ablation of AR from the adrenal 
cortex, and that this model permits tissue-specific interrogation of androgen signalling 
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Figure 4-1. Breeding strategy and confirmation of AR ablation in the 
adrenal cortex. (A) Schematic detailing breeding strategy for Ad-ARKO 
females. AR is X-linked so requires two rounds of breeding to achieve a 
complete adrenal AR knockout female. 1st generation offspring are 
generated by breeding an AR floxed female to a male carrying the 
Cyp11a1-Cre. 2nd generation breeding uses an AR floxed female and an AR 
knockout male from the F1 offspring.  (B) Immunostaining of AR in the 
adrenal cortex reveals partial ablation in the 1st Generation Ad-ARKO and 
complete adrenal AR ablation in the 2nd generation Ad-ARKO females. 
N=5. Red: androgen receptor protein, Green: sytox counterstain. Scale Bars 50µm. 
Annotations; ZF= zona fasciculata, ZG = zona glomerulosa. 
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4.2.2 Analysis of population ratios reveals significantly fewer 2nd Generation 
Ad-ARKO females  
General observations made when breeding 2nd generation Ad-ARKO females noted 
that there appeared to be fewer of them being born. To address this, a Chi squared 
analysis was performed (315). Results showed the expected 50/50 distribution between 
1st generation Cre- and Cre+ males and females (Fig. 4-2A). Analysis of 2nd 
generation litters revealed a normal distribution of 50/50 between Cre+ and Cre- 
males, however, this was not observed in 2nd generation females. 79% of 2nd generation 
females are Cre- with only 21% of females carrying complete ablation of adrenal AR 
(Fig. 4-2B). Due to the small numbers of 2nd Generation females that were born during 
the study, analysis using these mice was limited to a d80 cohort and a pregnancy cohort 
only. These results demonstrate that following complete adrenal AR ablation, either 
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Figure 4-2. Significantly fewer 2nd Generation Ad-ARKO females are 
born. (A) Chi squared analysis of 1st Generation Ad-ARKO observed and expected 
litter ratios revealed 50% Cre- and 50% Cre+ in males (X2 P=0.2416) and females 
(X2 P=0.6891). (B) Chi squared analysis of 2nd Generation Ad-ARKO observed and 
expected litter ratios revealed 51% Cre- and 49% in males (X2 P=0.5034) and 79% 
Cre- and 21% Cre+ in females (X2 *P=0.0192), showing significantly fewer Cre+ 
females being born.  
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4.2.3 Large lesions are observed in the outer cortex of 1st Generation Ad-
ARKO females  
To establish whether there is any impact on the developing adrenal following AR 
ablation, investigation of time points postnatal day (d)12, d21, d35 and d80 were 
performed. No changes in body weight could be detected at any of the time points 
investigated when compared to age matched controls (Fig. 4-3A). Analysis of adrenal 
weight revealed no changes compared to controls at d12, d21 or d35, but adrenal 
weight is significantly increased in 1st Generation Ad-ARKO females at d80 when 
compared to littermate controls (Fig. 4-3B). Histological analysis reveals no 
differences in the postnatal developing adrenal when compared to littermate controls, 
but at d80 large lesions in the adrenal cortex of 1st Generation Ad-ARKO females are 
observed (Fig. 4-4A). Together these data demonstrate that loss of AR does not impact 
the female postnatal developing adrenal at d12, 21 or d35, with a phenotype not being 
observed until d80. For these reasons, the only time point analysed was d80. 
Additionally, these results demonstrate the development of lesions and disruption to 
the adrenal cortex following loss of AR in early adulthood. 
Figure 4-3. 1st Generation Ad-ARKO show increased adrenal weight at 
d80. (A) Interrogation of body weights at d12, d21, d35 and d80 revealed no changes 
in body weight in 1st Generation Ad-ARKO females compared to WT controls (Two-
way ANOVA, Tukeys post-hoc analysis, error bars SEM),  N=8. (B) Interrogation of 
adrenal weights at d12, d21, d35 revealed no changes compared to WT controls. A 
significant increase in adrenal weight is observed at d80 compared to WT controls. 
(Two-way ANOVA, Tukeys post-hoc analysis, error bars SEM), N=8.  
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Figure 4-4. 1st Generation Ad-ARKO show no differences during 
development but display large cell clusters in the outer cortex.  (A) H&E 
analysis of adrenal morphology show no differences at d12, d21, d35 compared to WT 
controls. At d80 large cell clusters can be observed in the outer adrenal cortex of 1st 
Generation Ad-ARKO females. N=5. Annotations; ZF= zona fasciculata, ZG = zona 
glomerulosa, M=medulla. Scale Bars 100µm.  
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4.2.4 Partial and complete ablation of adrenal AR results in spindle cell 
hyperplasia and X-zone vacuolization  
 
To investigate adrenal disruption in more detail, analysis of d80 littermate controls, 1st 
Generation Ad-ARKO and 2nd Generation Ad-ARKO was performed. Body weight 
measurements reveal no changes in either cohort when compared to littermate controls 
(Fig. 4-5A). Adrenal weight was increased in both 1st Generation and 2nd Generation 
Ad-ARKO females compared to littermate controls (Fig. 4-5B). Histological analysis 
of both experimental cohorts revealed significant disruption to the outer cortex 
compared to littermate controls. Upon closer inspection, morphology of the cell types 
that make up the abnormal cell clusters in the outer capsule are characteristic of spindle 
cells with their ovoid or spindle shape (287), classically named ‘type A cells’(287, 
299). Another, but rarer form of spindle cell hyperplasia can also occur termed ‘type 
B cells’, which are polygonal in shape and can vary in size.  Morphological analysis 
show no B type cells are present (287). Spindle cells can be seen in both 1st and 2nd 
Generation Ad-ARKO females, with 2nd Generation Ad-ARKOs displaying a 
progressive phenotype from 1st to 2nd generations and presence of spindle cells 
throughout the majority of the outer cortex (Fig. 4-5C). Spindle cell hyperplasia is not 
uncommon in aging mice and has been noted more commonly in females than in 
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Figure 4-5. Spindle cell lesions can be observed in 1st and 2nd 
Generation Ad-ARKO females. (A) Bodyweight analysis of d80 WT controls, 1st 
Generation Ad-ARKO and 2nd Generation Ad-ARKO females revealed no changes. (B) 
Adrenal weight analysis shows a significant increase in 1st and 2nd Generation Ad-
ARKO mice compared to respective controls (one-way ANOVA; n=5-8, *p<0.05, 
*p<0.05, Tukeys post-hoc analysis, error bars SEM).  (C) H&E analysis reveals 
spindle cell lesions in the outer adrenal cortex that protrude down from the ZG into 
the ZF in 1st Generation Ad-ARKO females. These spindle cell lesions can also be 
observed in 2nd Generation Ad-ARKO females but are more progressive and occupy a 
larger portion of the adrenal cortex. Spindle cells denoted by arrows. N=5. 
Annotations; ZF= zona fasciculata, ZG = zona glomerulosa, M=medulla. Scale Bars 
100µm.   
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Due to the potential for spindle cells to occur naturally it was important to determine 
if the presence of these cells increased following partial or complete adrenal AR 
ablation. 20% of littermate controls at d80 had spindle cell hyperplasia, increasing to 
60% of 1st Generation Ad-ARKO females d80 and a further increase to 80% in 2nd 
Generation Ad-ARKOs at d80 (Fig. 4-6A). The X-zone in the female adrenal is 
maintained in adulthood, but is kept in a well-defined region at the cortex-medulla 
boundary (34, 95). Interrogation of X-zone morphology revealed expansion of foetal 
cells from the X-zone through the cortex in 1st and 2nd Generation Ad-ARKOs. Again, 
this phenotype is visually more pronounced in the 2nd Generation Ad-ARKO females. 
In addition to the development of spindle cell hyperplasia, pockets of vacuolization 
can also be seen in X-zones of both experimental cohorts following AR ablation, which 
is not observed in littermate controls, presence of vacuoles suggests damage and 
potential breakdown of the adrenal cortex (Fig. 4-6B).  Together this data demonstrates 
the early onset and increase in occurrence of spindle cell hyperplasia as a result of 
adrenal AR ablation. Body weight, adrenal weight and adrenal morphology of 1st and 
2nd generation controls show no differences, so from this point on both 1st and 2nd 
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Figure 4-6. There is an increase in spindle cell occurrence in 1st and 2nd 
generation Ad-ARKO females. (A) Interrogation of spindle cell development in 
Ad-ARKO females reveals a 60% occurrence in 1st Generation Ad-ARKO females (X2 
P=0.0001) that increases to 80% in 2nd Generation Ad-ARKO females (X2 P=0.0001) 
compared to only a 20% occurrence in WT controls (X2 P=0.5398), (n=5). For 
statistical analysis, observed vs. expected values were obtained from morphology 
analysis in WT controls (80% no hyperplasia and 20% hyperplasia), these were then 
used for the statistical analysis on 1st and 2nd generation Ad-ARKO mice.(B) Analysis 
of X-zone revealed expansion and migration up the cortex, with pockets of 
vacuolization throughout in 1st Generation Ad-AKRO females. The same but more 
progressive phenotype can also be observed in 2nd Generation Ad-ARKO females 





Chapter 4: Loss of androgen signalling via AR results in increased spindle cell 





4.2.5 Ablation of AR results in disruption to cortical markers 20 alpha-HSD 
and AKR1B7 
To determine if cortex disruption observed in Ad-ARKO females impacted stress 
response or resulted in disruption to cortical markers, analysis of the stress biomarkers 
corticosterone (316) and Mc2r (317) was performed. In addition 20-α-hydroxysteroid 
dehydrogenase (20 alpha-HSD), a well described X-zone marker (281), and Aldo-keto 
reductase family 1, member 7 (AKR1B7) a well-defined zona fasciculate marker 
known for detoxifying cholesterol cleavage products was also analyzed (298). No 
changes are observed in circulating corticosterone or Akr1b7 transcript (Fig.4-7A, B) 
but a significant increase in 20alpha-HSD is observed (Fig. 4-7C). Analysis of 20 
alpha-HSD immunostaining highlights disruption to the X-zone with migration of 
foetal cells through the cortex (Fig. 4-8A). AKR1B7 immunostaining showed 
disruption in both 1st Generation and 2nd Generation Ad-ARKO females with large 
portions of the adrenal cortex no longer positive for AKR1B7 (Fig. 4-8B). Together 
these data demonstrate that ablation of AR in the adrenal does not impact the adrenal 
response to stress, however, spread of foetal cells through the cortex and loss of 
AKR1B7 could have serious implications for adrenal function, as the adrenal may no 
longer be able to deal with toxic products from steroidogenesis.  
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Figure 4-7. AR ablation results in no changes in the adrenals stress 
response. (A) Analysis of serum corticosterone revealed no changes in 1st or 2nd 
Generation Ad-ARKO females when compared to controls. (B) Investigation of Akr1b7 
transcript revealed no changes when compared to compared to controls (C) 
Investigation of 20alpha-HSD transcript revealed a significant increase in expression 
in 1st and 2nd Generation Ad-ARKO females when compared to controls (one-way 
ANOVA; n=8, *p<0.05, **p<0.001, Tukeys post-hoc analysis, error bars SEM). 
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Figure 4-8. AR ablation results in disruption to adrenocortical markers.  
(A) Immunostaining of 20alpha-HSD revealed migration of foetal cells in 
2nd generation Ad-ARKO females up through the cortex, compared to WT 
controls were the X-zone is maintained at the cortex medulla boundary.  
Red: 20alpha-HSD protein, Green: sytox counterstain. N=5. (B) Immunostaining 
of AKR1B7 revealed loss of positive cells throughout the adrenal cortex in 
1st and 2nd Generation Ad-ARKO females. Red: AKR1B7 protein, Green: sytox 
counterstain. N=5. Scale Bars 100µm.  Annotations; ZF= zona fasciculata, X=X-
zone.   
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4.2.6 Spindle cells in the adrenal cortex are positive for GR 
As the adrenal plays an integral role in steroidogenesis (280, 318), a panel of 
steroidogenic enzymes and additional steroid receptors were analyzed for any 
disruption. Changes in protein immunolocalization of steroid cell marker 3βHSD were 
observed (319). Littermate controls have 3βHSD positive cells in the ZG and ZF, 
analysis of 1st and 2nd Generation ARKO females revealed that spindle cells are not 
steroidogenic and do not stain positive for 3βHSD (Fig. 4-9A). Protein localization of 
GR showed that the spindle cells that have developed in the outer cortex are positive 
for GR (Fig 4-9B). Due to the substantial portions of the adrenal being occupied by 
spindle cells in Ad-ARKO females, this could suggest that large parts of the adrenal 
are now no longer producing steroids and normal adrenal function is impaired. 
Additionally, over expression of GR in ACTs and has been used as a marker to help 
distinguish between benign and malignant ACTs (320). 
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Figure 4-9. Spindle cell lesions are positive for GR and lack 3βHSD 
expression. (A) Immunostaining of 3βHSD localisation revealed that the spindle 
cells do not express 3βHSD in 1st or 2nd Generation Ad-ARKO females, compared to 
WT controls that are positive in both the ZG and ZF. Red: 3βHSD protein, Green: 
sytox counterstain. N=5. (B) Immunostaining of GR revealed that spindle cells are 
positive for GR in 1st and 2nd Generation Ad-ARKO females. (*) denotes insert 
location. N=5. Scale Bars 100µm. Annotations; ZF= zona fasciculata, ZG= zona 
glomerulosa.  
  
Chapter 4: Loss of androgen signalling via AR results in increased spindle cell 





4.2.7 Fewer proliferating cells are observed in Ad-ARKO females  
The balance between cell proliferation and cell death is essential to maintain healthy 
tissue (2, 15). As spindle cell hyperplasia is present in Ad-ARKO adrenals, 
proliferation marker PCNA (321) and apoptosis marker cleaved caspase 3 (322)  were 
analyzed. Cell clearance from the adrenal cortex under normal conditions occurs at the 
cortex medulla boundary (2), immunostaining of cleaved caspase 3 showed no changes 
in location or frequency of apoptosis in any experimental cohort compared to littermate 
controls (Fig. 5-10A). Proliferation and differentiation of cells in the outer cortex is 
essential for appropriate population and maintenance of the adrenal cortex zones (323); 
immunostaining and cell counts revealed significantly fewer proliferating cells in 1st 
and 2nd Generation Ad-ARKOs compared to littermate controls (Fig. 4-10B). Fewer 
PCNA positive cells suggests that the normal proliferation and differentiation of the 
adrenal cortex is perturbed following loss of AR (Fig. 4-10B, C). It has been noted that 
in the presence of spindle cells, there is an increase in infiltrating mast cells into the 
adrenal cortex (299), for these reasons analysis of C-kit transcript, a specific marker 
for mast cells was analyzed (324). Results show a decrease in C-kit transcript (Fig. 4-
10D) which suggests that there is not an increase but a decrease in mast cell infiltration 
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Figure 4-10. Fewer proliferating cells are observed on 1 st and 2nd 
Generation Ad-ARKO females compared to WT controls.  (A) 
Investigation of cleaved caspase localisation revealed no ch anges in either 
1st or 2nd Generation Ad-ARKO females when compared to WT controls. 
(B, C) Immunostaining of PCNA localisation and cell counts reveal fewer 
proliferating cells in 1st Generation and 2nd Generation Ad-ARKO females 
compared to WT controls.  N=5 (D) Transcript analysis of C-kit showing a 
significant downregulation compared to controls (one -way ANOVA; n=7-
8, *p<0.05, ***p<0.001,  Tukeys post-hoc analysis, error bars SEM). Scale 
Bars 100µm. Annotations; M=medulla, ZF= zona fasciculata.  
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4.2.8 Progression of spindle cell hyperplasia and X-zone expansion can be 
observed in aged 1st Generation Ad-ARKOs  
 
Due to changes observed in X-zone cells in d80 Ad-ARKOs, examination of these 
foetal cells was carried out to establish if they regressed as normal with age or if they 
continued to expand throughout the cortex and to ascertain whether the spindle cell 
hyperplasia progresses with age, so a 12 month old (12m) aged cohort of 1st generation 
Ad-ARKOs was analyzed. Analysis of body weights revealed no change in 1st 
Generation Ad-ARKO females when compare with 12m littermate controls (Fig. 4-
11A). A significant decrease in adrenal weight is observed in 1st Generation Ad-ARKO 
females (Fig. 4-11B). There is no significant difference in circulating corticosterone 
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Figure 4-11. 12 month Ad-ARKO 1st Generation females have decreased 
adrenal weight.  (A) Analysis of body weight revealed no changes in 12m 
1st Generation Ad-ARKO females compared to 12m WT controls . (B) 
Analysis of adrenal weight revealed a significant decrease in 12m 1 st 
Generation Ad-ARKO females when compared to age matched controls 
(one-way ANOVA; n=3, *p<0.05, *p<0.05, Tukeys post-hoc analysis, error 
bars SEM). (C) Analysis of serum corticosterone revealed no changes in 
12m 1st Generation Ad-ARKO females compared to aged matched WT 
controls.   
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It is known that aging littermate females can develop spindle cell hyperplasia (299), 
therefore the aim was to establish if the occurrence of these cells increased with age in 
Ad-ARKO females and how that compares to the development of spindle cells in 
littermate females. Interrogation of morphology revealed 12m littermate controls had 
developed spindle cell hyperplasia that was mainly localized to the outer capsule. In 
1st Generation Ad-ARKO females however, spindle cells protrude down into the ZF 
and occupy a large proportion of the outer cortex (Fig. 4-12A). In addition to this, X-
zone regression usually occurs in aging littermate females that have not had a 
pregnancy (34, 89), and this regression was indeed observed in 12m littermate control 
females. However, the X-zone in nulliparous 1st Generation Ad-ARKO females does 
not regress with age and has in fact become more disrupted, with observed migration 
further into the cortex (Fig. 4-12B). This X-zone expansion and increase in spindle 
cells leaves very little ZF left in the cortex. Presence of spindle cells in the cortex 
increases from 20% of d80 littermate females to 80% of 12m littermate females, and 
from 60% of d80 1st Generation Ad-ARKO females to 100% of 12m Ad-ARKO 
females (Fig. 4-12C). Although the occurrence of spindle cells does increase in 
littermate females with age, becoming similar to 1st generation Ad-ARKOs, spindle 
cells appear more severe and X-zone expansion is noted. This data highlights that loss 
of AR results in progressive spindle cell hyperplasia and X-zone expansion in aged 
female mice.  
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Figure 4-12. 12 month Ad-ARKO 1st Generation females reveals 
progressive spindle cell hyperplasia.  (A) Morphology analysis reveals 
spindle cell development in 12m WT controls and is maintained in the ZG 
region of the cortex. The same lesions can be observed in 12m 1st 
Generation Ad-ARKO females, however, lesions are more extensive. (B) 
Analysis of X-zone morphology in 12m old cohorts revealed X-zone 
regression in WT controls as expect, but X-zone expansion can be seen in 
12m 1st Generation Ad-ARKO females with progression up through the 
adrenal cortex with minimal ZF remaining in the cortex. (C) Occurrence 
of spindle cells in 12m WT females increases to  80% (X2 P=0.5.398) and 
12m 1st Generation Ad-ARKO females have spindle cell hyperplasia in 
100% of samples analysed (X2 P=0.0001). N=5. Scale Bars 100µm.  
Annotations; ZF= zona fasciculata, ZG = zona glomerulosa, M=medulla, 
X=X-zone.  
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4.2.9 AR is dispensable for X-zone regression during pregnancy in the female 
adrenal  
 
Results in chapter 3 show that AR is required for X-zone regression during puberty in 
male mice (Fig. 3-4). Due to failed X-zone regression in Ad-ARKO males and X-zone 
expansion and migration through the cortex in ageing female Ad-ARKOs, it was 
important to investigate if loss of AR resulted in failure of the normal X-zone 
regression during pregnancy. Interrogation of morphology reveals normal X-zone 
regression in both parous littermate controls and parous 2nd Generation Ad-ARKOs. 
(Fig. 4-13A). Immunostaining of cleaved caspase reveals apoptosis of the X-zone in 
both parous littermate controls and parous 2nd Generation Ad-ARKOs (Fig. 4-13B). 
Immunostaining for 20 alpha-HSD confirms removal of X-zone cells with only a few 
positive cells remaining in both parous littermate controls and 2nd Generation Ad-
ARKOs (Fig. 4-13C). Despite no changes in X-zone regression being observed 
between littermate controls and Ad-ARKOs during pregnancy, circulating 
corticosterone is significantly elevated in parous 2nd Generation Ad-ARKO females 
compared to parous littermate controls (Fig. 4-13D). These results demonstrate that, 
in contrast to males, AR is dispensable for X-zone regression in females, but results in 
an elevated stress response after pregnancy. 
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Figure 4-13. AR is dispensable for X-zone regression during pregnancy.  
(A) Analysis of X-zone morphology following a single pregnancy in WT and 2nd 
Generation Ad-ARKO females reveals regression of the X-zone in both cohorts. N=5. 
(B) Immunostaining of cleaved caspase 3 shows apoptosis of the X-zone in both WT 
and 2nd Generation Ad-ARKO females. N=5. (C) Immunostaining of 20 alpha-HSD 
localisation shows only a few X-zone cells remaining in the cortex of WT controls and 
2nd Generation Ad-ARKO females. Red: 20alpha-HSD protein, Green: sytox 
counterstain. N=5. (D) Analysis of circulating corticosterone shows a significant 
increase in 2nd Generation Ad-ARKO females following pregnancy (Students t-test; 
n=5-6), *p<0.05, *p<0.05, error bars SEM) compared to WT controls. (*) denotes 
insert location. Scale Bars 100µm. Annotations; M=medulla, X=X-zone.    
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4.3 Discussion  
Through the use of the Cyp11a1-Cre, ablation of androgen receptor in the female 
adrenal cortex was achieved, with AR ablation confirmed via immunostaining. This 
provided a suitable model to investigate the role of AR in the female adrenal. Due to 
AR being X-linked the first generation are mosaic for AR in the adrenal cortex due to 
random X-chromosome inactivation, this required a second generation to completely 
ablate AR from steroidogenic adrenocortical cells in the female adrenal. Inclusion of 
both generations of Ad-ARKOs in the study did however provide the opportunity to 
investigate the resulting phenotype of partial and complete loss of androgen signaling 
from the adrenal. Results highlighted that following complete ablation in 2nd 
generation Ad-ARKO females, significantly less were being born or surviving after 
birth, although the mechanisms underpinning this is still not clear. These data 
demonstrate that AR is dispensable in postnatal development of the adrenal cortex and 
Ad-ARKO females do not show any differences in morphology when compared to 
littermate controls. Investigation into the effects of AR ablation in the X-zone reveals 
that partial and compete AR ablation results in X-zone expansion and migration 
through the cortex, however it is not required for regression during pregnancy. 
Following ablation of AR the development of spindle cell hyperplasia is observed in 
the adrenal cortex which is rare in young adults. These results highlight new roles for 
AR in the female adrenal and suggests that AR protects against the early development 
of spindle cell hyperplasia.  
One of the main issues when carrying out this study was the relatively small number 
of 2nd generation Ad-ARKO females that were present. Over a long period it was noted 
that second generation litters frequently had none or very few Cre+ females. To 
investigate this observation in more depth, a Chi squared test was used (315). This 
provides the ability to analyze expected litter ratios against observed ratios. This test 
highlighted that there were significantly fewer second generation Cre+ females being 
born. The dams from these breeding pairs were ARflox females with no gene ablation 
so there should not be a maternal or intrauterine issue. The HPA-axis has been shown 
to be important during foetal development (1), this potentially could be perturbed 
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following loss of AR. However, continued breeding of this line would be needed to 
rule out that this result is an artifact and is due to chance.  
Initial observations of body weight and adrenal weight during postnatal development, 
show that the adrenal AR is not required for normal adrenal processes during postnatal 
development and puberty, which is in contrast to what is observed in Ad-AKRO male 
littermates. No differences can be detected until adulthood, where a significant 
increase in adrenal weight can be seen in partial and compete AR ablated female 
adrenals. Coinciding with this increase in weight in adulthood, large cell clusters can 
be observed in both generations of female Ad-ARKOs, with a more severe phenotype 
present in complete AR ablated adrenals. This highlights an important relationship 
with the amount of AR present and the severity of the cell clusters present in the cortex. 
Histological analysis revealed the cell clusters in the adrenal cortex were spindle 
shaped, characteristic of ‘type A’ cells that make up spindle cell hyperplasia. Spindle 
cell development has been documented across a number of mouse strains (IQI/jc) (299) 
and these models have been used in the investigation of the development of 
adrenocortical tumors (ACTs)(287). These studies highlighted that the development 
of spindle cell hyperplasia is common in older mice however its expression in young 
mice is extremely rare. Mouse models describing early development of spindle cell 
hyperplasia have suggested that they are integral in understanding the development of 
ACT’s, highlighting that an AR ablation model can help understand the contributing 
factors of ATC development.  
As spindle cells can arise naturally in older mice, an analysis was performed that 
scored presence or absence of spindle cells in histological sections. This demonstrated 
that 80% of mice that had complete AR ablation in the adrenal cortex had spindle cell 
hyperplasia, compared to only 20% in littermate controls, suggesting that AR 
potentially can protect against the development of spindle cell hyperplasia. In addition 
to the disruption caused by spindle cell development, it could also be observed that the 
X-zone had expanded and migrated through the cortex. This suggests that female X-
zone regression is also controlled by AR, as seen in Ad-ARKO male littermates.  
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To establish if the presence of spindle cell hyperplasia or X-zone enlargement could 
be impacting the adrenals stress response and to determine if the disruption to the 
cortex results in changes to cortical markers, analysis of corticosterone, AKR1B7 and 
20 alpha-HSD was performed. Analysis of serum corticosterone revealed no 
differences in partial or complete ablated female adrenals when compared to controls. 
This result suggests that there is no impact on the HPA-axis as a result of AR ablation, 
however, there is variability observed in the serum samples of all cohorts analyzed. 
This could be in part due to females not being collected in the same time during their 
estrus cycle. Corticosterone levels have been shown to fluctuate throughout estrus 
(325), re-sampling during a selected window could provide a more reproducible result 
and help clarify if there is in fact no changes to corticosterone or impact on stress 
response. No changes were observed in Akr1b7 transcript, however, changes in protein 
localization could be seen. In partial and complete ablated adrenals large portions of 
the adrenal no longer stained positive for AKR1B7. This change in localization is 
important for a number of reasons, first it confirms the disruption to the cortex zones 
supporting the morphology analysis, and additionally AKR1B7 plays an important 
functional role in the adrenal cortex as well as serving as a zona fasciculata marker. 
AKR1B7 is responsible for detoxifying isocaproaldehyde generated by 
steroidogenesis (326). Disruption to AKR1B7 could lead to the buildup of toxins in 
the adrenal driving further damage to the adrenal cortex. This result is strengthened by 
the disruption to AKR1B7 observed in Ad-ARKO male littermates, highlighting that 
androgen signaling, not SF1 (298) could be regulating its expression in the adrenal as 
it does in the vas deferens (297).  
Significant upregulation of 20 alpha-HSD transcript can be observed in partial and 
complete adrenal Ad-ARKOs, this coincides with X-zone expansion observed 
morphologically and again through 20 alpha-HSD localization. X-zone cells in the 
virgin female adrenal cortex typically show concentric organization at the cortex 
medulla boundary adjacent to the other cortex zones (24, 281). Localization of 
20alpha-HSD in Ad-ARKO females shows foetal cells that are dispersed throughout 
the cortex, a similar phenotype has been previously described in Prkar1a adrenal 
ablation models and suggested that the development and maintenance of foetal cells 
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(or foetal precursor cells) predisposes these females to manifest a more severe form of 
primary pigmented nodular adrenocortical disease (PPNAD)(29).  
As the adrenal plays an important role in steroidogenesis (280, 318), analysis of steroid 
marker 3βHSD was performed. Results reveal that spindle cells were not 
steroidogenic, suggesting that large portions of the outer adrenal cortex taken up by 
spindle cells is now unable to produce steroids. Spindle cells have also been shown in 
a number of studies to be a precursor for the development of benign and malignant 
adrenocortical tumors (ACT) (287, 299, 320). Additionally, spindle cells stained 
positive for GR. A high percentage of spindle cell tumors are benign and do not cause 
any further complications, however some of these go on to be malignant and 
metastatic. The reasons for this is still not clearly understood and early detection of 
these malignant cells are essential to treatment or identification of adrenocortical 
tumors. The presence of GR in spindle cells has been shown to highly correlate with 
ACTs that go on to become malignant carcinomas (320). This suggests loss of AR 
signaling in the adrenal not only results in spindle cell hyperplasia, but spindle cells 
that are primed for malignancy.   
Examination of spindle cell progression with age reveal, consistent with the literature, 
that littermate controls develop spindle cell hyperplasia by 12m in 80% of the samples 
analyzed, and in 100% of Ad-ARKO females. The presence of spindle cell hyperplasia 
becomes similar to that of littermate controls at 12 months, however, the severity of 
spindle cell hyperplasia in Ad-ARKOs appears to be more advanced than controls, 
occupying the majority of the outer cortex rather than being contained to a certain 
region of the outer cortex, these cells can also be seen protruding down into the ZF. 
Differences in morphology of the X-zone can also be observed between 12m Ad-
ARKOs and 12m littermate controls. The X-zone is known to regress in aged females 
providing they have not had a pregnancy (34). This can be seen in littermate controls 
with X-zone shrinking and the influx of blood vessels to this region. This is not 
observed in the 12m Ad-ARKOs, as the X-zone has expanded and occupies a large 
portion of the adrenal cortex. These animals also show a decrease in adrenal weight, 
despite progressive spindle cell and X-zone development. This could potentially be a 
result of loss of the ZF. Unfortunately, during the aging experiment some mice died 
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due to age related illnesses, resulting in a sample size of three for the weight and 
corticosterone measurements. Whilst spare age appropriate tissue was obtained from 
sample stocks for the morphology analysis, there was no weight or body recordings 
for these animals. Whilst there was a significant decrease in the adrenal weight and 
corticosterone in 12m 1st generation Ad-ARKO mice, the power may not be high 
enough to rule out that these results could have occurred through chance. Whilst 
interesting, additional animals would have to be analyzed to ensure the results are 
accurate.   
To establish if the X-zone regression during pregnancy is under the control of AR in 
the female adrenal complete Ad-ARKOs were examined after a pregnancy (parous) 
and compared to WT BL6 parous female adrenals. These results demonstrate that AR 
signaling is dispensable during X-zone regression in pregnancy, which is in contrast 
to what is observed in Ad-ARKO male littermates during puberty. This suggests that 
its regression during pregnancy is under the control of a different pathway, potentially 
Prkar1 as they note the maintenance and progression of the rodent X-zone in parous 
Prkar1 knockout females. Despite this, X-zone expansion does occur in 12m Ad-
ARKO females, it was hypothesized by Starkey et al that the small amounts of 
circulating testosterone in females is what leads to the eventual regression of the X-
zone with age (36) and loss of AR is preventing this from occurring. Despite no 
changes being observed in X-zone regression in parous Ad-ARKOs, a significant 
increase in corticosterone was observed. It has been noted that fluctuations of 
hormones during pregnancy can on occasion result in a psychiatric condition in post-
partum women. Development of postpartum depression has been associated with 
dysregulated HPA-axis and elevated cortisol levels (233, 327). Although more 
experiments would be needed to investigate this relationship, this data could point to 
a role for adrenal AR during pregnancy and postpartum stress regulation.  
Together this data highlights an important role for AR in the female adrenal, 
independent of what can be observed in male Ad-ARKOs. Results demonstrate that 
dysregulation of adrenal AR permits spindle cell hyperplasia development and its loss 





Chapter 5: The Cyp11a1-Cre not only permits investigation of the 
adrenal cortex, but provides a novel model to investigate GR 
signalling in the hindbrain and its impact on the HPA-axis  
 
5.1 Introduction 
The HPA axis is part of the body’s neuroendocrine system which regulates responses 
to internal and external stressors. The HPA axis responds to a stressor by detection in 
the hippocampus that signals to the hypothalamus to release corticotrophin releasing 
hormone and arginine-vasopressin (AVP) from the paraventricular nucleus (PVN). 
Once released into the hypothalamic portal circulation CRH induces the production of 
adrenocorticotrophic hormone (ACTH) by the corticotrophs of the anterior pituitary. 
ACTH in turn stimulates the adrenal cortex to release the glucocorticoids cortisol (in 
humans) or corticosterone (in rodents) (109, 232, 316, 317). This activation results in 
low affinity for food, low sex drive, increased blood flow to muscle, increased 
locomotor activity and raised blood sugars which prime the body to respond to a stress 
event (232). In normal conditions these bursts of activity last for only a few minutes 
at a time, however, prolonged stress is thought to overstimulate the HPA axis causing 
hypersecretion of CRH and can ultimately, if left untreated, lead to the dysregulation 
of the HPA axis (233). Glucocorticoids and glucocorticoid receptor (GR) are essential 
in regulating this process. GR is a nuclear steroid hormone receptor. Binding of 
glucocorticoids to GR permits the repression or induction of transcription of target 
genes, this occurs through binding to DNA response elements or through interactions 
with other transcription factors. GR signalling has been shown to be important in a 
wide array of biological systems, such as immunosuppression (328), metabolism 
(329), inflammatory response (330), cell proliferation (331), and animal behaviour 
(332). Due to the numerous biological processes controlled by GR signalling and the 
widespread expression of GR, understanding this pathway and its interactions is 
essential. The potential for GR signalling being able to directly target the adrenal was 
demonstrated in the rodent adrenal in the 1970s, describing adrenal atrophy in 
hypophysectomised rats treated with glucocorticoids which showed adrenal cortex 
shrinkage and impaired adrenal function (333). More recent studies have identified the 
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presence of GR in the human adrenal through foetal development and its presence in 
the development of diseases such as primary pigmented nodular adrenocortical disease 
and in adrenocortical tumours (320, 334-336).   
GR signalling interactions are complex and results obtained in the previous two 
chapters have highlighted a potential relationship between AR and GR in the adrenal 
cortex of the mouse adrenal. Interactions between AR and GR have been noted in the 
literature in various tissues throughout the body, some of these examples include the 
negative regulation of GR by AR in prostate cancers, and this study demonstrated an 
inverse correlation between AR activity and GR protein expression during prostate 
cancer progression (203). However, the converse relationship has been demonstrated 
in human adipocytes where glucocorticoid signalling inhibited AR (337). In addition 
to these studies, it has also been demonstrated that AR and GR have a high degree of 
sequence homology, especially in regards to their DNA-binding domains. They both 
bind to a DNA site termed a hormone response element, this is thought to permit 
extensive cross talk between the two receptors (205). Again, this relationship was 
demonstrated in prostate cancer treatment, where cancer progression and metastasis 
was achieved through GR targeting and upregulating genes controlled by AR and thus 
negating enzalutamide treatment (338). Despite this relationship being highlighted in 
various tissues, the relationship and potential crosstalk between AR and GR in the 
adrenal cortex has yet to be defined. For these reasons, the same Cyp11a1-Cre utilised 
in chapters three and four was again used to try and target GR in the adrenal cortex, to 
generate a novel model to investigate GR signalling in the adrenal, investigate its 
impact on the HPA-axis, and investigate the impact of androgen signalling in the 
adrenal cortex as a result of GR ablation.  
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5.1.1: Preliminary data   
5.1.1.1Cyp11a1-Cre fails to target GR expressing cells in the adrenal cortex  
The initial aim was to target GR expressing cells in the adrenal cortex. However, 
double immunofluorescence analysis for YFP and GR in Cyp11a1-YFP reporter mice 
shows that the Cre does not target GR expressing cell types in the adrenal (Fig. 5-1A), 
and immunohistochemistry confirms no GR ablation in the adrenal cortex of adrenal 
GR knockout (Ad-GRKO) mice (Fig. 5-1B). GR was found to be localised in the small 
pockets between the cell types expressing the Cre. Unfortunately this highlights that 
the Cyp11a1-Cre was unsuitable for the intended purpose and was not able to target 
the adrenal as originally intended. The adrenal cortex receives signals from multiple 
organs, two most notably are the brain and the pituitary in the regulation of the HPA-
axis. It is essential that signalling from both these organs do not become perturbed, if 
they do, this can lead to a number of disorders that can over or under stimulate the 
adrenal cortex ultimately resulting in adrenal cortex damage and inappropriate action 
of the adrenal.  
Despite not being able to target the required cell types in the adrenal, the Cyp11a1-Cre 
does have the potential to target the hindbrain (253). For these reasons, interrogation 
of the genomic hindbrain DNA was performed. Investigation of hindbrain genomic 
DNA shows recombination of GR, highlighting that the Cre has targeted the brain (Fig. 
5-1C). These results demonstrate that any subsequent phenotype arising in these mice 
results from ablating GR specifically from the hindbrain. Various studies have 
demonstrated that mutations of GR in the brain can disrupt the adrenal cortex through 
a dysregulated HPA-axis and can result in psychiatric conditions. Identifying new and 
appropriate models to investigate stress and their impact on the adrenal are extremely 
useful (178). Previous studies have highlighted the role of GR in the brain and its 
control of stress and cognitive function (234). For example, it has been shown that 
glucocorticoids acting through GR in the hindbrain can enhance the arterial pressure 
in response to acute restraint stress (235) suggesting that GR is required for an 
appropriate stress response in healthy individuals. Persuasive evidence points to 
dysfunctional GR in HPA axis dysregulation, which have been successfully resolved 
upon antidepressant treatment (232). These claims are backed by transgenic studies 
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that use antisense RNA complimentary to mRNA to knock down GR in the brain and 
these mice display characteristics of depression in addition to altered behaviour (236). 
For these reasons, the initial aims were revised to address the role of hindbrain GR and 
its impact on the adrenal cortex (5.1.2-3).  
 
Figure 5-1. Cyp11a1-Cre does not target GR expressing cells in the 
adrenal cortex.   (A) Immunohistochemical localisation of GFP (blue) and GR 
(green) in the adrenal of Cyp11a1+/GC: R26-EYFP mice show that despite the Cre 
expression in the adrenal cortex, it does not target GR positive cells. (B) PCR 
interrogation of genomic PCR confirms recombination of floxed GR in the hindbrain. 
Control sample demonstrated by 2.5kb fragment, recombined GR demonstrated by 
500bp fragment. (C) Immunohistochemical localisation of GR in the adrenal cortex of 
Ad-GRKO shows that GR has not been targeted in the adrenal cortex and show no 
differences in localisation when compared with littermate controls. Scale bars 50µm. 
Abbreviations; ZG=zona glomerulosa, ZF= zona fasciculata.  
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5.1.2 Initial aims  
 To generate specific GR ablation in the adrenal cortex through the use of 
Cyp11a1-Cre 
 To establish the impact of GR ablation in the adrenal cortex and HPA axis 
 To determine if there is any impact on androgen signalling  
 
5.1.3 Revised aims 
 To establish the impact of GR ablation in the hindbrain on the adrenal cortex  
 To determine if hindbrain GR ablation leads to abnormal behaviour  
 To define any potential impacts on androgen signalling  
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5.2 Results  
5.2.1 Animals used in this study 
A number of mouse lines were ultimately investigated as part of this study. For clarity, 
genotypes and abbreviations are detailed below in table 5-1. Breeding of these animals 
is detailed in materials and methods section 2.1.3.4. 
Genotype Abbreviation  
Cre- GRflox Homozygous  ‘littermate control’ (LMC) 
Cre- GRflox Heterozygous ‘Het littermate control’ (Het LMC) 
Cre+ GRflox Homozygous ‘Hindbrain GR knockout’ (HB-GRKO) 
Cre+ GRflox Heterozygous ‘Het hindbrain GR knockout’ (Het HB-GRKO) 
c57bl/6J wildtype ‘WT Bl6’ 
GR floxed  ‘GRflox’ 
Table 5-1. Genotypes and abbreviations.  
 
5.2.2 HB-GRKO mice show stressed behaviours via excessive barbering and 
digging 
As disruption to GR is known to play a role in stress and anxiety (230, 232, 339), 40 
cages consisting of between 4-6 male or female mice of mixed genotypes were first 
observed for signs of behaviour consistent with stress. Monitoring of cage behaviour 
via video recording prior to collection revealed that WT BL6 mice explored the cage 
with multiple rearing attempts made (normal behaviour associated with the explorative 
nature of mice) (340). By contrast, HB-GRKO mice spent little time exploring and 
focused on repetitive digging in the same spot, behaviour characteristic of a stressed 
state (Fig. 5-2A)(341) 
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Barbering in mice is a normal social behaviour although excessive or abnormal 
barbering has been associated with stress and anxiety (263, 264). Both male and female 
HB-GRKO mice display excessive barbering resulting in hair loss from large portions 
of the face, back and stomach (Fig. 5-3A). HB-GRKO mice are also observed 
barbering LMCs, and this suggested that HB-GRKO mice were the cause of the excess 
cage barbering. In support of this, individually housed HB-GRKO males self-barbered, 
frequently resulting in large portions of hair removal. (Fig. 5-3B). However, this was 
not observed in individually housed LMC males (Fig. 5-2C). Mice were assigned a 
‘barbering score’ (outlined in section 2.3.3.7) based on a previously determined scale 
(263, 264). WT BL6 mice were recorded to have a barbering score between 0-1 
whereas HB-GRKO mice were given a barbering score of between 3 and 5, which is 
above the accepted limit for normal husbandry barbering. Cages containing a higher 
number of HB-GRKO animals demonstrated some of the most severe barbering, all 
falling within 4-5 on the barbering scale (Fig. 5-3D). Interestingly, stress behaviour 
and severe hair loss through barbering does not present until at least d90. Because the 
apparent interaction between HB-GRKO mice and their littermates leading to 
observable phenotypes in all genotypes, which may act as a confounder, an external 
C57BL6 cohort was also included in the analysis to act as a further control. These mice 
were bred and held in the same rack as the HB-GRKO colony but had no direct contact 
with HB-GRKO mice, and displayed no evidence of excessive barbering. Together 
this data suggests that loss of GR signalling in the hindbrain results in increased stress-
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Figure 5 -2. HB-GRKO mice display behaviour consistent cage stress.  (A) 
Observations of cage behaviour over a 5 minute period. Control animals can be seen 
exploring that cage with multiple rearing observed. HB-GRKO mice did little cage 
exploration and displayed obsessive behaviour via excessive and compulsive digging. 
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Figure 5-3. HB-GRKO mice display moderate to severe barbering.  (A) 
Whole body examination shows excessive barbering to face and back in male and 
females, often resulting in broken skin and complete removal of whiskers. (B) 
Individually caged HB-GRKO male showing excessive barbering and broken skin.  (C) 
Individually caged LMC male displaying no hair loss or barbering. (D) Histograph 
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5.2.3 CT/PET imaging confirms kyphosis in HB-GRKO mice   
 
The excessive barbering observed of LMCs suggests that they could be affected by 
HB-GRKO mice, for these reasons an external WT Bl6 male and female cohort was 
included in body weight and adrenal weight measurements. Body weight is 
significantly increased in HB-GRKO males compared to male WT BL6 mice (Fig. 5-
4A), whilst in contrast, a significant decrease in body weight is observed in female 
LMCs and HB-GRKO mice compared to female WT BL6 mice (Fig. 5-4B). Analysis 
of body weights in heterozygous males show no differences in weight compared to 
WT bL6 males (Fig. 5-4C), however heterozygous females show the same significant 
decrease in body weight when compared to WT bL6 females (Fig. 5-4D). During 
collection and weighing it could be seen that HB-GRKO mice have excessive spinal 
curvature in both males and females (Fig. 5-4E). To investigate this further, micro-CT 
scans were taken, WT BL6 mice were not included in this part of the analysis as LMCs 
did not show increased spinal curvature. These results reveal an increase in spinal 
curvature in HB-GRKO male and female mice compared to LMC male and females 
(Fig. 5-5A). This accentuated spinal curvature was also observed in Het HB-GRKO 
males and females compared to Het LMCs (Fig. 5-5B). Closer inspection of the 
vertebrae was used to establish whether this curvature is a result of vertebral fusing, 
however, results show no fusing of the vertebrae in any group analysed (Fig. 5-6A). 
The absence of vertebral fusing in these mice suggests that the curvature of the spine 
is not due to a disorder in development. As used in standard orthopaedic practice, the 
inward angle of the spine was measured to quantify the extent of the curvature 
observed in HB-GRKO and Het HB-GRKO mice (342). These measurements confirm 
increased spinal curvature in HB-GRKO mice compared to LMCs, highlighting 
kyphosis development (Fig. 5-6B-E).  
Elevated levels of serum corticosterone have been linked to the development of 
kyphosis in Cushing’s patients (300), so corticosterone was measured in these mice. 
This revealed significantly elevated levels in HB-GRKO, Het HB-GRKO and LMC 
males compared to WT BL6 mice (Fig. 5-7A), this increase was not observed in any 
female cohort compared to WT BL6 females (Fig. 5-7B)   
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Figure 5-4. Excessive spinal curvature can be seen in HB-GRKO mice. 
 (A) Male body weights compared to an external WT BL6 cohort reveals a significant 
increase in HB-GRKO mice (one-way ANOVA; n=7-8, **p<0.001, Tukeys post-hoc 
analysis, error bars SEM). (B) Female body weights compared to an external C57BL6 
control show a significant decrease in both in HB-GRKO LMC and HB-GRKO mice 
(one-way ANOVA; n=8, ***p<0.0001, *p<0.05, Tukeys post-hoc analysis, error bars 
SEM). (C) Male body weights of Het mice compared to an external WT BL6 cohort 
reveals no difference between the cohorts.  There is no difference in weights in HB-
GRKO LMC compared to BL6 controls. (D) Female body weights of Het mice 
compared to an external WT BL6 cohort show a significant decrease in both in HB-
GRKO LMC and HB-GRKO mice (one-way ANOVA; n=8, ****p<0.0001, **p<0.001 
Tukeys post-hoc analysis, error bars SEM).  (E) Whole body images demonstrating 
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Figure 5-5. Spinal curvature examination via CT/PET analysis.  (A) CT 
scans show that the spine in HB-GRKO mice have an increase in spinal curvature and 
show spinal collapse in HB-GRKO mice compared to littermate controls. (B) CT scans 
show that the spine in Het HB-GRKO mice have an increase in spinal curvature and 
show spinal collapse in HB-GRKO mice compared to littermate controls. Scale bar 
5cm.  
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Figure 5-6. Excessive spinal curvature confirmed through Cobb analysis. 
(A) Closer investigation of the spine shows no fusing of vertebrae in HB -
GRKO. (B, C) Interrogation of the anterior angle of the spine shows a 
significant decrease in HB-GRKO mice when compared to littermate 
controls. (Unpaired Student T-test;**p<0.001, ***p<0.0001. Error bars 
SEM). (D, E) Interrogation of the anterior angle of the spine shows a 
significant decrease in Het HB-GRKO mice when compared to littermate 
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Figure 5-7. Increased circulating corticosterone observed in male HB -
GRKO mice. (A) Circulating corticosterone levels are elevated in both male HB-
GRKO LMC and HB-GRKO mice compared to WT BL6 mice (One-way ANOVA; n=5-
8, *p<0.05, *p<0.05, Tukeys post-hoc analysis, error bars SEM). This increase is also 
observed in Het HB-GRKO mice (One-way ANOVA; n=5-8, **p<0.001, Tukeys post-
hoc analysis, error bars SEM), but not Het LMCs (B) Circulating corticosterone levels 
do not change in any female cohort compared to WT BL6 controls.   
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5.2.4 HB-GRKO leads to severe adrenal cortex disruption   
 
Due to the apparent stress behaviours displayed by HB-GRKO mice and the 
relationship between the adrenal gland and stress response (109) (e.g. raised 
corticosterone), we examined the adrenal glands to determine whether there are any 
impacts on their morphology and function. Interrogation of adrenal weights revealed 
a significant increase in HB-GRKO and LMC male mice compared to WT BL6 males. 
The same changes in adrenal weight can also be seen in Het LM and Het HB-GRKO 
males (Fig. 5-8A). No changes in adrenal weight were observed in any female cohort 
compared to an external WT BL6 control (Fig. 5-8B).  
 
Figure 5-8. HB-GRKO LMC and HB-GRKO present with severely 
disrupted adrenals. (A) Analysis of male adrenal weight revealed an 
increase in weight in all cohorts compared to WT BL6 controls (One -way 
ANOVA; n=6-8,*p<0.05, **p<0.001, ***p<0.0001, ***p<0.0001, Tukeys 
post-hoc analysis, error bars SEM). (B) Analysis of female adrenal weight 
revealed no differences between any of the cohorts compared to WT BL6 
controls.   
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Histological analysis of the adrenal in male HB-GRKO mice revealed severe 
disruption to the cortex with disorganised cortical zones. Interestingly, examination of 
male LMCs revealed a similar level of disruption to their adrenal cortex. However 
male WT BL6 mice have no such disruption to the adrenal, suggesting that the impact 
on LMC adrenals is also likely related to their being housed with HB-GRKO mice 
(Fig. 5-9A).   
 
 
Figure 5-9 LMCs and HB-GRKO males present with severely disrupted 
adrenals. (A) Morphology analysis of male HB-GRKO LMC and HB-GRKO 
adrenals both display major disruption to the entire cortex. Due to the disruption 
observed in littermate controls, an external BL6 cohort was included in the analysis. 
Enlarged images of regions of interest denoted by a box. (B) Morphology analysis of 
male Het LMC and Het HB-GRKO adrenals again display major disruption to the 
entire cortex. N=5. Scale bars 100µm. Abbreviations; ZG= zona glomerulosa, ZF= 
zona fasciculata, X=X-zone, M=medulla.   
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The adrenals of female HB-GRKO and LMCs mice show a similar disruption to the 
cortex as seen in the males, with the addition of enlargement of the X-zone, which 
occupies a large portion of the cortex compared to the X-zone in female WT BL6 mice 
which is maintained in a compact zone around the medulla (Fig. 5-10A). The same 
adrenal cortex disruption can also be seen in Het littermates (Fig. 5-10B), further 
supporting that littermates are being effected by HB-GRKO mice.  
 
 
Figure 5-10 LMCs and HB-GRKO females present with severely disrupted 
adrenals. (A) Morphology analysis of female HB-GRKO LMC and HB-GRKO 
adrenals both display major disruption to the entire cortex. Due to the disruption 
observed in littermate controls, an external WT BL6 cohort was included in the 
analysis. Enlarged images of regions of interest denoted by a box. (B) Morphology 
analysis of female Het LMC and Het HB-GRKO adrenals again display major 
disruption to the entire cortex and X-zone expansion compared to WT BL6 females. 
N=5. Scale bars 100µm. Abbreviations; ZG= zona glomerulosa, ZF= zona 
fasciculata, X=X-zone, M=medulla. 
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Due to all genotypes in the cage presenting with a stress phenotype, to rule out that 
this could be caused by the insertion of the loxP sites into exon 3, GR floxed male 
adrenals were examined and showed adrenal morphology was normal in these animals 
(Fig. 5-11A). 
 
Figure 5-11. Insertion of loxP sites does not result in disruption to 
adrenal morphology.  (A) Morphology analysis of GR flox adrenals show no 
disruption to the adrenal cortex.  N=4. Scale bars 100µm. Abbreviations; ZG= zona 
glomerulosa, ZF= zona fasciculata, M=medulla. 
 
5.2.5 Loss of HB-GRKO leads to disruption to cortical markers 20 alpha-HSD 
and AKR1B7 
 
Analysis of X-zone marker 20-α-hydroxysteroid dehydrogenase (20 alpha-HSD) (281) 
localization reveals 20 alpha-HSD positive cells in LMCs and HB-GRKO males, 
compared to WT BL6 males which normally do not express this marker in adulthood. 
Fitting with the morphology analysis, Het LMCs and Het HB-GRKO mice show the 
same disruption to 20 alpha-HSD in the adrenal cortex (Fig 5-12 A, B). 20 alpha-HSD 
localization analysis in LMCs and HB-GRKO females revealed dispersed positive 
cells throughout the cortex compared to the compact X-zone observed in WT BL6 
females, this disruption again could also be observed in Het LMCs and Het HB-GRKO 
mice (Fig. 5-13 A, B).  
A 
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Figure 5-12. Male LMCs and HB-GRKO males show the presence of 
foetal cells in the adult adrenal cortex.  (A) Immunohistochemical localisation 
of 20 alpha-HSD revealed the presence of foetal X-zone cells in both male LMCs and 
HB-GRKO mice compared to WT BL6 mice in which no expression is normally 
observed. (B) Immunohistochemical localisation of 20 alpha-HSD revealed the 
presence of foetal X-zone cells in both male Het LMC and Het HB-GRKO mice also. 
Green; 20alpha-HSD, Grey; sytox counterstain. N=5. Scale bars 100µm. 
Abbreviations; ZG= zona glomerulosa, ZF= zona fasciculata, X=X-zone, M=medulla. 
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Figure 5-13. LMCs and HB-GRKO females have disrupted and dispersed 
X-zones. (A) Immunohistochemical localisation of 20 alpha-HSD revealed the 
presence of foetal X-zone cells in both female LMCs and HB-GRKO mice compared 
to WT BL6 mice in which no expression is normally observed. (B) 
Immunohistochemical localisation of 20 alpha-HSD revealed the presence of foetal X-
zone cells in both female Het LMC and Het HB-GRKO mice also. Green; 20alpha-
HSD, Grey; sytox counterstain. N=5. Scale bars 100µm. Abbreviations; ZG= zona 
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Localization of AKR1B7 a well described zona fasciculata marker (297), showed 
disruption to both male and female LMCs and HB-GRKO, compared to WT BL6 
which normally stains the whole ZF. LMCs display partial loss of AKR1B7 positive 
cells with HB-GRKO mice showing even fewer positive cells (Fig. 5-14A). Again, 
Het LMCs and Het HB-GRKO males show the same disruption to AKR1B7 in the 
adrenal cortex (Fig 5-14B). The same phenotype is observed in females (Fig 5-15 A, 
B). 
 
Figure 5-14. HB-GRKO LMC and HB-GRKO males have disruption to 
AKR1B7. (A) Immunohistochemical localisation of AKR1B7 revealed 
disruption in both male LMCs and HB-GRKO mice compared to WT BL6 
controls, with fewer AKR1B7 positive cells being observed. (B) 
Immunohistochemical localisation of AKR1B7 revealed disruption in both 
male Het LMC and Het HB-GRKO mice, with fewer AKR1B7 positive cells 
being observed.  Green; AKR1B7, Grey; sytox counterstain. N=5. Scale bars 
100µm. Abbreviations; ZG= zona glomerulosa, ZF= zona fasciculata, X=X-zone, 
M=medulla.  
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Figure 5-15. HB-GRKO LMC and HB-GRKO females have disruption to 
AKR1B7. (A) Immunohistochemical localisation of AKR1B7 revealed disruption in 
both female LMCs and HB-GRKO mice compared to WT BL6 controls, with fewer 
AKR1B7 positive cells being observed. (B) Immunohistochemical localisation of 
AKR1B7 revealed disruption in both female Het LMC and Het HB-GRKO mice, with 
fewer AKR1B7 positive cells being observed. Green; AKR1B7, Grey; sytox 
counterstain. N=5. Scale bars 100µm. Abbreviations; ZG= zona glomerulosa, ZF= 
zona fasciculata, X=X-zone, M=medulla.  
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5.2.6 No changes in circulating androgens or AR can be detected in HB-GRKO 
mice 
Due to the presence of foetal cells in the adrenal cortex in male LMCs and HB-GRKO 
mice along with the disruption to AKR1B7, these mice displayed a similar phenotype 
to that observed in Ad-ARKO mice in chapter 3. In addition to this, GR has been 
shown to be significantly up regulated in mice that are castrated (section 3.2.10). 
Circulating androgens have also been noted in playing a role in stress response. Mice 
treated with testosterone were shown to spend more time in open maze tests and 
increased exploratory behaviour (332, 343). For these reasons circulating testosterone 
and AR immunolocalisation were analysed to determine if there was any change to 
AR signalling in the adrenal cortex. Circulating testosterone is elevated in Het HB-
GRKO and HB-GRKO males compare to LMCs, however, this increase is not 
significant (Fig 5-16A). Immunostaining of androgen receptor also showed no changes 
in localisation in the adrenal cortex (Fig 5-16B).  
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Figure 5-16. No changes in circulating testosterone or AR detected.   (A) 
Circulating testosterone in male LMC and Het LMC and Het HB-GRKO and HB-
GRKO mice. No significant difference was detected in any cohort analysed however 
there does appear to be increased circulating testosterone in HB-GRKO and Het HB-
GRKO mice. N=5. (B) Immunostaining for AR revealed no differences in any cohort 
analysed. Green; androgen receptor, Grey; sytox counterstain. N=5. Scale bars 
100µm. Abbreviations; ZG= zona glomerulosa, ZF= zona fasciculata, X=X-zone, 
M=medulla.  
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5.2.7 HB-GRKO mice show cell death throughout the adrenal cortex 
To establish whether disruption to the adrenal cortex leads to changes in cell clearance, 
the apoptosis marker cleaved caspase 3 was examined. Normal apoptosis usually 
occurs at the cortex-medulla boundary however, cleaved caspase 3 localization in male 
HB-GRKO mice revealed many caspase-positive cells throughout the whole adrenal 
cortex indicating a large amount of abnormal cell death (Fig. 5-17A). Interrogation of 
cleaved caspase staining in Het LMCs and Het HB-GRKO males showed caspase 
positive cells throughout the cortex, however this was not as severe as HB-GRKO 
males (Fig. 5-17B). Cleaved caspase 3 localization in female HB-GRKO mice again 
revealed many caspase-positive cells throughout the whole adrenal cortex (Fig. 5-18A) 
and many positive cells throughout the X-zone. Unlike Het males, Het LMC and Het 
HB-GRKO females showed similar amounts of cell death throughout the cortex (Fig. 
5-18B).   
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Figure 5-17. HB-GRKO males show aberrant apoptosis throughout the 
adrenal cortex.  (A) Cell clearance from the cortex occurs at the cortex -
medulla boundary which can be observed in Bl6 male controls via 
immunohistochemical analysis. HB-GRKO male cleaved caspase protein 
localisation show abundant cleaved caspase 3 positive ce lls throughout the 
cortex. Inserts denoted by (*). Scale bars 50µm. (B) Both Het LMC and 
Het HB-GRKO show cleaved caspase staing throughout the cortex.  Scale 
bars 100µm Abbreviations; ZG= zona glomerulosa, ZF= zona fasciculata, 
X=X-zone, M=medulla.  
A 
B 
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Figure 5-18. HB-GRKO females show aberrant apoptosis throughout the 
adrenal cortex. (A) Cell clearance from the cortex occurs at the cortex-medulla 
boundary which can be observed in Bl6 female controls via immunohistochemical 
analysis. HB-GRKO female cleaved caspase protein localisation show abundant 
cleaved caspase 3 positive cells throughout the cortex. Inserts denoted by (*). Scale 
bars 50µm. (B) Both Het LMC and Het HB-GRKO show cleaved caspase staing 
throughout the cortex. Scale bars 100µm. Abbreviations; ZG= zona glomerulosa, ZF= 
zona fasciculata, X=X-zone, M=medulla.  
A 
B 
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In contrast to cleaved caspase staining, no changes in localization of the proliferation 
marker PCNA was observed in any male or female experimental cohort compared to 
WT BL6 mice (Fig. 5-19, 5-20).  Together, these results show that loss of GR signaling 
in the hindbrain of both male and female mice, leads to disruption of structure of the 
adrenal glands. Similar disruption to the adrenal glands of LMCs (who retain hindbrain 
GR signalling) suggests that the adrenal phenotype is likely a secondary consequence 
of the stressed behavior (excessive barbering of LMCs) exhibited by HB-GRKO cage-
mates. This interpretation is consistent with previous studies linking a chronic stress 
response to degeneration of the adrenal gland (224).  
 
Figure 5-19. LMC and HB-GRKO males show no changes to 
proliferation.  (A, B) Immunohistochemistry analysis of PCNA revealed no 
changes in proliferation in any male experimental cohorts compared to WT 
BL6 controls. Scale bars 100µm. Abbreviations; ZG= zona glomerulosa, 
ZF= zona fasciculata, X=X-zone. 
A 
B 
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Figure 5-20. LMC and HB-GRKO females show no changes to 
proliferation. (A, B) Immunohistochemistry analysis of PCNA revealed no changes 
in proliferation in any female experimental cohort compared to WT BL6 controls. 
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5.3 Discussion  
The initial intention of this work was to ablate GR expressing cells in the adrenal 
cortex, however, due to the inability of the Cyp11a1-Cre to target these cells the 
parameters of the study were re-focused to investigate the impacts of hindbrain GR 
signalling on the HPA-axis and the adrenal cortex. Ablation of GR in the hindbrain 
has provided a new animal model for investigating stress and anxiety (253). PCR 
analysis confirmed recombination of GR in the hindbrain with no off target GR 
ablation in the adrenal cortex, ensuring any phenotype is a result of hindbrain targeting. 
These results demonstrate that following GR ablation, stress behaviours presenting as 
excessive barbering and lack of cage exploration coupled with tendencies of repetitive 
behaviour can be observed. Additionally, disruption to hindbrain glucocorticoid 
signalling results in severe adrenal cortex disruption and an elevated stress response 
that is passed onto littermate controls. Excessive spinal curvature is also observed and 
could be attributed to the high levels of circulating corticosterone. These results 
highlight that GR ablation in the hindbrain could provide a novel model to better 
understand the development of stress and anxiety in patients.  
 
Figure 5-21 Locations of the fore, mid, and hindbrain. The hindbrain is comprised 
of the Medulla Oblongata, the Pons (provides the connection between the spinal cord 
and the rest of the brain), and a large proportion of cranial nerves. The hindbrain is 
integral in control of autonomous and sub-conscious functions. Adapted from (344). 
Chapter 5: The Cyp11a1-Cre not only permits investigation of the adrenal 
cortex, but provides a novel model to investigate GR signalling in the hindbrain 




Tackling psychiatric conditions such as depression and anxiety has proved difficult 
with multiple components of the brain being implicated. The initial body of research 
investigating depression and anxiety focused upon fast acting neurotransmitters such 
as the impact of serotonin, norepinephrine and dopamine depletion. Despite this, these 
neurotransmitter systems are short term and cannot account for the progressive and 
increase in disease severity observed over time in patients with depression or anxiety 
(345). It was later noted that long term exposure to stress is a leading cause of 
psychiatric disorders and therefore highlighted glucocorticoids as an important factor 
for research and future treatment of anxiety and depression (230, 234, 346). The 
forebrain is well known for its control of cognitive function, so initial models of the 
role of GR signalling in the brain focused upon this region. Forebrain-specific GR 
knockout mice generated by Boyle et al under a calcium-calmodulin-dependent 
protein kinase promoter, demonstrated a mouse model with a depressive phenotype 
and anxiety like behaviours (197). In contrast to this, mice generated by Wei et al with 
an over expression of GR in the forebrain demonstrated an increase in emotional 
ability in response to applied stressors (199). GR is not limited to the forebrain but has 
also been identified in the structures of the hindbrain. The hindbrain although known 
for its role in autonomous regulation, has in recent years, become a region of interest 
for research into the development of anxiety and depression. Studies conducted by 
Zhang et al demonstrated that glucocorticoids are important for tuning hindbrain stress 
integration via GR expression in the nucleus of the solitary tract (NTS) (248). Studies 
have also demonstrated increased glucocorticoids impacting neuronal plasticity and 
tissue shrinkage suggesting that sustained elevated levels of glucocorticoids cause a 
reduction in neurogenesis (232). The current challenge facing this field is the two 
relevant but opposing concepts. The detrimental effects of excessive glucocorticoid 
levels on the hippocampus seems to require GR to be functioning normally, whereas 
these same excessive glucocorticoid levels in depression may result from impaired 
negative feedback inhibition on the HPA axis, which is caused by loss of function of 
GR. For these reasons, more research is needed into the various regions of the brain 
expressing GR and their role in depression and anxiety which can be helped through 
the development of novel models.  
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Finding an appropriate method to target GR in specific tissues to reduce off target 
effects is essential to understanding its mode of action. As of late, more research has 
focused on refined methods to target GR in specific tissues. Using the Smith lab’s 
mouse model of Cre targeted to the mouse Cyp11a1 locus, highlighted a new way to 
generate a model of stress. Characterising stress has proved difficult in humans due to 
the heterogeneity of the behaviours reported in patients with psychiatric disturbances 
(347). Using mouse models for psychiatric disorders is challenging for these reasons 
as there is often not a set criteria but a collection of signs and symptoms, made more 
difficult by the fact that reaction to stress differs in animals and humans. Despite this, 
a range of indicators of stress behaviour have been well documented in rodents (341, 
248, 263). Although not all behaviour observed is identical in humans and rodents, it 
is indicative of a stressed state and thus enables investigation of the biological 
mechanisms that may underlie its aetiology, elucidating the neurobiological basis for 
stress disorders. This model demonstrates a number of characteristics linked to stress 
behaviour. Initial observations revealed severe hair removal via barbering. Although 
this is part of normal behaviour for rodents in bonding, dominance and cleaning (264), 
if performed to excess is indicative of elevated stress levels. HB-GRKO mice had hair 
loss to the face, head, back and stomach which falls outside normal barbering 
behaviour (263, 264). In addition to this, monitoring of WT controls and HB-GRKO 
animals over a five minute period revealed explorative cage behaviour in WT controls, 
with 16 rears counted and exploration around the cage which falls in line with their 
normal investigative nature (343). This was not observed in HB-GRKO mice. Little 
cage exploration was noted and only 2 rears or vertical attempts over the same five-
minute period with prolonged periods of excessive digging in the same spot, indicative 
of a stressed state. This demonstrates that ablation of GR in the hindbrain results in a 
stress phenotype. An interesting observation of these behaviour was that they did not 
present themselves until adulthood, with symptoms not becoming apparent before d90-
100. The reasons for this still aren’t clear, and may be an accumulative effect that 
progresses and worsens over time.  
A study conducted by Webster et al demonstrated GR mRNA presence across many 
structures of the brain, including the hindbrain. They investigated patients with 
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diagnosed mood disorders and demonstrated GR dysfunction in depression, bipolar 
and schizophrenia and in much lower mRNA levels compared to 15 healthy 
individuals. They also noted that there is variability of GR mRNA between each 
disorder investigated and the anatomical site of GR dysfunction suggesting that GR 
dysfunction, depending on what region is disrupted, can impact what mood disorder 
develops (348). There are a number of higher-order autonomic integrative sites in the 
hindbrain.  These include the raphe pallidus, the lateral parabrachial nucleus and the 
Kölliker-Fuse nucleus, which are responsible for the autonomic response to stressors. 
Although all of these circuits participate in autonomic integration, their precise role 
and function in stress-induced responses and behavioural components is not yet 
defined and requires further research (345). To further investigate the stress phenotype 
described in this chapter, analysis of GR location and abundance would need to be 
identified in the hindbrain of HB-GRKO mice and compared with studies such as the 
one conducted by Webster et al. Further to this, a receptor not investigated as part of 
this study was mineralocorticoid receptor (MR). As described in the literature review 
of this thesis, glucocorticoids bind to MR with a higher affinity than GR and have been 
shown to be expressed in the hindbrain (190, 286). With regards to the relation between 
the MR and GR, both receptors have complementary roles in the regulation of HPA-
axis functionality. Additionally, MR has been shown to be an important modulator of 
stress and influences stress appraisal. However, the primary focus of this research has 
been on forebrain structures, such as the hippocampus (349). For these reasons, it 
would be interesting to investigate the impacts on MR as a result of GR ablation in 
HB-GRKO mice.  
In addition to stress behaviours increased spinal curvature was also noted during 
collection. Kyphosis is the excessive inward concave shape of the spine (350). Studies 
have described a relationship between the spinal abnormality kyphosis and 
psychological aspects such as anxiety, depression, and aggression (351). During 
collection of HB-GRKO mice, it could be seen that these mice have exaggerated spinal 
curvature. To investigate this further CT scans were used examine bone structure and 
analyse spinal curvature. CT scans show a significant curvature in HB-GRKO males 
and females compared to controls. A closer inspection of the spine revealed no fusing 
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of the vertebrae which suggests that the kyphosis is not due to a developmental 
problem. The Cobb method of spine measurements confirmed a decreased inward 
angle compared to controls confirming a significant increase in curvature. Elevated 
levels of glucocorticoids have been associated with kyphosis and is thought to affect 
bone density, leading to spinal collapse (300, 302). This data combined with the 
disruption in the adrenal cortex points to elevated serum corticosterone.  
The adrenal is integral in mediating the stress response and defining how it responds 
to stress and the impacts of dysregulation is essential in understanding and treating 
psychiatric disorders (109, 317).  Mounting evidence shows that patients suffering 
from stress or depression consistently exhibit hyperactivity of the HPA axis, which 
results in increased levels of glucocorticoids in these patients (232, 233, 248). For these 
reasons it was important to ascertain any impacts on the adrenal and determine if 
disruption to GR in the hindbrain resulted in hyperactivity or disruption to the adrenal 
cortex. Analysis of adrenal morphology revealed severe disruption in male and female 
HB-GRKO mice with disorganisation of cortex zones, loss of structure in the ZF and 
pockets of vacuolisation and hyperplasia. The X-zone in HB-GRKO females was 
shown to be much larger and had migrated up through the cortex. Surprisingly, Cre- 
GRflox littermate controls display a similar phenotype. To ensure the phenotype has 
nothing to do with any disruption of GR that may have occurred through insertion of 
loxP sites into the gene (195), histology analysis was performed on GR floxed mice 
from a closed colony and confirmed a normal adrenal. This suggests that the littermate 
controls are being affected by the HB-GRKO mice. This phenomenon has been 
described in behavioural studies that demonstrate that stress behaviours in stress-
model mice can be passed on to WT cage mates and persist even when the stressed 
model has been removed (352).  For these reasons, an external control was included in 
the analysis that has had no contact with the stressed mice. HB-GRKO males have an 
increase in body weight compared to external controls and females have a decrease in 
body weight. Males also have an increase in adrenal weight, however there were no 
changes observed in females. These results are fitting of the range of characteristics 
that are seen in patients with stress disorders and potentially suggests that males and 
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females differ in their response to stress. Together this data demonstrates that 
prolonged or chronic stress negatively impacts the adrenal cortex.  
Due to results obtained in the chapter three and four of this thesis, describing AR and 
androgens as important regulators of the adrenal cortex and its markers, analysis of 
circulating androgens and protein localisation of AR was investigated. The presence 
of foetal cells in the cortex suggested that there may be a decrease in circulating 
androgens, however the results show a potential increase. Increasing the sample size 
could help clarify if this is in fact the case, as results do show a varying range of values. 
Alternatively, it has been shown in the literature that treatment with endogenous 
testosterone increases exploratory behaviour in mice and has been shown to help with 
anxiety (243, 245). This increase in circulating testosterone could potentially be to try 
to counteract the chronic stress response in HB-GRKO mice.    
Changes in circulating glucocorticoids are often used as a measure of stress in many 
species (282, 289). For these reasons analysis of serum corticosterone was used to 
determine if HB-GRKO mice had an elevated stress response. Male HB-GRKO and 
HB-GRKO LMC mice both showed an increase in corticosterone compared to an 
independent control, revealing an elevated stress response in these animals. 
Surprisingly, this was not observed in female cohorts. Corticosterone values can vary 
widely during the oestrous cycle and these females were not collected at a designated 
stage of the oestrous cycle, which could have contributed to not detecting a difference 
between the groups. Synchronising of oestrous cycles could potentially provide a more 
reproducible result. In addition to this, the variability of genotypes per cage could 
potentially be playing a role. Cages with higher number of Cre+ animals most 
commonly displayed the most severe phenotype and a less severe phenotype if it was 
primarily Cre- animals, this could have led to a large variation in samples analysed. 
These observations coupled with the disruption in heterozygous mice demonstrate 
strongly that cage mates were impacted by HB-GRKO mice. One of the major 
drawbacks of the present study was the impact observed in controls. Due to the 
phenotype observed in all mice, additional external controls had to be included adding 
to the complexity and additional analysis required to investigate the phenotype 
observed in knockout mice. The Cyp11a1-Cre has been previously used in the lab to 
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investigate other genes of interest and there have been no identifiable issues with this 
Cre line prior to, or after breeding to a floxed animal (Appendix, fig. 7-1, a-e). 
Furthermore, the GR floxed line was also investigated and showed no disruption. This 
limits the phenotype observed in LMCs to arise from exposure to HB-GRKO mice. 
For future experimentation, the controls would have to be separated as soon as possible 
following genotyping. As the phenotype often did not present itself until day 90 
onward, this separation would be feasible, although, this separation in itself could 
create problems. It was noted as part of the study that animals that had a cage with a 
higher proportion of Cre+ animals often exhibited a more severe phenotype. By 
separating out the controls, this could be selecting for a more pronounced and 
exacerbated phenotype.  These factors would need to be considered for future use of 
this model.  
Analysis of cortex marker 20 alpha-HSD revealed presence of foetal cells in the cortex 
of HB-GRKO and HB-GRKO LMC mice, these foetal cells are known to make up the 
rodent X-zone (95). As discussed in chapters 3 and 4, regression of the X-zone occurs 
during puberty in males so it should not be present in the adult cortex (23). Females 
retain the X-zone in adulthood (34, 89), however in this model foetal cells are not 
constrained in a defined zone, but instead are widely distributed throughout the adrenal 
cortex. This migration of X-zone cells throughout the cortex have been associated with 
pathologies such as primary pigmented nodular adrenocortical disease and Cushing’s 
(29). Another cortical marker AKR1B7, known for its role in detoxifying products 
from cholesterol cleavage was examined (297). Loss of function models show its 
importance in metabolic function and dysregulation can have serious implications for 
the adrenal cortex (353). Analysis of AKR1B7 revealed a loss of localisation 
throughout the cortex in both males and females. Loss of expression could result of 
toxic products building up in the adrenal cortex and ultimately lead to damage to the 
cortex.  
Normal cell turnover in the adrenal cortex involves the migration of cells from the 
outer cortex to the cortex-medulla boundary, at the boundary cells undergo apoptosis 
and removal from the cortex (323). Analysis of cleaved caspase localisation revealed 
many positive cleaved caspase cells throughout the entire adrenal cortex in HB-GRKO 
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mice, highlighting considerable cell death and damage to the adrenal cortex. This could 
be attributed to failed feedback at the hindbrain due to GR ablation, resulting in a 
maintained stress response and prolonged stimulation of the adrenal cortex. Despite 
major disruption to the adrenal recognised in all genotypes, an increase in spinal 
curvature was not present in littermate controls. This suggests that this phenotype is 
solely caused by ablation of GR from the hindbrain and is not due to a behavioural 
impact that is being transferred from knockout to control cage mates. The reasons for 
this are still uncertain, further analysis of bone structure and density could potentially 
help elucidate the underlying problem or mechanism leading to spinal collapse in HB-
GRKO mice.  
Previous work looking at chronic stress and its impact on the HPA axis has focused 
primarily on characterizing chronic stress-induced alterations in the brain. This central 
focus has occurred in part because the observed brain changes resemble those that are 
believed to occur in some types of stress-related psychiatric disorders, such as 
depression and anxiety. Although there is little research in mouse models as to the 
impact of chronic stress on the adrenals, this has been more extensively researched in 
rat adrenals. A study conducted by Yvonne et al highlighted that chronic stress induced 
by restraint in male rats, resulted in adrenal hyperplasia and hypertrophy to the adrenal 
cortex in a zone specific manner (224). This is in line with what is observed in HB-
GRKO mice with enlarged adrenals and hyperplasia observed throughout the cortex. 
This study also noted that there was a decrease in ZG size due to hypoxia. 
Measurements used in chapter three of this thesis of cortex zones would be useful to 
determine if there is an impact to specific zone size as a result of chronic stress. 
Another study investigating chronic stress in female rats during pregnancy noted a 
resistance to apoptosis (354). This is in contrast to what is observed in the HB-GRKO 
animals which have apoptosis throughout the adrenal cortex.  
According to the World Health Organization, mental disorders will be the second 
leading cause of disability by the year 2020 (355), so the need for appropriate models 
to understand psychiatric disorders is ever pressing. This data together further 
describes the relationship between the GR ablation in the hindbrain and the 
development of stress. Additionally, it builds on previous literature that describes a 
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relationship between stress and the dysregulation of the HPA axis. Although further 
experiments would be needed to identify a specific psychiatric disorder that would be 
most relevant to the phenotype observed, these results however, demonstrate a new 





Chapter 6: General Discussion  
6.1 Androgen signalling and the male adrenal cortex  
Historical studies investigating both male and female rodents have shown that 
gonadectomy can result an inappropriately maintained X-zone or a re-developed X-
zone (34, 36, 38, 53, 95, 356). This highlights that even though it does not produce 
androgens, the adrenal is responding to androgen signalling and warrants further 
investigation. Due to the potential relationship between androgen signalling and foetal 
cells, known to be essential for cortex development and providing stem/progenitor 
cells, this lead to the hypothesis that androgen signalling is required for normal cortex 
development and renewal in adulthood in both male and female adrenals. Ablation of 
androgen receptor from the male adrenal highlighted numerous novel interactions and 
new roles within the adrenal cortex. Key findings noted the maintenance of the X-zone 
after puberty and significant morphological differences of the X-zone depending on 
whether AR or androgens had been targeted. This suggests AR and circulating 
androgens not only target the adrenal but can do this via independent mechanisms. 
This result was further strengthened by the loss of AKR1B7 expression following 
castration but not AR ablation. Although disruption to androgen signalling revealed 
maintenance or redevelopment of an X-zone, these mice appeared to be overall healthy 
and made it to adulthood. Experiments to determine if the phenotype progressed with 
age revealed that prolonged castration resulted in a phenotype similar to what would 
be observed in aging females, however, ablation of AR alone resulted in an expanded 
X-zone and development of spindle cell lesions in the outer cortex.  
This data highlighted numerous pathways that androgens could be controlling or 
working in tandem to regulate the adrenal cortex. The consistent renewal of the adrenal 
cortex and its zones requires is an intricate process with clearly many cell mechanisms 
and pathways at play. Although there are more studies now beginning to interrogate 
the mechanisms that regulate the adrenal cortex, there are still many unanswered 
questions. Changes observed in key cortex regulation genes such as Sf1 and Dax1 
following AR ablation was noted. These are two key regulators in adrenal homeostasis. 
Relationships between these genes and AR signalling have been described in other 
tissues such as the gonads (357, 358) and recognised that AR could directly bind to 




Sf1 to block communication, furthermore, showing that androgens can act via Dax1 to 
inhibit aromatase expression in breast cancer cell lines (358). Despite this, these 
relationships have not yet been clearly highlighted in the adrenal cortex. The data 
suggests androgens are working with these signalling pathways to regulate zonation, 
which puts the adrenal among the key regulators of the adrenal cortex. An interesting 
observation of the X-zone during development in Ad-ARKO mice revealed a more 
pronounced and developed X-zone, where previously it was thought that androgen had 
no impact on the cortex until puberty (95, 311). Studies examining the process in which 
the adrenal switches from the foetal to the adult lineage is essential in understanding 
adrenal development. Dax1 has been described as a potential adult adrenal enhancer 
required for the regression of the X-zone and switch to definitive cortex development, 
this was based on the fact that the X-zone remained in rodent following Dax1 ablation 
(61). The same phenotype is also observed in Ad-ARKO mice. This suggests that AR 
could also be an adult adrenal enhancer, and that the switch from foetal to definitive 
cortex development has multiple regulators.  
 
Contrary to the literature, AKR1B7 is thought to be regulated by Sf1 in the adrenal 
(298), the loss of AKR1B7 following castration suggests that it is in fact regulated by 
androgens, as is the case for the vas deferens . Following loss of androgen signalling, 
no apoptotic cells could be observed in the adrenal cortex of these mice. This has been 
described previously in a global ARKO model (162), but this potential resistance to 
apoptosis was thought to be from chronic levels of ACTH from the pituitary. Elevated 
ACTH levels may contribute to the phenotype in the global knockout, however, the 
results from this project suggests that this phenotype is a result of loss of AR from the 
adrenal cortex and not the pituitary.  
WNT/ β-catenin has been shown to be essential in the appropriate maintenance of the 
adrenal cortex (30, 46, 68, 251). Due to the presence of the X-zone and spindle cell 
development in aging animals, this highlighted a potential issue with differentiation. 
It was hypothesised that there would be disruption to Wnt4 or β-catenin, however, no 
changes in transcript were observed. This does not rule out that androgens are not 
interacting with this pathway. There have been studies conducted that describe β-
catenin and AR specific interactions (359). This study highlighted that under certain 




conditions, β-catenin and AR can drive the development of prostate cancer. Due to the 
changes in morphology, key pathways in cortex regulation and HPA-axis noted 
following disruption to AR and circulating androgens, demonstrates androgen 
signalling is essential for normal regulation of the adrenal cortex and that the Cyp11a1-
Cre permitted the novel opportunity to examine the role of androgen signalling 
specifically within the adrenal cortex. For these reasons, the original hypothesis was 
accepted and the objectives met.   
 
6.1.1 Future perspectives   
This project highlighted numerous new targets and avenues for further investigation. 
Investigation into functional targets in the WNT/β-catenin pathway (Fz, LRP6, Axin2, 
TCF/LEF, Naked (a Dvl antagonist), Dkk1, and Rspo) (360-362) following androgen 
manipulation could help elucidate if androgens could be interacting with this pathway 
to promote differentiation in the adrenal. Unfortunately, due to time constraints, a 
suitable β-catenin antibody that worked on the adrenal cortex was not identified. With 
additional time it would be interesting to see if the localisation of this protein changes 
upon androgen manipulation. Furthermore, the use of an adrenal cell line such as Y1 
cortical cells (363) could potentially have helped investigate additional molecular 
targets of androgen signalling and their impact on adrenocortical cells following 
knockdown of AR or treatment with androgens. The isolation of X-zone cells and 
investigating them in culture under various treatments could help further our 
understanding in their development or differentiation into definitive cortical cells. This 
may be difficult to investigate in the mouse due to the size of the adrenal and lack of 
suitable cell surface markers that could be used in cell sorting. However, adrenals in 
the rat may be feasible as they are much larger and could potentially be separated easier 
via fine dissection.  
Ad-ARKO mice were kept in a consistent environment which resulted in no situations 
in which the adrenal becomes challenged. There are periods of stress that can arise 
through handling during cage cleaning and situations like cage dominance, but these 
exposures are often short. Determining if the adrenal is able to respond to stressors 
under conditions such as restraint stress or treatment with dexamethasone would help 
answer if AR is important in HPA-axis regulation when challenged. Furthermore, 




corticosterone levels were only analysed in the morning when corticosterone levels are 
low. Sampling at different time points throughout the day would allow investigation 
of the impact of AR signalling not only in stress response but normal cyclical basal 
levels of corticosterone secretion. Another mouse line that was investigated throughout 
this thesis, as part of the male and female ARKO projects was an ARE-luciferase 
mouse line (364). This hoped to identify where androgen signalling was active in the 
adrenal cortex under normal conditions, castration and hCG treatment. This would 
permit investigation of adrenal cortex zones and if they respond to androgen signalling. 
By understanding cell regions and cortex zones in which androgen signalling is active, 
this could help direct future research regarding specific cellular processes and 
signalling pathways regulating a particular zone and how they interact with androgens. 
Despite all animals for these experiments being treated and collected, in the timeframe 
of this thesis an appropriate antibody to permit localisation of AR signalling was not 
identified. Investigation via qRT-PCR also did not work and struggled to detect 
luciferase activity. Future work would see the optimisation of an appropriate antibody 
and primers.  
 
6.2 Androgen receptor and the female adrenal cortex  
Due to the noted relationship between androgen signalling and the X-zone observed in 
male Ad-ARKO mice, this lead to the hypothesis that androgen signalling is required 
for normal cortex regulation and regression of the X-zone during pregnancy in female 
adrenals.  
The investigation of androgen receptor ablation in the female was initially to 
investigate the impact on the female X-zone, however, results obtained through this 
study suggests that AR plays a vital role in protecting against the development of 
spindle cell hyperplasia. Key findings during this project highlighted significantly 
fewer Ad-ARKO females being born compared to male counterparts. No early 
postnatal developmental issue was identified as a result of partial or complete adrenal 
AR ablation, however, the development of spindle cell hyperplasia could be observed 
in early adulthood. This can occur naturally, therefore to observe spindle cells in young 
mice is rare. Analysis of presence in d80 samples revealed 80% of 2nd generation Ad-




ARKO presented with this phenotype compared to only 20% in littermate age matched 
controls. Although X-zones are maintained in the female adrenal cortex in adulthood, 
AR ablation resulted in enlarged X-zones corresponding with an increase in adrenal 
weight. However, ablation of AR did not result in failed X-zone regression 
highlighting AR is dispensable for X-zone regression during pregnancy. Despite this, 
elevated serum corticosterone was revealed in parous Ad-ARKO females, a symptom 
noted in patients with postpartum depression (327).   
This data revealed key differences in males and female in the response to the loss of 
androgen signalling. Despite AR being required for the regression of the X-zone 
during puberty in males, results demonstrate AR is not required for the regression 
during pregnancy. Historical studies have suggested that the X-zone is purely 
andromimetic (36), however, more recent studies investigating Prkar1a (29) and Thrb 
(40), show that the X-zone is under a complex control mechanism that additionally, is 
sexually dimorphic. It has also been suggested that progesterone could regulate the X-
zone in females (34) but the mechanisms as of yet still aren’t clear. Despite not 
regressing during pregnancy, the X-zone does enlarge and can be seen occupying large 
portions of the adrenal cortex, suggesting an overlapping mechanisms in male and 
female mice in relation to X-zone regulation. Again, potentially the WNT/β-catenin 
pathway could be at play.  
A major hindrance to this project was the low numbers of 2nd generation Ad-ARKO 
females being born. Chi squared analysis did highlight significantly less of this 
genotype being born compared to male littermates. The reasons for this discrepancy 
are still not clear, there should be no maternal impact as dams in these matings were 
ARflox. This phenotype has not been documented in global AR knockout models which 
targets the adrenal (160). This suggests that despite there being significantly fewer 
born, that it could potentially be an artefact.  
The presence of spindle cell hyperplasia in female rodents highlights that AR could be 
required to protect against the development of this disease.  Although it has been noted 
that many of adrenocortical lesions are benign and cause no further issue in adrenal 
function, some of these do go on to become malignant (365) and are extremely difficult 
to treat, knowing what causes progression from benign to malignant is essential for 




management of the disease. The spindle cell lesions observed in Ad-ARKO females 
also stain positive for GR. This study was carried out by Clifton-Bligh et al and 
examined the expression of GR in adrenocortical carcinomas. They suggested that 
immunohistochemistry of GR localisation in compliment with the Weiss score could 
help distinguish adrenocortical adenomas from carcinomas, however, the 
transcriptional activity of GR would need to be further investigated in ACCs to 
determine if GR is not only a marker but responsible for disease progression. These 
GR positive spindle cells were also observed in castrated male Ad-ARKOs and aged 
male Ad-ARKO mice, suggesting that a similar mechanism in males and females is 
resulting in this spindle cell hyperplasia. Whether this is through interactions with 
normal homeostasis signalling pathways in the adrenal cortex or a relationship 
between AR and GR needs further investigation. It has been demonstrated that 
glucocorticoid receptor expression is negatively regulated by androgen receptor in 
prostate tumours (203). The fact we see a significant upregulation of GR in the 
castrated animals during this project could point to a potential mechanism of adrenal 
tumour development via an AR/GR relationship.   
Infiltrating mast cells have also been shown to be important during the development 
of spindle cell hyperplasia (299, 314, 366). Studies examining infiltrating mast cells 
in prostate cancer invasion and metastasis describe suppression of AR signals permits 
the influx of mast cells and the development of metastasis (367). This prompted the 
examination of C-kit transcript in Ad-ARKO females, results however show a 
significant decrease in C-kit transcript. Further investigation would be needed to 
explore this relationship in the adrenal. However, this change seen in C-kit transcript 
following AR ablation points to a potential mechanisms driving the tumour 
development in females. The development of spindle cell hyperplasia following 
disruption to AR and circulating androgens, demonstrates androgen signalling is 
essential for normal regulation of the female adrenal cortex and prevention of spindle 
cell development. For these reasons, the original hypothesis was accepted and the 
objectives met.   However, AR signalling is not required for X-zone regression during 
pregnancy, so this part of the hypothesis was rejected.   
 




6.2.1 Future perspectives 
Extended breeding of 2nd generation litters would be needed to ascertain whether or 
not the discrepancy between genotypes is an artefact. Increasing the samples sizes 
could clarify this observation. If results do confirm there are significantly less Cre+ 
females being born, experiments would be needed to investigate the cause. First, 
examination of litters at d0 would be needed to determine if pups are being born but 
not surviving and are dying shortly after birth. Alternatively, if the discrepancy is 
already present in the pups that are born and surviving, an investigation examining 
embryonic development to see if pups are being reabsorbed or dying in utero could 
help dissect this problem.  
Investigation of mast cell marker in adrenal tissue would be important to investigate 
the result of c-kit transcript downregulation. Attempts were made with markers C-KIT 
and CD63, however neither antibodies worked in the adrenal tissue. Given more time, 
it would be important to try these antibodies in adrenals in a different fixative as Bouins 
can be a difficult fixative to get antibodies to work in due to the cross-linkage of 
proteins. Attempts made in the Smith group with antibody staining in cryopreserved 
sections have shown promising results, this could be a potential avenue to examine C-
KIT and CD36.  LH signalling has also been shown to be an important regulator of the 
human adrenal cortex. It has been shown following castration in certain mouse strains, 
that adrenal tumours develop (53). Further studies have shown that surges in LH can 
switch LH receptor (LHR) on in the rodent adrenal cortex to drive tumour formation 
(154). Performing transcript and immunohistochemistry analysis would be needed to 
determine if LHR has potentially became switched on in the adrenal cortex. In addition 
to LHR interrogation, circulating LH analysis would be needed to determine of Ad-
ARKO females have increased circulating LH.  
Despite X-zone regression in Ad-ARKO females following pregnancy, it would be 
interesting to investigate these parous females at later stages post pregnancy. This 
would be to investigate if AR is required for continued suppression of the X-zone post 
pregnancy. Additionally, investigation of serum corticosterone at later time points post 
pregnancy would be needed to determine if corticosterone levels remain elevated in 
these mice. It was observed that the pups from these litters all died at birth. Rodents 
with high postpartum corticosterone have been noted to neglect pups (327), which 




could potentially be the reason for this. However, the Cre also targets the ovary and 
could likely be an impact from ovary AR ablation than adrenal.  
Additionally, examination of female adrenals from the ARE-luciferase mice for the 
purposes previously described would provide insight into androgen activity in the 
female adrenal and if this differs from male adrenals.  
 
6.3 Glucocorticoid receptor and the HPA axis 
HPA-axis. The hypothalamic-pituitary-adrenal (HPA) axis is the body’s key system 
when responding to or dealing with stress (368). Intense or chronic bouts of stress have 
been shown to result in emotional disturbances and hormonal disruption that can 
ultimately culminate in a psychiatric disorder (229). Due to the known relationship 
between GR and stress response, this led to the hypothesis that hindbrain GR is 
essential for normal HPA regulation and adrenal cortex response to stress in males and 
females.  
Key findings from this project revealed that targeting GR in the hindbrain resulted in 
a stressed phenotype in adult mice that could be transferred to littermates. This 
presented as moderate to severe barbering of knockout animals and littermate controls. 
Investigation of individually housed HB-GRKO males and LMC males, showed 
severe barbering in HB-GRKO mice but not in LMCs. This demonstrated the severe 
barbering observed in cages regardless of genotype, was stemming from the GR 
ablated mice. Observations of these same mice under normal conditions prior to 
collection revealed normal exploratory cage behaviour in LMCs, but anxiety and stress 
related behaviour in HB-GRKO males. These behaviours manifested as obsessive 
digging and limited cage exploration. Investigation of adrenal morphology revealed a 
severely disrupted adrenal cortex in male and females across all genotypes. This result 
along with the barbering strengthens the argument that HB-GRKO mice were 
negatively impacting LMCs. Damage to the adrenal cortex in HB-GRKOs and LMCs 
coincided with disruption to cortical markers AKR1B7 and 20 alpha-HSD, along with 
aberrant cell death throughout the cortex. Increased spinal curvature was also observed 
in these animals but were limited to the HB-GRKO mice. These results demonstrate 




that ablation of GR in the hindbrain via Cyp11a1-Cre provides a new model to 
investigate stress and anxiety related behaviours and their impact on the adrenal.  
Due to the changes observed in GR transcription following adrenal AR ablation in Ad-
ARKO mice, the original intention of this part of the project was to examine the role 
of GR in the adrenal cortex and the impact of ablation on adrenal function and 
androgen signalling. However, due to the location of GR in epithelial like cells in the 
adrenal cortex, the Cyp11a1-Cre did not target the GR expressing cell types. However, 
the Cre is active in the hindbrain postnatally (253), and provided a tissue specific 
ablation without off target effects. Due to the wealth of literature regarding GRs impact 
in psychiatric disorders and their involvement in the HPA-axis, this provided an 
opportunity to explore the impact of hindbrain GR signalling on the adrenal cortex in 
a novel model.    
Dysfunctional glucocorticoid signalling has been demonstrated through analysis of 
patients with depression compared to healthy individuals, which exhibit twice the 
average daily levels of cortisol outputs (369). Often psychiatric conditions are 
multifactorial but it is thought to be dysfunctional GR in the brain leading to a failure 
of the HPA-axis feedback mechanism (286). Understanding the mechanism and using 
appropriate models to understand the development of anxiety or depression is 
essential. In an ideal situation, animal models would recapitulate exactly the symptoms 
displayed in patients, but this is rare. Finding models that best suit a particular 
condition is often the outcome. With the development of excessive barbering in HB-
GRKO animals and the lack of cage exploration, behaviours that are characteristic of 
animals in a stressed state (263, 352) suggests that HB-GRKO mice could provide a 
new model for neuropsychiatric research. The impact on littermates, not only in 
barbering but the resulting impact on their HPA-axis denotes a clear behavioural 
abnormality in these mice. Further validation of these models however would be 
required to determine the most appropriate use. There are three criteria are used when 
validating an animal model, 1. Construct validity (370), incorporates a conceptual 
analogy to the cause of the human disease i.e. genetic ablation of a target of interest. 
2. Face validity (371), incorporates a conceptual analogy to the symptoms of the 
human disease i.e. behavioural responses and neurophysiological response and 3. 
Predictive validity (372), incorporates specificity of responses to treatments that are 




effective in the human disease i.e. response to a drug treatment. For this model to 
progress further and be used in neurobiological research, additional work would be 
required in face validity and predictive validity. An interesting point to mention, is that 
the phenotype observed in this study did not arise until at least d90 and progressed 
with age. This could suggest that there is an accumulative effect occurring. The Cre 
does not become active in the hindbrain until after birth, however, the point in which 
the Cre becomes active postnatally in the hindbrain is not known. The timing of its 
expression could help pinpoint the initial development of the phenotype observed and 
could answer why the phenotype in these animals is not observed during early 
development and arises in only in adulthood.  
As previously mentioned, due to the changes in GR observed in Ad-ARKOs, 
investigation of androgen signalling in these mice could provide an interesting insight 
into the relationship between AR and GR in stress. Circulating androgens have been 
shown in a number of studies to reduce anxiety and enhanced cognition (245, 373-
375).  With the X-zone data from chapter 3 and 4 and the presence of foetal cells in 
the adrenal cortex of HB-GRKO mice, this potentially pointed towards disruption to 
AR in the adrenal or a decrease in circulating androgens. Results highlighted no 
significant circulating androgens which was opposite to what was expected, with no 
changes in AR localisation, however, transcript levels of AR were not investigated 
which would help confirm if there was no impact to AR signalling.  
 
6.3.1 Future perspectives  
 
Further work would be required to investigate the adverse behaviours in HB-GRKO 
mice and define exactly the behavioural component of this phenotype. Due to the 
unexpected nature of the phenotype observed in this study. Experiments that examined 
behaviour were not covered under the labs license, however if this was to be 
investigated, numerous neurological tests have been designed for rodents. Examples 
of relevant tests include, reciprocal and social interaction, elevated plus maze, 
light/dark exploration or Porsolt forced swim test (376). These are tests specifically to 
define if a genetic manipulation has resulted in a phenotype relating to anxiety or 
depression.  




Due to the behavioural impact on littermate controls, separation of genotypes at an 
early stage would be needed to avoid influence from knockout animals. Cages that had 
a higher proportion of Cre+ animals per cage showed some of the worst barbering. 
Interrogation of hindbrain GR in littermate controls would be important to see if GR 
was downregulated in these animals, potentially highlighting a feedforward 
mechanism between HB-GRKO and littermates. Investigation of CRF and ACTH 
would be important to establish if they are elevated in HB-GRKO mice and are leading 
to overstimulation of the adrenal leading to cortex damage or if the damage is a result 
of sustained increases circulating corticosterone. Analysis of spinal measurements 
revealed an increase in curvature, this phenotype was limited to the Cre+ mice only 
and was not passed onto littermates. Analysis of bone density in these mice would 
answer if disruption or increased glucocorticoids is impacting bone density leading to 
spinal collapse.  
The initial hypothesis for this project stated that the Cyp11a1-Cre could be used to 
permit investigation of GR function in the adrenal. Preliminary data showed that the 
Cre did not target GR expressing cells in the adrenal so was therefore rejected. 
However, the hindbrain was targeted and permitted the generation of a new hypothesis 
that hindbrain GR was important in HPA regulation. Due to the disturbances in normal 
cage and barbering behaviour and adrenal cortex disruption the hypothesis was 












6.4 Final Conclusions  
The original hypothesis for this thesis is that AR and GR are important for normal 
adrenal cortex function during development, X-zone regulation, cortex maintenance, 
and regulation of the HPA-axis. Through the use of Cyp11a1-Cre, ablation of adrenal 
AR and hindbrain GR, the hypothesis has been proven, describing the following 
observations:  
 AR is required during postnatal development in the male adrenal and is 
required for X-zone regression and maintenance into adulthood, however 
is not required X-zone regression during pregnancy.  
 Androgen receptor is required for the normal maintenance of cortical 
marker AKR1B7 and significant morphological differences in X-zone 
between cohorts demonstrated that androgens are targeting the adrenal 
cortex independently of their receptor.  
 Androgen signalling is required to prevent the development of spindle cell 
hyperplasia 
  GR function in the hindbrain is required to maintain normal HPA axis 
function and normal behaviour 
Additional novel, previously undocumented observations through the course of this 
thesis have been: 
 The presence of AR localisation in embryonic adrenals, showing androgen 
receptor expression early in embryonic adrenal development.  
 The changes in localisation of androgen receptor in the postnatal 
developing adrenal cortex, showing migration through the adrenal cortex.  
 Location of androgen receptor in the human adrenal, showing AR 
localisation in foetal and adult adrenal.  
The Cyp11a1-Cre has enabled adrenal specific interrogation of the roles of AR in 
the adrenal cortex describing new and novel results. This data highlighted 
relationships with well described signalling pathways and the role of AR in 
preventing adrenal disease. The Cyp11a1-Cre, although not the original intention, 




Chapter 7: Appendix  
 
 
Figure 7-1. There are no morphological differences between Cyp11a1+/+ and 
Cyp11a1+/GC mice. (A) There are no observable morphological differences as a result 
of targeting Cre to the Cyp11a1 locus. (B) Immunostaining of androgen receptor and 
3βHSD shows no impact to steroidogenesis or impact to androgen receptor protein 
localisation as a result of targeting Cre to the Cyp11a1 locus. Blue; androgen receptor 
protein, Red; 3βHSD protein, Green; sytox counterstain. Scale bars 100µm. 
Abbreviations; ZG= zona glomerulosa, ZF= zona fasciculata.







Figure 7-2. There are no weight or transcript differences between Cyp11a1+/+ and 
Cyp11a1+/GC mice. (A, B) There are no observable differences in body or adrenal 
weight as a result of targeting Cre to the Cyp11a1 locus.(C) Transcript analysis shows 
a significant downregulation of Cyp11a1 in mice carrying the Cre (one-way ANOVA; 
n=8, *p<0.05, Tukeys post-hoc analysis, error bars SEM). Despite this, there is no 
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